Sleep, 24-hour activity rhythms, and brain structure by Zuurbier, L.A. (Lisette)
Lisette A. Zuurbier
Sleep, 24-hour activity 
rhythms, and brain structure
A population-based study 
Uitnodiging
Voor het bijwonen van 
de openbare verdediging van 
het proefschrift
Sleep, 24-hour activity
rhythms, and brain structure 
A population-based study
door
Lisette A. Zuurbier
Vrijdag 29 april 2016
om 11:30 uur
Senaatzaal
Erasmus Universiteit Rotterdam
A-gebouw 
Burgemeester Oudlaan 50
Rotterdam
Na afloop bent u van harte
welkom op de receptie
Lisette Zuurbier
Evenaar 142
2408 JS Alphen a/d Rijn
lisettezuurbier@hotmail.com
Paranimfen
Annemarie Luik
Olivera Story-Jovanova
S
leep, 24-hour activity rhythm
s, and brain structure
Lisette A
. Zuurbier
Sleep, 24-hour activity rhythms,  
and brain structure: 
A population-based study
 
Lisette A. Zuurbier
The work in this thesis was conducted at the Department of Epidemiology of the Erasmus 
Medical Center, Rotterdam, the Netherlands.
The research described in this thesis was performed within the framework of the Rotterdam 
Study. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University 
Rotterdam; the Netherlands Organization for Scientific Research (NWO), the Netherlands 
organisation for Health Research and Development (ZonMw); the Research Institute for 
Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry 
of Health, Welfare and Sports; the European Commission (DG XII) and the Municipality 
of Rotterdam. This research was supported by a Netherlands Organization for Scientific 
Research grant (017.106.370) awarded to H.Tiemeier.
We thank the staff of the Rotterdam Study and the participating general practitioners and 
pharmacists for their contributions.
Financial support for the publication of this thesis was kindly provided by the Department of 
Epidemiology of the Erasmus MC and Erasmus University Rotterdam.
Cover: Marlous ten Wolde
Layout and printing: Gildeprint – www.gildeprint.nl
ISBN: 978-94-6233-262-1
All rights reserved. No part of this thesis may be reproduced, stored in a retrieval system 
or transmitted in any form or by any means, without permission from the author or, when 
appropriate, from the publishers of the publications.
Sleep, 24-hour activity rhythms,  
and brain structure: 
A population-based study
Slaap, het 24-uurs bewegingsritme en hersenstructuur:  
Een populatiestudie 
Proefschrift
ter verkrijging van de graad van doctor aan de  
Erasmus Universiteit Rotterdam  
op gezag van de  
rector magnificus
Prof. dr. H.A.P. Pols
en volgens besluit van het College voor Promoties.
De openbare verdediging zal plaatsvinden op
vrijdag 29 april 2016 om 11.30 uur
door
Lisette Anna Zuurbier 
geboren te Langedijk
Promotor: Prof.dr. H.W. Tiemeier
Overige leden: Dr. M.A. Ikram
 Prof.dr. E. van Cauter
 Prof.dr. J.G.G. Borst
Copromotor: Dr. M.W. Vernooij
Paranimfen: Annemarie Luik
 Olivera Story-Jovanova
Contents
Chapter 1  General introduction 9
Chapter 2 Sleep, 24-hour activity rhythms and health  
            2.1 Stability and fragmentation of the activity rhythm across the 19 
 sleep-wake cycle: the importance of age, lifestyle and mental 
 health
            2.2 Fragmentation and stability of circadian activity rhythms predict 33
 mortality: The Rotterdam Study
            2.2a Three authors reply: A comment on “The ongoing issue of how 53
 best to measure sleep in epidemiologic studies needs to be
 addressed”
            2.3 Associations of heart failure with sleep quality: The Rotterdam  59
 Study 
Chapter 3 Brain structure and sleep  
            3.1 Cerebral small vessel disease is related to disturbed 24-h activity 77
 rhythms: A population-based study
            3.2 Apnea-hypopnea index, nocturnal arousals, oxygen desaturation 89
 and structural brain changes: A population-based study
            3.3 Brain structure, EEG activity during sleep and sleep quality: 101
 A population-based study of middle-aged and elderly persons
            3.4 Gray matter, white matter and hippocampal volume in 117
 middle-aged and older adults with insomnia: A population-based
 study
Chapter 4 General Discussion 137
Chapter 5 Summary 157 
 Samenvatting 161
Chapter 6 PhD Portfolio 167 
 List of publications 169 
 Dankwoord 171 
 About the author 175
  
  
  
Manuscripts based on the studies described in this thesis
Chapter 2.1
Luik AI, Zuurbier LA, Hofman A, Van Someren EJ, Tiemeier H. Stability and fragmentation of 
the activity rhythm across the sleep-wake cycle: the importance of age, lifestyle, and mental 
health. Chronobiol Int 2013;30:1223-30.
Chapter 2.2
Zuurbier LA, Luik AI, Hofman A, Franco OH, Van Someren EJ, Tiemeier H. Fragmentation and 
stability of circadian activity rhythms predict mortality: the Rotterdam study. Am J Epidemiol 
2015;181:54-63.
Chapter 2.2a
Zuurbier LA, Kocevska D, Tiemeier H. Three Authors Reply. Am J Epidemiol 2015;182:470-1.
Chapter 2.3
Zuurbier LA, Luik AI, Leening MJ, Hofman A, Freak-Poli R, Franco OH, Stricker BH, Tiemeier 
H. Associations of heart failure with sleep quality: The Rotterdam Study. J Clin Sleep Med 
2015;11:117-21.
Chapter 3.1
Zuurbier LA, Ikram MA, Luik AI, Hofman A, Van Someren EJ, Vernooij MW, Tiemeier H. 
Cerebral small vessel disease is related to disturbed 24-h activity rhythms: a population-
based study. Eur J Neurol 2015;22:1482-7.
Chapter 3.2
Zuurbier LA, Vernooij MW, Luik AI, Kocevska D, Hofman A, Whitmore H, Ikram MA, Tiemeier 
H. Apnea-hypopnea index, nocturnal arousals, oxygen desaturation and structural brain 
changes: A population-based study. Submitted.
Chapter 3.3
Zuurbier LA, Luik AI, Tiemeier H, Niessen WJ, Whitmore H, Ikram MA, Vernooij MW. Brain 
structure, EEG activity during sleep and sleep quality: A population-based study of middle-
aged and elderly persons. Submitted.
Chapter 3.4
Zuurbier LA, Vernooij MW, Spiegelhalder K, Hofman A, Niessen WJ, Van Someren EJ, Ikram 
MA, Tiemeier H. Gray matter, white matter and hippocampal volume in middle-aged and 
older adults with insomnia: A population-based study. To be submitted.
Uitnodiging
Voor het bijwonen van 
de openbare verdediging van 
het proefschrift
Sleep, 24-hour activity
rhythms, and brain structure 
A population-based study
door
Lisette A. Zuurbier
Vrijdag 29 april 2016
om 11:30 uur
Senaatzaal
Erasmus Universiteit Rotterdam
A-gebouw 
Burgemeester Oudlaan 50
Rotterdam
Na afloop bent u van harte
welkom op de receptie
Lisette Zuurbier
Evenaar 142
2408 JS Alphen a/d Rijn
lisettezuurbier@hotmail.com
Paranimfen
Annemarie Luik
Olivera Jovanova
Chapter 1
General Introduction
Uitnodiging
Voor het bijwonen van 
de openbare verdediging van 
het proefschrift
Sleep, 24-hour activity
rhythms, and brain structure 
A population-based study
door
Lisette A. Zuurbier
Vrijdag 29 april 2016
om 11:30 uur
Senaatzaal
Erasmus Universiteit Rotterdam
A-gebouw 
Burgemeester Oudlaan 50
Rotterdam
Na afloop bent u van harte
welkom op de receptie
Lisette Zuurbier
Evenaar 142
2408 JS Alphen a/d Rijn
lisettezuurbier@hotmail.com
Paranimfen
Annemarie Luik
Olivera Jovanova
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 1
10
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
General Introduction
11
1
A good night of sleep is very important for a healthy life. Many people probably only realize 
this after a night of poor sleep, feeling physically, cognitively and emotionally busted. 
However, sleep problems are very common, especially in the older population.
In elderly persons, about 80% have sleep complaints.1 For example, elderly persons report 
trouble falling asleep, waking up too early, a low sleep quality, napping during the day, and 
obtaining not enough sleep during the night.2,3 These sleep problems can partly arise due 
to reduced physical activity during the day, less exposure to light, and more physical and 
mental problems, such as cardiovascular disease, diabetes and depression. Many, if not 
most, chronic physical and mental health problems are established risk factors for sleep 
problems.3,4 Furthermore, two specific sleep disorders are common in older age; insomnia 
and sleep apnea. Over 10% of the adult population suffers from clinically relevant insomnia. 
Insomnia is a sleep disorder characterized by problems of falling or staying asleep. Daytime 
impairment, typically due to fatigue during the day, is another core characteristic.5 Sleep 
apnea is characterized by repetitive respiratory events (apneas and hypopneas) during 
sleep, leading to sleep fragmentation, nocturnal intermittent oxygen desaturation, arousals 
and also to daytime fatigue. Over 10% of the adult population (30 – 70 years old) have 
an apnea-hypopnea index (AHI) ≥15, indicating sleep apnea, but the prevalence increases 
to about 20% in adults aged 60-70 years old.6 Insomnia and sleep apnea have both been 
prospectively related to physical and mental health such as cardiovascular disease, cognitive 
decline and mortality.7-11 The resulting fatigue can impact social and occupational life.
The sleep changes with ageing are paralleled by structural brain changes that are also more 
prevalent in elderly populations. Typical changes observed in elderly populations are loss 
of brain tissue (i.e. cerebral atrophy), cerebral vascular lesions, and reduced connectivity 
between brain areas.12 A good night of sleep is important for a healthy and functioning brain. 
There are several mechanisms through which poor sleep may negatively affect the brain. First, 
during sleep potentially neurotoxic waste products are removed from the brain interstitial 
space.13 Chronic dysregulation of this process could lead to brain structural changes. Second, 
sleep deprivation has been related to impairment of the neuroendocrine system, including 
emotional and cognitive problems. Functional impairment in the neuroendocrine system 
may precede long-term structural and functional changes in the brain. For example, sleep 
deprivation is related to an impaired ability to form new memories, to an inappropriate 
emotional response to negative aversive stimuli, and to decreased reaction speed and 
concentration.14-16 This is evident, for example, from the many car accidents occurring 
because of sleepiness. Third, sleep apnea causes disturbances in the sleep-wake pattern, 
such as fragmentation during sleep, and has been related to incident neurological diseases 
such as stroke.17 
Thus sleep is important for the brain, but the reverse relation is equally important; a healthy 
mind is important for a good sleep. In diseases that affect the brain, like Alzheimer’s disease, 
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sleep problems are highly prevalent.18 Furthermore, the brain works as an internal clock, 
regulating the 24-hour rhythm of the sleep-wake cycle. An important regulator of this 24-
hour or circadian rhythm is the suprachiasmatic nucleus, a structure in the hypothalamus of 
the brain. This structure is also called the biological clock of the brain. It integrates internal 
and external signals (e.g. light), to create stable circadian rhythms.19
Many brain changes in the elderly occur unnoticed. However, even small brain changes can 
affect health and behavior. To date, there is only scarce knowledge whether brain changes 
typically observed in an ageing population relate to altered sleep patterns. This is important 
to understand, in view of the high prevalence of sleep problems at old age and the potential 
important clinical consequences.
The aim of this thesis was to investigate the associations between sleep, 24-hour activity 
rhythms and health parameters in a middle-aged and elderly population, particularly focusing 
on the relation between sleep and age-related structural brain changes. The analyses 
performed in this thesis were based on data from the Rotterdam Study, a large population-
based cohort among adults aged 45 and over living in Rotterdam, the Netherlands, in which 
both sleep parameters and neuro-imaging data are acquired.20 
In the Rotterdam Study, sleep is measured with three different methods. First, sleep is 
measured subjectively with questionnaires. This is important for the assessment of how 
a person experiences sleep. However, personality or emotional states impact self-report, 
and even in healthy persons answers on sleep habits and times do not reflect their true 
sleep patterns well. Therefore, we also measured sleep objectively, by polysomnography 
(PSG) and actigraphy. PSG is the gold standard in sleep research. During PSG brain 
activity (electroencephalography), eye movements (electrooculography), muscle tone 
(electromyography), heart function (electrocardiography), breathing and oxygen 
desaturation are measured. The Rotterdam Study is one of the few cohort studies acquiring 
PSG. However, PSG cannot be used to study day-night rhythms. Therefore, actigraphy was 
used to measure sleep and the 24-hour activity rhythm on a seven-day basis. Activity rhythms 
were quantified by calculating the interday stability and the intraday variability. Interday 
stability is a measure of how stable the rhythm is over multiple days, that is, how similar the 
individual day-night patterns are over time. Intraday variability reflects the fragmentation of 
the rhythm, that is, the rate of shifting between rest and activity. 
Furthermore, brain imaging is included in the core protocol of the Rotterdam Study, enabling 
us to study a spectrum of age-related structural brain changes in relation to sleep.
In this thesis, Chapter 2 focuses on sleep, 24-hour activity rhythms and health. Chapter 2.1 
describes the influence of demographics, lifestyle and sleep on 24-hour activity rhythms. In 
Chapter 2.2 sleep and 24-hour activity rhythms are used to predict mortality. This chapter is 
extended with Chapter 2.2a in which the addition of information on circadian misalignment 
(the difference between the timing of sleep on workdays and weekend days) was discussed. 
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In Chapter 2.3 I present a study on the differential effects of clinical heart failure and 
echocardiographic indicators of cardiac dysfunction on sleep quality. 
Chapter 3 focusses on sleep, 24-hour activity rhythms and structural brain parameters. In 
Chapter 3.1 I present our research on the relation of cerebral small vessel disease with 
disturbed 24-hour activity rhythms. In Chapter 3.2 I investigated different aspects of sleep 
apnea in relation with brain structure. Chapter 3.3 describes the associations between brain 
structure and sleep parameters, measured both subjectively and objectively with PSG. In 
Chapter 3.4 differences in brain morphology between insomnia cases and good sleepers 
were explored.
Finally, in Chapter 4 I discuss the main findings of this thesis, together with methodological 
considerations, clinical implications and suggestions for future research.
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Chapter 2.1
Stability and fragmentation of the activity rhythm 
across the sleep-wake cycle: the importance of age, 
lifestyle and mental health
Annemarie I. Luik, Lisette A. Zuurbier, Albert Hofman, Eus J.W. van Someren, 
and Henning Tiemeier
Chronobiology International, 2013;30:1223-1230
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Abstract 
The rhythms of activity across the 24-hour sleep-wake cycle, determined in part by the 
circadian clock, change with aging. Few large-scale studies measured the activity rhythm 
objectively in the general population. The present population-based study in middle-aged 
and elderly persons evaluated how activity rhythms change with age, and additionally 
investigated socio-demographics, mental health, lifestyle and sleep characteristics as 
determinants of rhythms of activity. Activity rhythms were measured objectively with 
actigraphy. Recordings of at least 96 hours (138 ± 14 hours, mean ± SD) were collected 
from 1734 people (age 62 ± 9.4 years) participating in the Rotterdam Study. Activity 
rhythms were quantified by calculating interdaily stability, i.e. the stability of the rhythm 
over days, and intradaily variability, i.e. the fragmentation of the rhythm relative to its 24-
hour amplitude. We assessed age, gender, presence of a partner, employment, cognitive 
functioning, depressive symptoms, Body Mass Index, coffee use, alcohol use and smoking as 
determinants. The results indicate that older age is associated with a more stable 24-activity 
profile (β=.07, p=.02), but also with more fragmentation of activity and inactivity (β=.20, 
p<.001). Having more depressive symptoms was related to less stable (β=−.07, p=.003) 
and more fragmented rhythms (β=.10, p<.001). A high Body Mass Index and smoking were 
also associated with less stable rhythms (BMI: β=−.11, p<.001, smoking: β=−.12, p<.001) 
and more fragmented rhythms (BMI: β=.09, p<.001, smoking: β=.11, p<.001). We conclude 
that with older age the 24-hour activity rhythm becomes more rigid, while the ability to 
maintain either an active or inactive state for a longer period of time is compromised. Both 
characteristics appear important for major health issues in old age.
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2.1
Introduction
Circadian rhythm changes are commonly observed in middle-aged and elderly persons and 
have been attributed to functional changes in the suprachiasmatic nucleus, the biological 
clock of the brain.1 Observed age-related changes typically include alterations in the 24-
hour cycle of sleep and wakefulness. Previous studies have demonstrated several changes 
with increasing age: more frequent and longer napping,2 a higher fragmentation of the rest 
and activity pattern,3 a tendency to fall asleep earlier,4 and a tendency to wake up earlier.5 
While large population-based studies have objectively assessed nocturnal sleep, objective 
assessment of the circadian organization of the sleep-wake cycle in the elderly is scarce. 
The studies available have mostly focused on rhythm alterations in relation to disease,6,7 
determinants of circadian alterations and variations in the sleep-wake cycle in the general 
population have remained largely unclear.
Changes in sleep and their determinants have been studied extensively. For example, 
lifestyle and dietary habits are known to affect sleep. In particular, alcohol consumption 
initially improves sleep, but more awakenings and lighter sleep are seen during the latter 
part of the night.8 Smokers report greater difficulty initiating and maintaining sleep and 
a lower seep quality. Research on objective sleep data confirms these results in a clinical 
study.9 In a cross-sectional, population-based study, regular daily caffeine intake was also, 
albeit less clearly associated with disturbed sleep and daytime sleepiness.10 However, it is 
not known how these habits are related to the circadian organization of the sleep-wake 
cycle in middle-aged and elderly persons in the general population.
Mental health is intimately related to sleep and circadian rhythms. Depressive symptoms 
have been related repeatedly to sleep, the available literature suggests depressive symptoms 
to be associated with disturbed circadian rhythms as well.11 Disturbances in the sleep-wake 
rhythm are also more common in persons with poor cognitive functioning. The sleep-wake 
rhythm has been found to relate to cognitive functioning, even independent of age12 and as 
well in demented elderly people.13
In this study, we examined the circadian organization of the sleep-wake cycle in a large 
population-based study of middle-aged and elderly persons with actigraphy. Activity 
rhythms can be considered as an indicator of the circadian organization of the sleep-wake 
cycle14,15 and allows assessment of the rhythm over longer periods of time. Participants in 
the present study were asked to wear the actigraph for one week. We assessed whether 
age, lifestyle factors and mental health indicators were related to objectively assessed 
activity rhythms, independent of self-reported sleep. In addition, we studied whether self-
reported sleep characteristics and sleep quality were associated with the activity rhythm 
across the sleep-wake cycle.
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Materials and methods
Study population
The current study was embedded in the Rotterdam Study, a population-based cohort 
of older persons which started in 1990 in the district of Ommoord, Rotterdam, The 
Netherlands. The Rotterdam Study targets cardiovascular, endocrine, hepatic, neurological, 
ophthalmic, psychiatric, dermatological, oncological, and respiratory diseases.  In 2000, the 
study population was extended with a second cohort by inviting inhabitants of the same 
district aged 55 and over. In 2006, a new cohort with inhabitants aged 45 and over was 
added. No health-related exclusion criteria were used. A more detailed description of the 
study can be found elsewhere.16 The Medical Ethics Committee of the Erasmus University 
Rotterdam approved the Rotterdam Study and written informed consent was obtained from 
all participants. All procedures were conform international standards.17
From December 2004 until April 2007, in total 2634 consecutive participants were invited 
to enter the actigraphy study; of these 2084 (79%) agreed. The actigraphy study comprised 
participants of the second cohort (second examination, December 2004 - December 2005), 
and the new cohort (baseline, January 2006 - April 2007). No exclusion criteria were used, 
although participants had to be able to understand the instructions for participation. Due 
to technical problems and the requirement that the recording must be a minimum of 4 
consecutive days and nights, the recordings of 1734 participants (83%)  were available for 
further analyses.
Assessment of the activity rhythm
All participants were asked to wear an actigraph around the wrist (Actiwatch model AW4, 
Cambridge Technology Ltd, Cambridge, United Kingdom) continuously for 7 consecutive days 
and nights. The actigraph had to be removed from the wrist while bathing only. Actigraphs 
were measured in 30-second epochs. 24-hour periods with more than 3 continuous hours 
missing were excluded to prevent a time-of-day effect. Recordings of less than 4 complete 
days and nights were also excluded from the analyses. 
Activity rhythms were quantified using non-parametric indicators.18 This allows us to describe 
the rhythm without making untenable assumptions about the shape of the rhythm. We 
calculated three variables, the interdaily stability, the intradaily variability and amplitude of 
the rhythm. The interdaily stability (IS) indicates the stability of the rhythm, i.e. the extent to 
which the profiles of individual days resemble each other. Intradaily variability (IV) quantifies 
how fragmented the rhythm is relative to its 24-hour amplitude; more frequent alterations 
between an active and an inactive state lead to a higher intradaily variability. The amplitude 
is calculated as the normalized difference between the most active 10 hours and the least 
active 5 hours. We do not report data using the amplitude as it correlated highly with 
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interdaily stability (r=.68 p<.01) and intradaily variability (r=−.69 p<.01) and it is less specific 
than interdaily stability and intradaily variability. Data are available upon request. Interdaily 
stability and intradaily variability were moderately and inversely correlated (r=−.49, p<.01).
Assessment of sleep parameters
Sleep parameters were assessed subjectively with a sleep diary and objectively by 
actigraphy on the same days. The sleep diary included questions about sleep characteristics, 
sleep medication, sleep quality and dietary habits for each day. To evaluate use of sleep 
medication, participants filled out whether they had used sleep medication and which 
medication they used. Sleep onset latency was assessed by asking participants how long 
it took them to fall asleep. For total sleep time participants estimated how long they slept 
during the night. Participants also filled out if they had been awake during the night, 
and if so, how often. Daily values were generally averaged over the week; only napping 
indicates how many days per week participants had taken a nap during the day. We also 
used actigraphy to estimate total sleep time, sleep onset latency and wake after sleep onset 
objectively. The procedure to calculate total sleep time and sleep onset latency has been 
described in more detail elsewhere.19 Wake after sleep onset is calculated as the total time 
of the epochs scored as wake between sleep start and sleep end, all defined according to the 
Actiwatch manual.20 A threshold of 20 was used to distinguish sleep from waking.21 Possible 
sleep apnea was assessed with two questions from the Pittsburgh Sleep Quality Index.22 We 
considered apnea possible when participants reported (1) loud snoring at least two nights 
per week and at least occasional respiratory pauses or (2) respiratory pauses during sleep 
with a frequency of at least 1–2 nights weekly.23
Assessment of sleep quality
Sleep quality was assessed with the sleep diary. Participants answered the dichotomous 
questions, “Did you sleep well this night?”, “Do you feel well rested after getting out of 
bed?” and “Do you have the feeling that the amount of sleep was too little?”. Perceived sleep 
quality indicates the average of these three questions (range 0-7). Perceived impairment 
indicates how many days of the week participants felt so tired that it impaired activities 
during the day.
Assessment of demographics, mental health and lifestyle
Partnership, employment status, cognitive functioning, depressive symptoms and 
Body Mass Index (BMI) were routinely collected in the Rotterdam Study. During a home 
interview all participants were asked about partnership and employment status. Cognitive 
functioning was measured using the Mini Mental State Exam (MMSE)24 during one the visits 
to our center. Depressive mood was assessed using the Center for Epidemiologic Studies 
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Depression (CES-D) scale25 as part of a home interview.  Height and weight were measured 
without shoes and heavy clothing during a center visit to calculate the Body Mass Index (kg/
m2). Coffee use was defined as the number of days coffee was consumed after 18:00 h per 
week. Alcohol use indicated how many units of alcohol were used after 18:00 h summed up 
over the week. Current smoking assessed whether the participant smoked cigarettes, cigars 
or pipe at the time of the interview.
Assessment of confounders
Education and general health were studied to control for confounding. Education was 
assessed routinely in the home interview and subdivided in low, intermediate and high 
education. As an indicator of general health we assessed the ability to perform activities 
of daily living (ADL) with the Stanford Health Assessment Questionnaire26, questions were 
answered in a 0 to 3 range.
Analyses
All parameters were assessed quantitatively, except the use of sleep medication, possible 
apnea, employment and education. Sleep medication was dichotomized as no use of sleep 
medication versus any use of sleep medication during the week of actigraphy. As the number 
of missing values per parameter never exceeded 5%, missing values in quantitative predictors 
were replaced by the median. For qualitative predictors a separate missing category 
was used. Interdaily stability, intradaily variability and the actigraphically assessed sleep 
parameters were winsorized at 4 standard deviations from the mean. To obtain normally 
distributed values, interdaily stability, intradaily variability, actigraphic sleep onset latency 
and actigraphic wake after sleep onset were transformed using a Box-Cox transformation27,28 
Continuous dependent variables were standardized to facilitate comparison. 
Correlations between the activity rhythm, sleep parameters and sleep quality parameters 
were computed using a Pearson Correlation coefficient. A point-biserial correlation was 
computed to assess the correlation between quantitative and binomial data.
We assessed the relation of the demographic, mental health and lifestyle with interdaily 
stability and intradaily variability using multivariate linear regression analyses. Analyses 
included all demographic, mental health and lifestyle parameters and were thus mutually 
adjusted. The relation between sleep characteristics and interdaily stability and intradaily 
variability were assessed in a separate model adjusted for demographic, mental health 
and lifestyle parameters. In addition, we controlled for education and ADL in all models. 
Analyses were performed using SPSS Statistics (version 20).
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Results
The population characteristics are described in Table 1. Of the total sample of 1734 
participants, 53% was female and the mean age was 62.3 years ± 9.4 years. Participants 
were generally in good health as indicated by the low average ADL-score (0.29 ± 0.42) and 
medical records; 2.6% of participants had a cardiovascular accident, 2.0% had a myocardial 
infarction and 12.9% was diabetic. 11.8% reported having cancer at least once in their lives. 
The mean interdaily variability was .80 ± .10, the mean intradaily variability was .42 ± .14. 
Interdaily stability and intradaily variability were moderately negatively correlated (r=−.49, 
p<.01). This negative correlation is also reflected in the mostly inverse association patterns 
of several demographic, mental health, lifestyle and sleep parameters with intradaily 
variability and interdaily stability. 
Table 2 shows the association of demographics, mental health and lifestyle with the 
stability and fragmentation of the activity rhythm. All analyses were fully adjusted, thus 
the different possible determinants were mutually corrected for the other risk factors. 
Older age was associated with a high interdaily stability (β=.07, p=.020), i.e. more stable 
rhythms. Male gender (β=.11, p<.001) and being employed (β=−.11, p=.001) were related to 
a low interdaily stability. Persons with better cognitive functioning (β=.08, p=.001) and less 
depressive symptoms (β=−.07, p=.003) were more likely to have a high interdaily stability. A 
high Body Mass Index (β=−.11, p<.001) and smoking (β=−.12, p<.001) were associated with 
less interdaily stability. Individuals who had a high coffee intake (β=.09, p<.001) had a more 
stable rhythm, reflected in a high interdaily stability. Additional adjustment for possible 
apnea did not change the results for Body Mass Index and the stability (β=−.10, p<.001) of 
the activity rhythm.
Next, we studied the associations of demographics, lifestyle and mental health indicators 
with the intradaily variability, i.e. the fragmentation of the rhythm (see also table 2). Older 
age (β=.20, p<.001) was associated with more intradaily variability, thus a high interdaily 
stability was accompanied by high intradaily variability for older age. In contrast, female 
gender (β=−.13, p<.001) and being employed (β=−.07, p=.010) were associated with a low 
intradaily variability. Persons with depressive symptoms (β=.10, p<.001) were more likely to 
have a high intradaily variability. A high Body Mass Index (β=.09 p<.001) and smoking (β=.11 
p=.001) were also related to a high intradaily variability. Additional adjustment for possible 
apnea did not change the effects of Body Mass Index on intradaily variability (β=.08, p<.001). 
In summary, findings for intradaily variability corresponded to those observed for the 
interdaily stability (i.e. reversed direction of association), except for age and employment.
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Table 1 Population characteristics*, N=1734
Demographic
Female, % 53.4
Age (years) 62.25 ± 9.35
Partner, % 77.3
Employment, % 33.1
Education, %
  Low
  Intermediate
  High
15.2
63.3
19.7
ADL (score) 0.29 ± 0.42
Health indicators
Cognitive functioning (score) 27.98 ± 1.75
Depressive symptoms (score) 5.49 ± 7.13
Stroke, % 2.6
Myocardial infarction, % 2.0
Cancer, % 11.8
Diabetes Mellitus, % 12.9
Lifestyle
BMI (score) 27.86 ± 4.16
Coffee (days per week) 4.36 ± 2.91
Alcohol (units per week) 9.47 ± 9.34
Current smoking, % 20.6
Subjectively assessed sleep†
Sleep medication, % 14.5
Possible apnea, % 29.7
Sleep onset latency (minutes) 17.72 ± 11.74
Total sleep time (hours) 6.85 ± .95
Awakenings after sleep onset† (number) 1.51± 1.10
Napping (days per week) 1.66 ± 2.05
Objectively assessed sleep‡
Sleep onset latency (minutes) 14.56 ± 12.39
Total sleep time (hours) 6.38 ± 0.87
Wake after sleep onset (minutes) 69.46 ± 25.88
Sleep quality†
Perceived sleep quality (average per week) 5.54 ± 1.61
Perceived impairment (days per week) .75 ± 1.44
Activity rhythm‡
Interdaily stability (score) .80 ± .10
Intradaily variability (score) .42 ± .13
*Mean ± SD, unless stated otherwise
†Assessed on daily basis within one week of actigraphy through self-report 
‡Assessed by one week of actigraphy
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Table 2 Associations of demographics, mental health and lifestyle with interdaily stability and intradaily variability*
Interdaily Stability Intradaily Variability
B SE of B β p-value B SE of B β p-value
Demographic
Age .01 .00 .07 .019 .02 .00 .20 <.001
Sex (ref=men) .21 .05 .11 <.001 −.27 .05 −.14 <.001
Partner (ref=no) .19 .06 .08 .002 −.13 .06 −.06 .024
Employment (ref=no) −.23 .06 -.11 <.001 −.15 .06 −.07 .011
Mental Health
Cognitive functioning .05 .01 .08 .001 −.02 .01 −.04 .08
Depressive symptoms −.01 .00 −.07 .005 .01 .00 .10 <.001
Lifestyle
BMI −.03 .01 −.11 <.001 .02 .01 .09 <.001
Coffee (days/week) .03 .01 .09 <.001 −.02 .01 −.04 .07
Alcohol (units/week) −.01 .00 −.05 .06 −.00 .00 −.03 .25
Current smoking (ref=no) −.27 .06 −.11 <.001 .26 .06 .11 <.001
*Multivariate linear regression analyses mutually adjusted for sex, age, partner, employment, education, ADL, 
cognitive functioning, depressive symptoms, BMI, coffee use, alcohol use and current smoking.
Several indicators of poor sleep were consistently associated with less interdaily stability 
and more intradaily variability (see table 3). More daytime napping (β=−.25 p<.001), use of 
sleep medication (β=−.09, p<.001), and less subjective total sleep time (β=.07, p=.003) were 
all associated with less interdaily stability in the analyses fully adjusted for demographic, 
mental health and lifestyle parameters. Sleep parameters assessed by actigraphy had 
stronger associations with the stability of the rhythm; less objective total sleep time (β=−.15 
p<.001), longer objective sleep onset latency (β=.25 p<.001) and more objective wake after 
sleep onset (β=−.15 p<.001) were all related to less stable rhythms. Persons who perceived 
their sleep as good (β=.08, p<.001) and who experienced less impairment due to tiredness 
(β=−.11, p<.001) had a high interdaily stability. In line with these results, associations of 
the determinants with intradaily variability mostly showed a reverse pattern (see table 
3). Possible apnea was neither related to interdaily stability (β=−.02 p=.37) or intradaily 
variability (β=.03, p=.21) after full adjustment including BMI.
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Table 3 Associations of sleep characteristics and sleep quality with interdaily stability and intradaily variability*
Interdaily Stability Intradaily Variability
B SE of B β p-value B SE of B β p-value
Sleep disorders
Sleep medication (ref=no) −.26 .07 −.09 <.001 .16 .07 .06 .014
Possible apnea (ref=no) −.04 .06 −.02 .51 .07 .05 .03 .21
Subjectively assessed sleep
Sleep onset latency .00 .00 .01 .34 .00 .00 .00 .96
Total sleep time .07 .03 .07 .003 −.11 .02 −.10 <.001
Awakenings after sleep onset .02 .02 .02 .34 .05 .02 .05 .024
Napping −.12 .01 −.25 <.001 .19 .01 .39 <.001
Objectively assessed sleep
Sleep onset latency −.22 .04 −.15 <.001 .12 .04 .08 .003
Total sleep time .29 .03 .25 <.001 −.33 .03 −.28 <.001
Wake after sleep onset −.06 .01 −.15 <.001 .08 .01 .18 <.001
Sleep quality
Perceived sleep quality .05 .02 .08 .001 −.04 .02 −.07 .006
Perceived impairment −.08 .02 −.11 <.001 .07 .02 .10 <.001
*Multivariate linear regression analyses adjusted for sex, age, partner, employment, education, ADL, cognitive 
functioning, depressive symptoms, BMI, coffee use, alcohol use and current smoking.
Discussion
In a large population-based sample of middle aged and elderly persons, we assessed activity 
rhythms across the sleep-wake cycle. Older age was related to a more stable, but also to a 
more fragmented activity rhythm. Several demographic and lifestyle factors were associated 
with less stability and more fragmentation of the rhythm. The relation of a high Body Mass 
Index and smoking with less stable and more fragmented rhythms was most pronounced. 
In addition, sleep estimates derived from actigraphy had a consistent association with the 
stability and fragmentation of the rhythm. 
Older age was associated with more stable rhythms, yet with more fragmented rhythms 
in middle aged and elderly persons, independent of several demographic, mental health 
and lifestyle factors. More fragmented rhythms in older participants are possibly explained 
by morbidity. For example, disrupted circadian organization of activity rhythms have 
been related to cerebral changes,29 cardiovascular disease6 and mortality.30 Possibly the 
fragmentation of the rhythm is an nonspecific health indicator and reflects the presence 
of different clinical and subclinical diseases.  In contrast, the positive association between 
older age and more stable rhythms can better be explained by health-related behavior – 
as non-optimal health itself should not stabilize the circadian rhythm. Non-optimal health 
might underlie a stable rhythm in old age as disease necessitates certain routines. Moreover, 
adjustment for indicators of disease did not attenuate the association of age with the 
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stability of the activity rhythm. Secondly, the observed changes in circadian rhythms with 
age could be due to changes in behavior. For example, older age is most likely accompanied 
by lower activity levels. Lower levels of activity can lead to more fragmentation due to 
more awakenings during the night and naps during the day. In addition, the elderly are 
more stringent in their daily structure, as they adhere to more stable routines than younger 
persons, who tend to be more flexible with bedtimes. Lastly, more fragmented rhythms with 
older age could be due to biological aging. The aging process is known to be accompanied 
by biological changes which can disturb the circadian rhythm. The suprachiasmatic nucleus, 
which represents the biological clock of the brain, shows functional changes with age1 
which have been related to more fragmented rhythms in a postmortem study on demented 
elderly people.31 Importantly, the relation between aging and the circadian organization of 
the sleep-wake cycle is assumed to be bidirectional. Factors associated with the sleep-wake 
cycle can lead to more disturbed circadian rhythms, but a disturbed circadian rhythm can 
also increase changes in mental health and lifestyle. 
Our study also suggests that lifestyle is important for rhythm disturbances. A high Body 
Mass Index was associated with a less stable and a more fragmented activity rhythm, which 
indicates a disturbed circadian organization of the sleep-wake cycle. As a cross-sectional 
design does not allow assessment of the direction of the effect, we can only infer carefully 
that Body Mass Index influences the activity rhythm. This association might be due to breath-
related diseases such as apnea, which is known to be more prevalent in persons with a high 
Body Mass Index and can disturb sleep severely. In our study, possible apnea did not explain 
the association between Body Mass Index and the activity rhythm. Smokers were less likely 
to have more stable and less fragmented rhythms. Since smoking in elderly persons is mostly 
a longstanding addictive behavior, it is more likely to be a cause of poor sleep than to be 
induced by poor sleep in middle and old age. Pressure to smoke accumulates during sleep 
as the hours of not smoking lead to withdrawal effects which can disturb the sleep-wake 
cycle. Smoking might be an amenable determinant of rhythm disturbances if this behavior 
can be lastingly changed. Coffee use after 18:00h was related to less fragmentation of the 
rhythm. Earlier population-based studies found the opposite; high daily caffeine intake was 
related to poor sleep.10 This could be due to the different assessed times of intake, but can 
also reflect behavioral adaptations. Participants with a poor circadian rhythm probably have 
reduced their caffeine intake, since caffeine is widely known as a wake promoting agent 
and not as addictive as smoking. Only persons resilient to the effects of coffee on sleep may 
uphold the habit to drink coffee in the evening.
Cognitive status was associated with the stability of the activity rhythm, but not with 
the fragmentation. Stable activity rhythms and good global cognitive functioning may be 
indicators of a healthy brain. A previous study found that cognitive functioning was not 
related to the stability of the rhythm, while it was related to the fragmentation of the sleep-
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wake cycle.12 However, this study focused specifically on executive functioning, while in 
our study we assessed a global indicator of cognition. Depressive symptoms were related 
with both the stability and the fragmentation of the rhythm, which is as expected since 
disturbed sleep is one of the DSM-IV criteria for depression. In addition, in several studies 
depression has been linked to disturbed circadian rhythms11,13 and even more extensively to 
sleep characteristics.32
Sleep characteristics were consistently related to circadian rhythm in our study. Of the 
subjectively assessed sleep-related behaviors, napping had a particularly strong association 
with stability and fragmentation. Napping is inherently related to intradaily variability, but 
not necessarily to the stability of the rhythm. Shorter sleep onset latency, more total sleep 
time and less wake after sleep onset were, when assessed with actigraphy,  associated with 
more stable and less fragmented rhythms. This confirms the strong relation between sleep 
and the circadian organization of the activity rhythm. 
The current study was embedded in an existing population-based study; this allowed us to 
asses a large number of variables and makes our results generalizable. Lastly, we used non-
parametric measures of the activity rhythm, instead of more commonly used parametric 
indicators. The main advantage of a non-parametric indicator is that it does not make 
assumptions about the nature of the rhythm, which is problematic in elderly populations 
with less pronounced circadian rhythms. However there are some limitations that should be 
considered. Collection of sleep-related data was limited on sleep disorders, such as apnea 
or restless legs, which could have been possible confounders in our study. In addition, our 
study was cross-sectional, therefore we can only carefully infer temporal effects. Lastly, 
effects sizes were, although significant, sometimes small in this large population-based 
study. However, effect sizes in population-based samples tend to be smaller than in case-
control or clinical studies which compare more extreme groups.
We conclude that with older age the circadian organization of the sleep-wake cycle is more 
fragmented, but also more stable. The fragmentation of the rhythm is more related to 
health and biological processes, whereas the stability of the rhythm seems to be driven 
by behavior. In addition, mental health and lifestyle factors, in particular smoking and a 
high Body Mass Index, are important for the circadian rhythm. Known risk factors for 
common disease in middle aged and elderly persons were associated with disturbances 
in the circadian organization of the sleep-wake cycle. This strengthens the hypothesis that 
disturbances in circadian rhythms, more specifically disturbances in the activity rhythm, can 
be seen as sensitive markers of the effects of general aging.33 Future studies must show if 
changing our lifestyle is a way to reduce circadian disturbances across the sleep-wake cycle; 
this needs to be assessed longitudinally. 
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Abstract
Circadian rhythms and sleep patterns change as people age. Little is known about the 
associations between circadian rhythms and mortality rates. We investigated whether 
24-hour activity rhythms and sleep characteristics independently predicted mortality. 
Actigraphy was used to determine the stability and fragmentation of the 24-hour activity 
rhythm in 1,734 persons (aged 45–98 years) from the Rotterdam Study (2004–2013). Sleep 
was assessed objectively using actigraphy and subjectively using sleep diaries to estimate 
sleep duration, sleep onset latency, and waking after sleep onset. The mean follow-up time 
was 7.3 years; 154 participants (8.9%) died. Sleep measures were not related to mortality 
after adjustment for health parameters. In contrast, a more stable 24-hour activity rhythm 
was associated with a lower mortality risk (per 1 standard deviation, hazard ratio = 0.83, 
95% confidence interval: 0.71, 0.96), and a more fragmented rhythm was associated with a 
higher mortality risk (per 1 standard deviation, hazard ratio = 1.22, 95% confidence interval: 
1.04, 1.44). Low stability and high fragmentation of the 24-hour activity rhythm predicted 
all-cause mortality, whereas estimates from actigraphy and sleep diaries did not. Disturbed 
circadian activity rhythms reflect age-related alterations in the biological clock and could be 
an indicator of disease.
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Introduction
Most physiological processes, including body temperature, hormone secretion, and sleep-
wake timing, are regulated in cycles that last approximately 24 hours, called circadian 
rhythms. Circadian rhythms and sleep patterns change as people age.1 Elderly people sleep 
less during the night, have more fragmented sleep, have more difficulty in falling asleep, tend 
to fall asleep and wake up earlier, take more naps, and report a lower sleep quality.2-6 The 
longitudinal associations of these changes with adverse health consequences and mortality 
are not well understood. In previous studies, investigators found that people who slept for 
short durations each night (≤6 hours) and had poor sleep quality had higher risks of diabetes 
and cardiovascular diseases.7,8 Studies in which the association between sleep and mortality 
have been investigated were mainly focused on sleep duration. The results suggested that 
the association between sleep duration and mortality is U-shaped; both subjective short 
and long sleep durations are predictors of all-cause mortality.9,10
Few studies have investigated the associations of circadian rhythms with mortality. In the 
elderly, the amplitude of several physiological circadian rhythms is reduced compared with 
that of younger people, as is the stability of the day-night rhythm.1,4,11 This could be explained 
by an age-related decline in circadian organization. The aging process affects central and 
peripheral oscillators differently, possibly leading to suboptimal peripheral physiological 
functioning.12 The circadian rhythm of physical activity in elderly is better characterized by 
2 nonparametric variables that do not assume the 24-hour cosine-like shape that is present 
in, for example, core body temperature and hormones. Two nonparametric variables 
quantify stability and fragmentation. A stable activity rhythm is characterized by a 24-hour 
profile that remains very similar from day to day. This gives an indication of the strength of 
synchronization between the activity rhythm and zeitgebers, which are environmental cues 
with a 24-hour pattern. Fragmentation gives an indication of the frequency of alterations 
between rest and activity relative to its 24-hour amplitude.
In 2 previous studies in which 24-hour activity rhythms were analyzed parametrically, 
investigators found that older men and women with the least robust 24-hour activity rhythms 
had a 1.5–2-times higher risk of all-cause mortality.13,14 In addition, abnormal sleep-wake 
cycles were associated with a 3-times higher mortality rate in elderly persons older than 85 
years of age.15 These studies assessed 24-hour activity rhythms in very old persons and had 
relatively short follow-up periods (average follow-up of 4.1, 3.5, and 2 years, respectively). 
In these activity rhythm and mortality studies, a few subjective sleep parameters were taken 
into account. One study considered sleep medication and disturbed sleep due to pain as 
potential confounders.14 Anderson et al.15 assessed sleep quality using the Pittsburgh Sleep 
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Quality Index (PSQI) and daytime sleepiness using the Epworth Sleepiness Scale in relation 
to mortality but did not find an association. However, none of these studies accounted 
for objectively assessed sleep characteristics, such as sleep duration, sleep onset latency, 
and waking after sleep onset. In a large population-based study with a longer follow-up 
period, we aimed to evaluate the association between nonparametric measures of the 24-
hour activity rhythm, stability, and fragmentation, and mortality in middle-aged and elderly 
people. We also ran analyses in which we excluded deaths that occurred in the first 2 years 
to minimize the risk of reversed causality. Furthermore, actigraphic and subjective sleep 
diary estimates of sleep duration, sleep onset latency, waking after sleep onset, and sleep 
quality were studied in relation to mortality to investigate whether circadian rhythms and 
sleep characteristics predicted mortality independently.
Methods
Participants
The present study was conducted within the Rotterdam Study, a prospective study of 
persons 45 years of age or older living in Rotterdam, The Netherlands, that started in 1990. 
The aim of the study was to examine the incidence of and risk factors for neurological, 
cardiovascular, psychiatric, and other chronic diseases. Details of the study have been 
published previously.16 The Rotterdam Study was approved by the medical ethics committee 
according to the Wet Bevolkingsonderzoek ERGO (Population Study Act Rotterdam Study), 
executed by the Ministry of Health, Welfare and Sports of the Netherlands, and conforms to 
the Declaration of Helsinki. All participants provided written informed consent.
From December 2004 to April 2007, we invited 2,632 successive participants to participate in 
the actigraphy study; of these, 2,063 (78%) agreed. There were no exclusion criteria besides 
being able to understand the instructions for this study. After exclusion of recordings that 
failed because of technical problems or that contained fewer than 4 consecutive days and 
nights, 1,734 (84%) recordings (mean recording duration, 138 (standard deviation (SD), 14) 
hours) were available for analyses.17 No participants were lost to follow-up.
Actigraphy
We measured the 24-hour activity rhythm using an actigraph unit (Actiwatch model 
AW4, Cambridge Technology Ltd., Cambridge, United Kingdom) worn on each subject’s 
nondominant wrist, as described previously.18 In brief, participants were asked to wear 
the actigraph unit for 7 consecutive days and nights and to remove it only before bathing. 
Recordings were obtained in 30-second intervals. Because the elderly can have less distinct 
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circadian rhythms, subjects’ 24-hour activity rhythms were analyzed nonparametrically; 
thus, no assumptions were made about the underlying shape of the circadian rhythm. 
The actigraph unit was used to calculate two 24-hour activity rhythm variables (interday 
stability and intraday variability19) and 3 sleep variables (sleep duration, sleep onset latency, 
and waking after sleep onset20). Interday stability is a measure of how stable the rhythm is 
over multiple days, that is, how similar the individual day-night patterns are over time. It is 
calculated as the ratio of the variance of the average activity patterns around the mean and 
the overall variance.21. Intraday variability reflects the fragmentation of the rhythm, that is, 
the rate of shifting between rest and activity. It is calculated as the ratio between the mean 
squares of the difference between all successive hours (first derivative) and the mean squares 
around the grand mean.21 The variables have been shown to be sensitive in observational 
and experimental studies on aging.22,23 Examples of activity rhythms characterized by a high 
or low stability and fragmentation are given in Figure 1.
Sleep diaries
During the week of actigraphy assessment, each participant kept a sleep diary comprising 
data on sleep characteristics, sleep quality, use of sleep medications, napping, and alcohol 
consumption. To assess subjective sleep duration and sleep onset latency, participants were 
asked to answer the questions, “In total, how many hours did you sleep last night?” and 
“How long did it take you to fall asleep?” We averaged a weeks’ worth of daily values. Sleep 
quality was measured using 3 dichotomous questions: “Do you think you slept well last 
night?”, “Do you think the amount of sleep was not enough?”, and “Did you feel rested after 
getting out of bed?” We reverse-coded the answers to the second question so that a score 
of 1 indicated good sleep quality. The score for sleep quality was created by summing the 3 
dichotomous questions assessed each day (range, 0–3), taking the daily average of this score 
(range, 0–1), summing these scores over the days of participation, and taking into account 
the total number of days a person participated (range, 0–7). Higher scores represent a better 
sleep quality. Each day, participants specified which sleep medications were used, if any. In 
all analyses, use of sleep medication was dichotomized into no use of sleep medication or 
any use of sleep medication during the week of actigraphy. Napping was evaluated by asking 
whether the participant had taken 1 or more naps. The total number of days during which 
the participant took a nap, adjusted for the total number of days for which the participant 
contributed data, was used in analyses. Alcohol consumption was evaluated as the sum of 
cups of alcohol after 18:00 hours on day 1 in the week of actigraphy.
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Figure 1 Four examples of activity plots, the Rotterdam Study, the Netherlands, 2004–2007. Plots show activity 
rhythms of participants from the Rotterdam Study. The x-axis represents time (0:00, midnight; 12:00, noon) and 
the y-axis represents activity counts per 30 seconds. Participants started wearing the actigraph unit at 18:00 hours 
on day 1. These activity counts are scaled relative to the individual means and cannot be compared easily across 
persons. A) Activity rhythm with high stability and low fragmentation in a 73-year-old man; B) activity rhythm with 
high fragmentation in an 84-year-old woman; C) activity rhythm with low stability in a 47-year old man; D) activity 
rhythm with low stability and high fragmentation in a 62-year-old man.
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Pittsburgh Sleep Quality Index
The PSQI was used to measure subjective sleep quality (global PSQI score) and possible 
sleep apnea.24 Higher scores represent poorer sleep. We considered participants to have 
sleep apnea if they reported that they snored loudly at least 2 nights per week and if they 
reported occasional respiratory pauses or respiratory pauses during sleep at least 1–2 nights 
per week.25
Assessment of outcome
Records of general practitioners and hospitals were used to continuously assess death 
from any cause. In addition, information on vital status was acquired bimonthly from death 
certificates from the municipality. The number of person-years was calculated from the date 
of actigraphy start to the date of death or end of follow-up on September 27, 2013. The 
mean follow-up time was 7.3 years.
Covariates
We assessed the following variables as possible confounders based on previous 
literature14,17: sex, age, use of sleep medication, possible sleep apnea, napping, activities of 
daily living (ADL), educational level, cognitive functioning, depressive symptoms, body mass 
index, employment status, current smoking, alcohol consumption, myocardial infarction, 
diabetes, and stroke. Use of sleep medication, napping, and alcohol consumption were 
estimated using the sleep diaries. Information on possible sleep apnea, ADL, educational 
level, depressive symptoms, employment status, and current smoking (cigarettes, cigars, 
or pipe) was obtained in a home interview. ADL were measured with the Stanford Health 
Assessment Questionnaire and were used to indicate general health.26 Depressive symptoms 
were measured using the Center for Epidemiologic Studies-Depression scale.27 During 
a visit to our research center, cognitive functioning was measured using the Mini Mental 
State Examination28; height and weight were measured with the participants wearing light 
clothing and no shoes to calculate body mass index (weight (kg)/height (m2)). Myocardial 
infarction, diabetes, and stroke were determined using medical records.
Statistical analyses
The number of missing values for a variable never exceeded 5% (the maximum amount of 
missing data was 4.2% for ADL). Missing values for continuous variables were replaced with 
the median, and missing values for categorical variables were put into a separate category. 
Interday stability and intraday variability were standardized and Winsorized at 4 standard 
deviations from the mean. We analyzed the curvilinear association between sleep duration 
and mortality by adding a squared term of sleep duration to the model. In addition, we 
tested a nonlinear association by defining 3 categories of sleep duration (<6, 6–7.5 (reference 
group), and >7.5 hours).
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Table 1 Baseline Characteristics by Status at End of Follow-up in 1,734 Men and Women, Rotterdam Study, the 
Netherlands, 2004-2007 
 Status at end of follow-up
Total (n=1734) Alive (n = 1580) Dead (n = 154)
Mean (SD)
N(%)
Mean (SD)
N(%)
Mean (SD)
N(%)
Test Statistca
Age (years) 62.2 (9.3) 61.2 (8.6) 72.6 (10.4) -13.1d
Gender (male) 808 (46.6%) 723 (45.8%) 85 (55.2%) 5.0b
Employment (yes) 574 (33.1%) 558 (35.3%) 16 (10.4%) 39.9d
Education: low 264 (15.2%) 227 (14.4%) 37 (24.0%)
                     intermediate 1097 (63.3%) 1000 (63.3%) 97 (63.0%) 14.5c
                     high 341 (19.7%) 322 (20.4%) 19 (12.3%)
Activities of daily living (score) 0.29 (0.4) 0.25 (0.4) 0.66 (0.6) -8.3d
Cognitive functioning (score) 28.0 (1.8) 28.0 (1.7) 27.3 (1.9) 5.0d
Depressive symptoms (score) 5.5 (7.1) 5.4 (7.0) 6.6 (7.9) -2.1b
Myocardial infarction (yes) 67 (3.9%) 52 (3.3%) 15 (9.7%) 15.7d
Diabetes (yes) 205 (11.8%) 167 (10.6%) 38 (24.7%) 26.8d
Stroke (yes) 45 (2.6%) 30 (1.9%) 15 (9.7%) 34.1d
Body mass indexe 27.9 (4.2) 27.9 (4.1) 27.6 (4.1) 0.82
Current smoking (yes) 358 (20.6%) 328 (20.8%) 0.29
Alcohol (cups per week) 5.7 (1.3) 5.8 (7.3) 5.3 (6.9) 0.80
Interday stability (score) 0.80 (0.1) 0.80 (0.1) 0.77 (0.1) 3.2c
Intraday variability (score) 0.43 (0.1) 0.42 (0.1) 0.52 (0.2) -7.7d
Sleep duration (hours) 6.4 (0.9) 6.4 (0.9) 6.4 (1.0) -0.58
Sleep duration: <6 hours 523 (30.2%) 480 (30.4%) 43 (27.9%)
                               6-7.5 hours 1069 (61.6%) 977 (61.8%) 92 (59.7%) 3.9
                             >7.5 hours 142 (8.2%) 123 (7.8%) 19 (12.3%)
Sleep onset latency (minutes) 14.6 (12.4) 13.8 (11.8) 22.6 (14.7) -8.6d
Wake after sleep onset (minutes) 69.5 (25.9) 68.9 (25.2) 74.5 (30.4) -2.6b
Sleep medication (yes) 252 (14.5%) 218 (13.8%) 34 (22.1%) 8.6b
Apnea (yes) 507 (29.2%) 448 (28.4%) 59 (38.3%) 6.8b
Napping (days per week) 1.7 (2.0) 1.6 (2.0) 2.7 (2.4) -5.6d
Sleep duration: <6 hours 277 (16.0%) 244 (15.4%) 33 (21.4%) 4.1
                               6-7.5 hours 1048 (60.4%) 964 (61.0%) 84 (54.5%)
                             >7.5 hours 409 (23.6%) 372 (23.5%) 37 (24.0%)
Sleep onset latency (minutes) 17.7 (11.7) 17.7 (11.7) 17.8 (11.7) -0.09
Sleep quality sleep diary (score) 5.5 (1.6) 5.6 (1.6) 5.5 (1.6) 0.74
Global PSQI score§ 3.7 (3.5) 3.6 (3.5) 3.9 (3.7) -0.78
Poor sleep (PSQI score >5) 398 (23.0%) 353 (22.3%) 45 (29.2%) -1.80
Abbreviations: PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation. 
a Statistical test to compare the means of the alive or dead status at end of follow-up; t-test for continuous, Χ2 for 
categorical variables. 
b P <0.05. 
c P <0.01. 
d P <0.001. 
e Weight (kg)/length (m)2.
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Cox proportional hazards models were used to determine the hazard ratios and 95% 
confidence intervals for the associations of circadian rhythm and sleep parameters with 
mortality. We included a covariate in the model if it changed the estimate of the main 
determinants by more than 10%, if the covariate predicted mortality (P < 0.05), or if it was an 
important a priori confounder. On the basis of these criteria, educational level, employment 
status, and alcohol consumption were not included in the full model. We tested 2 different 
models. Model 1 was adjusted for age and sex. Model 2 was adjusted for age, sex, ADL, 
current smoking, diabetes, myocardial infarction, stroke, cognitive functioning, depressive 
symptoms, body mass index, use of sleep medication, possible sleep apnea, and napping. 
All statistical tests were 2-sided, and a P value <0.05 was considered statistically significant. 
We tested the proportional hazards assumption using Schoenfeld residuals.29 The residuals 
did not significantly deviate from zero slope. Analyses were performed in SPSS, version 20 
(SPSS Inc., Chicago, Illinois).
Results
Baseline characteristics
The average follow-up time for the 1,734 participants was 7.3 (SD, 1.3) years. The mean age 
was 62.2 (SD, 9.3) years, and 47% of subjects were male. In total, there were 154 deaths 
(8.9%) during the follow-up period. The participants’ baseline characteristics stratified 
whether they were alive at the end of follow-up are summarized in Table 1.
Interday stability and intraday variability were moderately correlated (r = −0.49, P < 0.001). 
The global PSQI score was moderately correlated with sleep quality as assessed using a 
sleep diary (r = −0.45, P < 0.001). Circadian rhythm and sleep variables were only weakly 
to mildly correlated, with the highest correlation between interday stability and objective 
sleep duration (r = 0.31, P < 0.001). All correlations between 24-hour activity rhythm and 
sleep parameters can be found in Supplemental Table 1.
Cox proportional hazards model
Both circadian rhythm variables were significantly related to mortality (Table 2). After full 
adjustment, interday stability was associated with a lower mortality risk (per SD, hazard 
ratio (HR) = 0.83, 95% confidence interval (CI): 0.71, 0.96), and intraday variability (i.e., 
fragmentation) was associated with a higher mortality risk (per SD, HR = 1.22, 95% CI: 1.04, 
1.44). To show the cumulative survival graphically, interday stability and intraday variability 
were divided into quartiles (Figure 2). Because interday stability and intraday variability were 
moderately correlated, we also analyzed a model adjusted for age and sex that included 
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both 24-hour activity rhythm variables (per SD of intraday variability, HR = 1.25, 95% CI: 
1.07, 1.47; per SD of interday stability, HR = 0.84, 95% CI: 0.71, 1.00).
Actigraphically measured sleep onset latency and waking after sleep onset were marginally 
related to mortality in an age- and sex-adjusted model, but these associations were 
nonsignificant in the fully adjusted analysis (per minute of sleep onset latency, HR = 1.01, 
95% CI: 1.00, 1.02; per minute of waking after sleep onset, HR = 1.01, 95% CI: 1.00, 1.01). 
The actigraphic estimates of sleep duration, both continuous and categorical, were not 
related to mortality. Subjective sleep duration was quadratically associated with mortality in 
the age- and sex-adjusted model. However, this association was not significant after further 
adjustment (per hour, HR = 1.07, 95% CI: 0.97, 1.17). When different cut-offs were chosen to 
categorize objective and subjective sleep duration, the results did not change meaningfully 
(results available upon request). Other subjective sleep parameters were not related to 
mortality (Table 2).
Sensitivity analysis
Because circadian rhythms can be influenced by undiagnosed morbidity, we also ran the 
analyses excluding deaths that occurred in the first year and in the first 2 years after the week 
of actigraphy. These exclusions reduce the possible effect of reversed causality. In these 
analyses, 148 and 128 deaths occurred during the remaining follow-up periods, respectively. 
In the fully adjusted model that excluded deaths in the first year, the observed hazard ratio 
was essentially unchanged compared with the previous analyses in which all participants 
were included (per SD of interday stability, HR = 0.83, 95% CI: 0.71, 0.97; per SD of intraday 
variability, HR = 1.23, 95% CI: 1.05, 1.45). Again, very similar results were observed when 
deaths that occurred in the first 2 years were excluded (per SD of interday stability, HR = 
0.86, 95% CI: 0.73, 1.02; per SD of intraday variability, HR = 1.18, 95% CI: 0.98, 1.41).
Discussion
In the present prospective, population-based cohort study, more fragmented and less stable 
24-hour activity rhythms were associated with a 20% increase in all-cause mortality risk in 
a middle-aged and elderly population. These associations remained after adjustment for 
health parameters, possible sleep apnea, and napping. After adjustment for age and sex 
only, subjective sleep duration showed a U-shaped marginal association with mortality risk. 
However, after full adjustment, no sleep parameter, whether estimated objectively using an 
actigraph unit or subjectively using a sleep diary, predicted all-cause mortality. This suggests 
that although the circadian rhythm and sleep both change during aging, the circadian 
rhythm is independently related to mortality.
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Table 2. Associations of 24-Hour Activity Rhythm and Sleep Parameters With All-Cause Mortality in 1,734 Men and 
Women, Rotterdam Study, the Netherlands, 2004-2013
 All-Cause Mortality
Age & gender adjusted Fully adjusteda
 HR 95% CI HR 95% CI
Activity rhythm
Interday stability (score) 0.75c 0.65, 0.86 0.83b 0.71, 0.96
Intraday variability (score) 1.37c 1.20, 1.57 1.22b 1.04, 1.44
 Objectively assessed sleep
Continuous sleep duration
     Sleep duration (hours) 0.42 0.11, 1.57 0.69 0.19, 2.53
     Sleep duration squared (hours2) 1.06 0.95, 1.18 1.02 0.92, 1.13
Categorical sleep duration
     <6 hours 1.29 0.89, 1.87 1.12 0.77, 1.65
     6-7.5 hours (reference) 0.00 0.00
     >7.5 hours 1.33 0.81, 2.18 1.18 0.70, 1.98
Sleep onset latency (minutes) 1.01b 1.00, 1.02 1.01 1.00, 1.02
Wake after sleep onset (minutes) 1.01b 1.00, 1.01 1.01 1.00, 1.01
Subjectively assessed sleep
Continuous sleep duration
     Sleep duration (hours) 0.23b 0.07, 0.74 0.40 0.11, 1.39
     Sleep duration squared (hours2) 1.12b 1.02, 1.22 1.07 0.97, 1.17
Categorical sleep duration
     <6 hours 1.45 0.97, 2.17 1.41 0.93, 2.13
     6-7.5 hours (reference) 0.00 0.00
     >7.5 hours 1.13 0.77, 1.67 1.10 0.74, 1.64
Sleep onset latency (minutes) 0.99 0.98, 1.01 0.99 0.98, 1.01
Sleep quality sleep diary (score) 0.92 0.83, 1.02 0.97 0.87, 1.09
Sleep quality PSQI (score) 1.01 0.97, 1.06 0.99 0.94, 1.04
Poor sleep (PSQI score >5) 1.28 0.90, 1.83 1.13 0.76, 1.69
Abbreviations: CI, confidence interval; HR, hazard ratio; PSQI, Pittsburgh Sleep Quality Index.
a Adjusted for age, gender, activities of daily living, current smoking, diabetes, myocardial infarction, stroke, 
cognitive functioning, depressive symptoms, body mass index, sleep medication, napping and apnea.
b P < 0.05.
c P < 0.001.
Our finding that fragmentation and low stability of the 24-hour activity rhythm predict 
mortality has several possible explanations. First, the biological aging processes may be 
involved. Although our analyses were adjusted for age, age-related changes to the circadian 
organization are complex and might differ per level of circadian organization.12 For example, 
changes may occur in the suprachiasmatic nucleus (the central clock of the brain), in 
peripheral oscillators, or in the ability of the suprachiasmatic nucleus to drive peripheral 
oscillators. In humans, postmortem studies demonstrated a reduction in the number of 
vasopressin-expressing neurons in the suprachiasmatic nucleus at old age (>80 years).30 
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Figure 2 Crude cumulative survival plots per quartile of A) interday stability and B) intraday variability, the Rotterdam 
Study, the Netherlands, 2004–2013. Quartile 1 is the lowest quartile and quartile 4 is the highest. Survival was 
lower in participants with a low interday stability or a high intraday variability (fragmentation).
This may underlie a smaller amplitude of several circadian rhythms, a more fragmented 
24-hour activity rhythm, and a temperature and melatonin phase that occur earlier than in 
younger people.12,30-35 This loss of temporal organization between different rhythms can lead 
to suboptimal physiological functioning because physiological processes do not all take place 
at their optimal time of day.36 As a result, people who suffer from temporal disorganization 
have a higher susceptibility to disease. Second, napping increases the fragmentation of the 
rhythm17 and can also be an indicator of bad health.37 However, previous literature on the 
association of napping with mortality were inconsistent. It was found that people who take 
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naps regularly might have a higher mortality rate,38,39 especially those who sleep more than 
9 hours per night.40 On the other hand, another study found no significant benefit or harm 
of napping,41 whereas yet another study found a protective association between napping 
and mortality for people with short sleep durations.40 In these studies, circadian rhythm 
parameters were not taken into account. In our study, self-reported naps could not explain 
the association between the stability and fragmentation of the 24-hour activity rhythm and 
mortality. Third, the disturbed 24-hour activity rhythm might be an indicator of poor health. 
Occurrence of disease has been related to disrupted circadian rhythms, for example in 
persons with cardiovascular disease and Alzheimer’s disease.21,42 Also, more fragmented and 
less stable 24-hour activity rhythms have been related to sleepiness, depression, cognitive 
deficits, high body mass index, smoking, high blood pressure, and obesity.17,23,43-45
Although we controlled for several health measures, such as ADL, depressive symptoms, 
and diabetes, residual confounding by disease might explain part of the results. We also ran 
analyses in which we excluded deaths that occurred in the first 2 years to test for reverse 
causality. The observed hazard ratio was very similar to that from the analyses that included 
all participants. This suggests that the association between the 24-hour activity rhythm and 
mortality is not exclusively driven by short-term mortality.
Circadian rhythms and sleep patterns change as people age. For example, elderly people 
sleep less during the night and tend to fall asleep and wake up earlier.2-6 Nevertheless, in the 
present study, the associations between sleep and 24-hour activity rhythm parameters were 
weak. We found that more fragmented and less stable circadian activity rhythms predicted 
mortality but none of the sleep variables, whether measured objectively or subjectively, 
predicted mortality in the fully adjusted model. During our follow-up period, 154 participants 
died, which implies that we had sufficient power to detect the moderate associations of 24-
hour activity rhythm parameters on mortality. Arguably, our study might not have been 
powered to detect mild associations between sleep characteristics and mortality. Yet, the 
findings suggest that the circadian rhythm is more strongly and independently associated 
with mortality than is sleep duration.
There have been few studies on the association between activity rhythms and 
mortality.13-15,46,47 Mortality risk was found to be higher in older men and women with less 
robust or abnormal 24-hour activity rhythms.13-15 In patients with metastatic colorectal 
cancer, a higher mortality rate was associated with disturbed circadian rhythms; in dementia 
patients, it was associated with abnormal timing of the rhythm.46,47 To our knowledge, the 
association of fragmentation and stability of the circadian activity rhythm with all-cause 
mortality has not been described before.
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Our estimates showed a significant U-shaped relationship between continuously analyzed 
subjective sleep duration and mortality. However, these associations were nonsignificant 
after adjustment for health parameters. A U-shaped relationship between sleep duration 
and mortality was found in several previous studies (for 2 meta-analyses, see Cappucio et 
al.9 and Gallicchio et al.10). In general, stronger associations between long sleep duration and 
all-cause mortality were observed in the more extreme sleep categories (≥9 hours). In our 
study, few persons were extreme short or long sleepers. Consequently, in our analyses, the 
power regarding extreme sleep duration was limited, which might explain the attenuation 
of the curvilinear relation between sleep duration and mortality after further adjustment. 
Previous studies in which sleep duration stratified on health status was examined were 
inconsistent.48,49 In 1 study, Magee et al.48 observed an association between sleep duration 
and mortality in persons with preexisting disease only; Mesas et al.49 also found this 
association in healthy people. In addition, part of the association of short sleep duration 
with mortality can be explained by sleep apnea.50 We adjusted for possible sleep apnea 
based on 2 questions from the PSQI.24,25 Possible apnea was not a significant predictor of 
sleep duration or mortality in our fully adjusted model. However, the PSQI cannot be used 
to diagnose sleep apnea. We cannot rule out that sleep apnea, if assessed more in detail, 
might explain part of the observed associations.
In the present study, as in previous studies, perceived sleep quality was not related to all-
cause mortality, whether it was measured using the sleep diary or with the PSQI.51 Previously, 
sleep disturbances were associated with higher all-cause mortality risk only in men younger 
than 45 years of age and not in women or men older than 45 years.52
One strength of our study is that it is embedded in the Rotterdam Study, a prospective 
population-based cohort study. This increases the generalizability of our results, and we 
were able to adjust for many covariates. A second strength was our use of both subjective 
and objective measurements to estimate sleep duration and sleep onset latency. Because 
subjective and objective sleep variables are not strongly associated,18 it is important to 
analyze both and to test whether they predict mortality independently. A third strength 
was the complete follow-up of the death date of all participants. Fourth, the 24-hour 
activity rhythms were analyzed nonparametrically, so no assumptions were made about the 
underlying shape of their circadian rhythms. This study also has some limitations. First, data 
collection on sleep disorders, such as restless leg syndrome and sleep apnea, was limited. 
Second, in our population-based study, 154 participants died. Therefore, we may not have 
been able to detect the mild associations of sleep parameters on mortality.
To conclude, in a representative middle-aged and elderly population, fragmentation and low 
stability of the 24-hour activity rhythm predicted all-cause mortality independent of and 
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better than sleep estimates. Changes in the regulation of circadian rhythms could indicate 
disease and reflect age-related alterations in the biological clock of the brain. Future 
research must show whether improving circadian activity rhythm disturbances can improve 
health and survival.
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Supplemental material
Supplemental Table 1 Correlations Between 24-Hour Activity Rhythm and Sleep Parameters in 1,734 Men and 
Women, Rotterdam Study, the Netherlands, 2004-2007
 1 2 3 4 5 6 7 8
1 Interdaily stability -
2 Intradaily variability -0.49a -
3 Objective sleep duration 0.31a -0.26a -
4 Objective sleep onset latency -0.09a 0.22a -0.11a -
5 Wake after sleep onset -0.19a 0.28a -0.23a 0.26a -
6 Subjective sleep duration 0.09a -0.08a 0.39a <0.01 0.07a -
7 Subjective sleep onset latency <0.01 0.03 0.11a 0.14a 0.13a -0.29a -
8 Sleep quality sleep diary 0.11a -0.08a <0.01 <-0.01 -0.10a 0.44a -0.27a -
9 Global PSQI score -0.07a 0.08a <0.01 0.12a 0.12a -0.41a 0.37a -0.45a
a P <0.05.
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In their letter to the editor1 about our article,2 Erren and Gross addressed the possibility that 
accumulated sleep disruption, that is, how much of an individual’s sleep is not in phase with 
his or her biological clock, underlines the observed association between fragmentation or 
stability of the 24-hour activity rhythm and mortality. If available, chronotype data should 
be incorporated when investigating sleep and circadian rhythm organization.3,4 Below, we 
share insights based on additional analyses of our data that address the importance of the 
issue. 
Employment status as a proxy of social timing was tested as a potential confounder in the 
presented associations of sleep and circadian rhythm with mortality, but adjustment for 
that variable did not change effect estimates. Nevertheless, we observed some indication 
of circadian misalignment5 among the employed participants. First, the absolute difference 
between time in bed on workdays and that on weekends was 66 (standard deviation, 48) 
minutes among the employed participants compared with 36 (standard deviation, 30) 
minutes in the nonworkers. Also, as an indicator of circadian misalignment,5 the absolute 
difference between the midpoint of sleep on workdays and the midpoint of sleep on 
weekends was 59 (standard deviation, 43) minutes in the workers compared with only 29 
(standard deviation, 26) minutes in the nonworkers.
Larger differences in time spent in bed on weekdays versus weekends and in the midpoint of 
sleep on weekdays versus weekends were associated with unstable activity rhythms (Table 
1), which suggests that nonparametrically derived stability of the circadian rhythm assessed 
with actigraphy6 can capture circadian misalignment. Table 1 also shows the importance 
of assessing fragmentation next to stability; fragmentation is barely related to circadian 
alignment (Table 1) and thus cannot be estimated from such questionnaire data.
Importantly, in contrast to stability and fragmentation, circadian misalignment indicators 
did not predict mortality, nor did including circadian misalignment in the survival models 
meaningfully attenuate the risk estimates (for stability, hazard ratio = 0.80, 95% confidence 
interval: 0.68, 0.93; for fragmentation, hazard ratio = 1.27, 95% confidence interval: 1.07, 
1.51) compared with the unadjusted results (for stability, hazard ratio = 0.83, 95% confidence 
interval: 0.71, 0.96; for fragmentation, hazard ratio = 1.22, 95% confidence interval: 1.04, 
1.44).2
In our elderly sample, 574 (33%) persons were still working at baseline, of whom only 16 
(2.8%) died during the follow-up period (compared with the 8.9% mortality rate in the total 
study population). To reevaluate the validity of the reported results, we conducted the 
survival analysis in the nonworkers (n = 1,145, including 137 deaths), whose sleep habits 
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would be expected to more closely align with their biological clocks. The results were 
essentially unchanged (for stability, hazard ratio = 0.83, 95% confidence interval: 0.71, 0.97; 
for fragmentation, hazard ratio = 1.20, 95% confidence interval: 1.02, 1.42).We concluded 
that prevalent circadian alignment cannot easily explain our findings, possibly because we 
studied a group with an older mean age (mean age, 62.2 (standard deviation, 9.3) years), 
which is known to converge towards the early chronotype.7
Table 1 Adjusted association between chronotype misalignment and circadian rhythm indices
Circadian misalignment
Interdaily Stabilitya Fragmentationa
B 95% CI p-value B 95% CI p-value
Time in bed 
Workday-weekend absolute difference -0.34 -0.41 ; -0.27 <0.01 0.04 -0.02 ; 0.10 0.19
Midpoint of sleep
Workday-weekend absolute difference -0.60 -0.68 ; -0.52 <0.01 0.08 0.07 ; 0.14 0.04
aOutcomes were standardized and Winsorized at 4SD. Models are adjusted for age, sex, activities of daily living 
score, current smoking, diabetes, myocardial infarction, stroke, cognitive functioning, depressive symptoms, body 
mass index, sleep medication, napping and apnea.
Finally, a logical fallacy in the letter by Erren and Gross needs to be pointed out. In their 
hypothetical example, the associations of reported sleep disruption and Actigraphically 
derived circadian rhythm indices with mortality are compared based on risk effect estimates. 
They concluded that if effects were similar, the former could be used “because it is less 
cumbersome and provides more readily interpretable information” (1, p. 186). We argue 
that such inferences about the measured constructs must be made based on their mutual 
dependence and not by comparing the strengths of the associations with mortality.
In conclusion, chronotype data can help investigators in future studies estimate doses of 
accumulated sleep disruption, though the validity and precision must be empirically tested.
The accuracy of sleep and circadian estimates derived from actigraphy might outweigh 
the simplicity of only administrating sleep questionnaires.8 Finally, the extent to which 
nonparametric circadian rhythm variables capture circadian misalignment should be 
systematically explored.
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Abstract 
Study Objectives: The prevalence of sleep disturbances and heart failure increases with age. 
We aimed to evaluate the associations of incident heart failure and cardiac dysfunction with 
changes in sleep quality.
Methods: This prospective population-based study was conducted in the Rotterdam 
Study. Of the 3445 eligible persons (mean age 72.0±7.1 years) available for cross-sectional 
analyses, 8.9% (n = 307) had prevalent clinical heart failure. In longitudinal analyses, 1989 
eligible persons (mean age 70.0±5.8 years) were followed for an average of 6.5±0.4 years, 
of which 4.6% (n = 91) had prevalent or incident clinical heart failure. Heart failure was 
assessed according to European Society of Cardiology criteria. To estimate cardiac function, 
we measured left ventricular fractional shortening, left ventricular systolic function, and E/A 
ratio by echocardiography. Heart failure and cardiac dysfunction were studied with linear 
regression in relation to sleep quality, assessed by the Pittsburgh Sleep Quality Index. 
Results: No associations between clinical heart failure and sleep quality were observed in 
cross-sectional analyses. Clinical heart failure predicted a reduction of sleep quality (B = 1.00 
points on the Pittsburgh Sleep Quality Index; 95% CI 0.40, 1.60) in longitudinal assessment. 
This association was driven by the sleep onset latency and sleep quality components of the 
Pittsburgh Sleep Quality Index. Cardiac dysfunction was not related to sleep quality in cross-
sectional or longitudinal analyses.
Conclusions: Clinical heart failure, but not cardiac dysfunction measured by echocardiography, 
increases the risk of poor sleep quality in the general population over time. These findings 
suggest that clinical manifestations of heart failure negatively affect sleep. 
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2.3
Introduction
Sleep disturbances have been reported in around 60% of patients with heart failure (HF).1,2 
Despite improved treatment and an overall decline in mortality after a cardiovascular event, 
the number of HF patients is increasing among the elderly.3 This is probably due to an aging 
population and to the improved chances of survival for HF patients.4 Nevertheless, only 
25% to 35% of patients with clinical HF survive up to 5 years after diagnosis, and HF poses 
a great burden in terms of treatment, hospitalization and quality of life.5-7 HF is related to 
multiple physical and mental problems, including shortness of breath, depressive symptoms, 
cognitive impairment, and sleep problems.8,9 Little is known about the changes in sleep 
occurring in these patients over time. 
Previous studies investigating HF and sleep have been mostly cross-sectional and cannot 
establish a temporal relation. Prospective sleep studies have demonstrated that short and 
long sleep durations increase the risk of cardiovascular disease.10-13 Furthermore, difficulty 
maintaining and initiating sleep are associated with incident HF.14 However, there is evidence 
for a bi-directional relation between sleep and heart disease. For example, poor sleep quality 
and difficulty maintaining and initiating sleep are consequences of cardiovascular disease.15 
How sleep quality changes over time in patients with cardiac dysfunction, prevalent HF or 
new-onset HF is unclear.
We examined whether prevalent and incident HF and echocardiographic indicators of 
cardiac dysfunction are associated with sleep quality in a community-dwelling population 
using both cross-sectional and longitudinal designs. Also, the associations between HF and 
the separate component scores of the Pittsburgh Sleep Quality Index (PSQI) were analyzed. 
Methods
Participants
This study is part of the Rotterdam Study, a prospective population-based cohort of the 
general population in Rotterdam, The Netherlands.16 The study conforms to the principles 
outlined in the Declaration of Helsinki, and was approved by the Medical Ethics Committee 
according to the Wet Bevolkingsonderzoek ERGO (Population Study Act Rotterdam Study), 
executed by the Ministry of Health, Welfare and Sports of The Netherlands. All participants 
provided written informed consent. 
Between 2002 and 2005, 3711 participants aged ≥ 55 years completed the PSQI and 
underwent echocardiography. Of these, 266 participants were excluded because of (1) 
diagnosis of HF that did not fulfill the criteria of the European Society of Cardiology; (2) 
poor cognitive function (Mini-mental state examination score ≤ 2317); or (3) <6 valid PSQI 
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component scores. This left 3445 participants for cross-sectional analyses. Five hundred 
forty-one participants died during follow-up. Between 2009 and 2012, 2105 participants 
completed the PSQI again. Of these, 116 participants were excluded because of (1) poor 
cognitive function at follow-up or (2) < 6 valid PSQI component scores at follow-up, leaving 
1989 participants for the longitudinal analyses.
Clinical Heart Failure 
Assessment of HF in the Rotterdam Study has been described previously.18 In brief, HF 
was determined in accordance with the guidelines of the European Society of Cardiology, 
requiring objective evidence of cardiac dysfunction, together with typical symptoms 
of heart failure such as breathlessness, ankle swelling, pulmonary crepitation, or use of 
cardiovascular medication for HF.19 In this study, HF was defined as prevalent if the date of 
diagnosis was before the date of the PSQI baseline measure. Incident HF was diagnosed if it 
occurred between the baseline and repeated PSQI assessment. Information on incident HF 
cases was obtained by digital linkage with medical records of general practitioners, which 
allowed continuous monitoring. Only definite and probable HF diagnoses were included in 
the analyses.20 
Echocardiography 
A resting echocardiogram was obtained from each participant at baseline to assess left 
ventricular systolic function (fractional shortening and visual assessment [normal, fair, 
moderate, or poor]) and diastolic function (E/A ratio [< 0.75, 0.75-1.50, > 1.50]) according 
to a standardized protocol.21 Fractional shortening was computed as (left ventricular end 
diastolic dimension – left ventricular end systolic dimension) divided by left ventricular 
end diastolic dimension*100%. E/A ratio was calculated as Doppler peak E filling velocity 
divided by Doppler peak A filling velocity. The echocardiograms were made with one of two 
commercially available systems. In the analyses, moderate and poor left ventricular systolic 
function were combined because of the low number of participants with poor function.
Sleep Quality
Sleep quality was measured with the PSQI, a self-rated 19-item questionnaire.22 The 
global PSQI score comprises of sleep onset latency, sleep efficiency, sleep quality, sleep 
disturbances, sleep duration, daytime dysfunction, and use of sleeping medication in the 
past month (range 0-21). Higher scores represent a poorer sleep quality. Participants with 
< 6 valid PSQI component scores were excluded. The global PSQI was calculated as the 
sum of the component scores. If a participant had only 6 valid PSQI component scores, we 
calculated the global PSQI score, but weighted the summed score by multiplying with 7/6 
(7*the sum of the 6 valid component scores)/6). The PSQI has a good test-retest reliability 
and validity.22 
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2.3
Statistical Analyses
Clinical HF, fractional shortening, left ventricular systolic function, and E/A ratio were 
studied as determinants of sleep quality. Clinical HF was continuously monitored, the 
echocardiographic indicators of cardiac function and confounders were measured at 
baseline, and sleep quality was measured at baseline and at follow-up. We performed cross-
sectional and longitudinal analyses to examine whether clinical HF and echocardiographic 
indicators of cardiac dysfunction are associated with sleep quality. To assess sleep quality 
changes in the longitudinal analyses, we adjusted for baseline sleep quality. Incident HF was 
also studied separately from prevalent HF. Additionally, the associations between HF and 
the separate component scores of the PSQI were analyzed longitudinally. 
We adjusted the linear regressions for age and gender. Additional adjustments were made 
for education (low, intermediate, and high), possible sleep apnea, depressive symptoms 
(Center for Epidemiologic Studies-Depression scale23), diabetes mellitus, cognitive function 
(mini-mental state examination score), diuretic use, and the echocardiographic system 
used, as these variables changed effect estimates (> 5%) or were a priori confounders. 
Possible sleep apnea was based on 2 questions of the PSQI. Apnea was considered possible 
when participants reported that they snored loudly ≥ 2 nights per week and if they reported 
occasional respiratory pauses, or if they reported respiratory pauses ≥ 1-2 nights per week.24 
Diuretic use (ATC code C03) was assessed with pharmacy records. Participants without a 
diuretic prescription were considered non-users, participants with a prescription up to 
the defined daily dose were considered low users, and participants with a prescription 
higher than the  defined daily dose were considered high users. Systolic and diastolic blood 
pressure, smoking, alcohol intake, and body mass index were not entered as covariates, as 
they did not change effect estimates. 
Missing values were handled by multiple imputation using 5 imputations. The maximum 
amount of missing data was for fractional shortening (4.9 %). A p value < 0.05 was considered 
statistically significant. Analyses were performed in SPSS version 20 (IBM SPSS Statistics for 
Windows, Version 20.0. Armonk, NY).
A validation of PSQI measures was performed within 2 months in a random subsample of 
173 participants with actigraphy and sleep diary measures conducted over the course of one 
week. The global PSQI score was correlated to sleep quality measured with three questions 
of the sleep diary (r = −0.41, p < 0.001), sleep duration correlated well with actigraphic 
assessment of average sleep duration (r = 0.33, p < 0.001).
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Results
Sample Characteristics
The cross-sectional sample consisted of 3445 eligible participants (mean age 72.0±7.1 
years; 43.2% male), of which 307 (8.9%) participants had prevalent HF at baseline (baseline 
characteristics can be found in Supplementary Table 1). The sample available for longitudinal 
analyses consisted of 1989 participants (mean age 70.0±5.8 years; 41.9% male), of which 
40 (2.0%) participants had prevalent HF at baseline and 51 (2.6%) had incident HF during 
follow-up (mean follow-up 6.5±0.4 years). Therefore a total of 91 participants with HF were 
studied (baseline characteristics for the 1989 participants in the longitudinal analyses can 
be found in Table 1). 
Table 1 Baseline characteristics (n = 1989)
 Measures  
Gender (male), n (%) 834 (41.9%)
Age, mean (SD) 70.0 (5.8)
Body mass index (kg/m2), mean (SD) 27.7 (4.2)
Education, n (%): Low 316 (15.9%)
                          Intermediate 1358 (68.3%)
                          High 315 (15.8%)
Depressive symptomsa, mean (SD) 5.1 (6.7)
Possible sleep apnea, n (%) 180 (9.0%)
Systolic blood pressure (mm Hg), mean (SD) 147.8 (19.8)
Diastolic blood pressure (mm Hg), mean (SD) 80.8 (10.3)
Diabetes Mellitus, n (%) 226 (11.4%)
Current smoking, n (%) 242 (12.2%)
Alcohol intake (units per week), mean (SD) 8.0 (9.8)
Fractional shortening, mean (SD) 38.5 (6.7)
Left ventricular systolic function, n (%): Normal 1160 (58.3%)
                                                         Fair 750 (37.7%)
                                                         Moderate 58 (2.9%)
                                                         Poor 21 (1.1%)
E/A ratio, n (%): < 0.75 553 (27.8%)
                         0.75-1.50 1398 (70.3%)
                         > 1.50 38 (1.9%)
Diuretics use, n (%): No 1741 (87.5%)
                                  Low 231 (11.6%)
                                  High 17 (0.9%)
Global PSQI scoreb, mean (SD) 3.7 (3.4)
Baseline (imputed data), the maximum missing data was for fractional shortening (4.9 %). a Measured with the Center 
for Epidemiologic Studies-Depression scale. bPSQI: Pittsburgh Sleep Quality Index. The baseline characteristics for 
the 3445 participants in the cross-sectional sample can be found in Supplementary Table 1.
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2.3
Linear Regression
No associations between clinical HF or cardiac dysfunction and sleep quality were found 
cross-sectionally (Table 2). The cross-sectional analyses only including the 1989 participants 
from the longitudinal analyses showed similar results (data available upon request). In Table 
3, we only present the fully adjusted model, as the age- and gender-adjusted model had 
similar results. In longitudinal analyses, HF was related to a poorer sleep quality, i.e., an 
increase in global PSQI score between baseline and follow-up (B = 1.00 points on the PSQI; 
95% CI 0.40, 1.60; p < 0.01; Table 3). This association was found in both prevalent (B = 1.04 
points on the PSQI; 95% CI 0.14, 1.94; p = 0.02) and incident (B = 0.97 points on the PSQI; 
95% CI 0.20, 1.75; p = 0.01) HF cases. None of the echocardiographic cardiac parameters 
were associated with changes in sleep quality. 
Table 2 The cross-sectional association of heart failure and echocardiographic parameters with sleep quality 
(n=3445)
 Global PSQIa  
 B (CI) p
Heart failure
No heart failure (n=3138) 0 (ref)
Prevalent heart failure (n=307)  -0.131 (-0.694, 0.432) 0.65
 
Cardiac function
Fractional shortening (per %) -0.001 (-0.017, 0.015) 0.88
Left ventricular systolic function
     Normal (n=1837) 0 (ref)
     Fair (n=1346)  -0.083 (-0.314, 0.148) 0.48
     Moderate or poor (n=262) 0.056 (-0.369, 0.481) 0.80
E/A ratio
     < 0.75 (n=1079)  -0.118 (-0.359, 0.123) 0.34
     0.75-1.50 (n=2292) 0 (ref)
     > 1.50 (n=74)  -0.231 (-1.000, 0.537) 0.56
Linear regression adjusted for gender, age, possible sleep apnea, depressive symptoms, diabetes mellitus, 
education, cognitive function, echo device used, and diuretic use. a PSQI: Pittsburgh Sleep Quality Index.
We analyzed the components of the global PSQI score separately with logistic regression. 
This enabled us to test how clinical HF affects the change of these aspects of sleep. HF was 
associated with changes in sleep quality (OR = 2.63; 95% CI 1.41, 4.93) and sleep onset 
latency (OR = 2.03; 95% CI 1.11, 3.72; component scores 0, 1 versus 2, 3; fully adjusted), 
but was not associated with changes in sleep duration, sleep efficiency, sleep disturbances, 
daytime dysfunction, or sleep medication (Table 4). 
To disentangle the effect of sleep medication on the association between HF and change in 
global PSQI score, we omitted the sleep medication component from the global PSQI score 
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(at baseline and at follow-up) and added sleep medication use at baseline as extra covariate 
in the analysis. The association between HF and global PSQI score was only modestly 
attenuated (B = 0.86; 95% CI 0.31, 1.40).
Table 3 The longitudinal associations of heart failure and echocardiographic parameters with sleep quality (n=1989)
 Change in global PSQIa 
 B (CI) p
Heart failure
No heart failure (n=1898) 0 (ref)
Clinical heart failure all (n=91) 1.002 (0.402, 1.602) <0.01
    Prevalent heart failure (n=40) 1.041 (0.141, 1.940) 0.02
    Incident heart failure (n=51) 0.973 (0.197, 1.749) 0.01
Cardiac function
Fractional shortening (per %-point)  -0.008 (-0.028, 0.012) 0.44
Left ventricular systolic function
     Normal (n=1160) 0 (ref)
     Fair (n=750) 0.106 (-0.163, 0.375) 0.44
     Moderate or poor (n=79)  -0.092 (-0.751, 0.567) 0.78
E/A ratio
     < 0.75 (n=553)  -0.019 (-0.311, 0.273) 0.90
     0.75-1.50 (n=1398) 0 (ref)
     > 1.50 (n=38)  -0.490 (-1.390, 0.410) 0.29
Linear regression adjusted for gender, age, global PSQIa score at baseline, possible sleep apnea, depressive 
symptoms, diabetes mellitus, education, cognitive function, echo device used, and diuretic use. aPSQI: Pittsburgh 
Sleep Quality Index, change modelled by correction for baseline PSQI.
Discussion
Clinical HF increased the risk of sleep problems in this sample of middle-aged and elderly 
persons. In our longitudinal analyses, we observed that sleep quality was reduced in 
participants with either prevalent or incident HF at follow-up. This relation could not be 
demonstrated with echocardiographic indicators of cardiac dysfunction. Therefore, findings 
suggest that it is clinical manifestations of HF that specifically affect sleep negatively.
Several studies have related poor sleep quality to prevalence of cardiovascular disease; 
however, these studies have not reported repeated sleep assessments.2,11,12,25 Therefore, 
any effect of cardiovascular disease upon sleep must be inferred from case-control studies, 
which have been undertaken in a clinical setting. Only one of the studies focused specifically 
on HF and observed that HF patients had a lower sleep quality than controls.2 In our cross-
sectional analyses, we did not observe an association between HF and sleep. In clinical 
studies HF is probably more severe than in our study, which might explain the absence of 
the association in our cross-sectional analyses. 
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For our longitudinal analyses we assessed sleep quality repeatedly. Our study suggests that 
clinical HF might lead to sleep problems. The reason why the association between HF and 
sleep quality was observed in longitudinal analyses, but not in cross-sectional analyses 
might be due to two reasons. First, in the longitudinal analyses, new-onset HF cases are 
included. Patients with new-onset HF probably experience the most substantial decline 
in sleep quality. Second, in the longitudinal analyses we tested the individual change in 
global PSQI score, while in cross-sectional analyses, the absolute level of this score was 
tested. Participants who develop HF might show a decline in global PSQI score compared to 
participants who do not develop HF, while their baseline global PSQI scores might not differ.
There are several explanations for the observed association between clinical HF and sleep 
quality. HF symptoms such as restless legs, orthopnea, and nocturia due to redistribution 
of extravascular fluid in supine position, can cause disturbances in sleep and changes in 
the sleep-wake pattern. Another explanation is that HF and sleep problems share common 
etiological mechanisms. For example, vascular pathologies could independently explain 
HF and sleep problems.26,27 Furthermore, sleep-disordered breathing is highly prevalent in 
people with HF.28 We adjusted for possible sleep apnea to take this into account. In our 
study, possible sleep apnea was assessed by two questions from the PSQI. However, this is 
not a formal diagnosis of sleep apnea. We cannot rule out that if sleep apnea was measured 
by polysomnography, results could differ. It would be optimal to replicate results with sleep 
apnea assessed using polysomnography.
Only 25% to 35% of people with HF survive 5 years after first diagnosis.5,7 In our study, the 
participants with prevalent HF completed the second PSQI assessment in the longitudinal 
analyses 10.2±2.8 years after onset of HF. The participants with recent-onset HF completed 
the PSQI assessment 3.5±1.8 years after onset of HF. Participants with HF in population-
based studies are thus more likely to be long-term survivors with less severe HF, and this can 
lead to an underestimation of the impact of HF on sleep changes. However, in this study, the 
effect of incident HF upon sleep was only slightly different than the effect of prevalent HF. 
We could not find any effect of cardiac dysfunction measured with echocardiography, and 
sleep problems. This suggests that HF symptoms are on the causal pathway between cardiac 
dysfunction and sleep disturbances.
The major strengths of this study are the prospective data collection and the use of general 
practitioners’ records to assess HF. HF was recorded early in the disease process, often 
before the patient was in specialist care and, hence, the chance of reverse causality was 
low. This study also has some limitations. First, healthy participants were more likely to 
complete the follow-up PSQI, as observed by the reduction in prevalent HF. Consequently, 
the longitudinal analyses included more relatively healthy older adults and could be less 
generalizable. Second, the number of participants with HF was relatively small. We had 
sufficient power to show consistent longitudinal effects, but including more participants with 
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HF might strengthen the findings and would have enabled us to evaluate specific subgroups. 
Third, information on sleep disorders such as sleep apnea was limited. In our study, possible 
sleep apnea was assessed with the PSQI. However, this is not a formal diagnosis of sleep 
apnea. We cannot rule out that formal diagnoses of sleep apnea could change the results. 
To conclude, clinical HF, but not cardiac dysfunction as measured by echocardiography, 
increases the risk of poor sleep quality in the general population over time. Moreover, no 
cross-sectional associations were observed in this population-based study. These findings 
suggest that clinical manifestations of HF negatively affect sleep. 
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Supplemental Material
Supplementary Table 1 Baseline characteristics of the cross-sectional sample (n = 3445)
 Measures  
Gender (male), n (%) 1487 (43.2%)
Age, mean (SD) 72.0 (7.1)
Body mass index (kg/m2), mean (SD) 27.6 (4.2)
Education, n (%): Low 660 (19.2%)
                          Intermediate 2302 (66.8%)
                          High 483 (14.0%)
Depressive symptomsa, mean (SD) 5.9 (7.2)
Possible sleep apnea, n (%) 288 (8.4%)
Systolic blood pressure (mm Hg), mean (SD) 149.4 (22.1)
Diastolic blood pressure (mm Hg), mean (SD) 80.0 (11.4)
Diabetes Mellitus, n (%) 504 (14.6%)
Current smoking, n (%) 456 (13.2%)
Alcohol intake (units per week), mean (SD) 7.7 (10.1)
Fractional shortening, mean (SD) 37.9 (7.3)
Left ventricular systolic function, n (%): Normal 1837 (53.3%)
                                                         Fair 1346 (39.1%)
                                                         Moderate 150 (4.3%)
                                                         Poor 112 (3.3%)
E/A ratio, n (%): < 0.75 1079 (31.3%)
                         0.75-1.50 2292 (66.5%)
                         > 1.50 74 (2.2%)
Diuretics use, n (%): No 2932 (85.1%)
                                  Low 455 (13.2%)
                                  High 58 (1.7%)
Global PSQI scoreb, mean (SD) 3.9 (3.6)
Baseline (imputed data). aMeasured with the Center for Epidemiologic Studies-Depression scale. bPSQI: Pittsburgh 
Sleep Quality Index.
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Cerebral small vessel disease is related to disturbed 
24-h activity rhythms: a population-based study
Lisette A. Zuurbier, M. Arfan Ikram, Annemarie I. Luik, Albert Hofman, 
Eus J.W. van Someren, Meike W. Vernooij, and Henning Tiemeier
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R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 3.1
78
Abstract
Background: Cerebral small vessel disease is common in elderly persons. Patients with 
dementia or stroke frequently have cerebral small vessel disease and often experience 
disturbances in the sleep-wake rhythm. It is unknown whether cerebral small vessel disease 
is related to disturbances in sleep and 24-hour activity rhythms. 
Methods: This study was conducted in the Rotterdam Study. A total of 970 community-
dwelling persons (mean age 59.2 years) underwent brain MRI scanning and actigraphy. 
Cerebral small vessel disease was defined as white matter lesions (total volume in mL), 
presence of cerebral microbleeds and lacunar infarcts. 24-Hour activity rhythms and 
sleep were measured with actigraphy by estimating the instability and fragmentation of 
the activity rhythm and total sleep time. Sleep quality was assessed with the Pittsburgh 
Sleep Quality Index. White matter lesions, instability, fragmentation and sleep quality were 
standardized for analyses. 
Results: Higher white matter lesion volume (B= 0.09 per standard deviation (SD), 95% CI=0.02; 
0.15) and cerebral microbleeds (B=0.19 per SD, 95% CI=0.02; 0.37) were significantly related 
to more fragmented 24-hour activity rhythms. None of the small vessel disease markers was 
related to total sleep time or sleep quality.
Conclusions: White matter lesion volume and presence of cerebral microbleeds are related 
to disturbed activity rhythms. This suggests that subclinical brain damage affects the 24-
hour activity rhythm.
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Introduction
Circadian rhythms are involved in the control of many physiological processes, such as 
hormone secretion, body temperature and sleep-wake timing. Many elderly persons suffer 
from disturbances in their circadian rhythm and sleep. These disturbances are characterized 
by an increased sleep latency, a fragmented 24-hour activity rhythm, an earlier bed and 
wake up time, more napping, less sleep during the night and a lower sleep quality.1,2 These 
disturbances could be explained by age-related changes occurring in the hypothalamic 
suprachiasmatic nucleus (SCN), the biological clock of the brain.3 With aging, decreases in 
cell number and volume of the SCN are observed.4 In persons with brain disease such as 
dementia and stroke disturbances in sleep and 24-hour activity rhythms are particularly 
profound,5,6 suggesting that structural brain changes may play a role in these disturbances. 
Patients with dementia and stroke frequently have structural brain damage caused by 
cerebral small vessel disease, which may manifest as lacunar infarcts, white matter lesions 
(WMLs) or cerebral microbleeds (CMBs).7,8 These markers of cerebral small vessel disease can 
often be detected in middle aged and elderly persons with magnetic resonance imaging.9-11 
Yet, it is unknown whether cerebral small vessel disease is related to disturbances in 24-
hour activity rhythms and sleep.
The aim of this population-based study was to investigate the associations between cerebral 
small vessel disease and 24-hour activity rhythm and sleep parameters in a community-
dwelling, stroke-free population. We hypothesize that WMLs, lacunar infarcts and CMBs are 
all associated with unstable and fragmented 24-hour activity rhythms, as well with worse 
sleep quality.
Methods
Participants 
This study was conducted in the Rotterdam Study, a population-based cohort of middle-aged 
and elderly persons, living in a district of Rotterdam, the Netherlands.12 The Rotterdam Study 
has been approved by the Medical Ethics Committee of the Erasmus MC. All participants 
provided written informed consent to participate in the study and to obtain information 
from their treating physicians. 
Between September 2004 and March 2007 all participants were asked to participate in the 
actigraphy study, 2063 persons participated (response rate 78.4%). After exclusion of failed 
recordings due to technical problems and recordings containing less than 4 consecutive days 
and nights, 1734 (83.2%) recordings were included.13 From these 1734 participants, 1179 
persons without magnetic resonance imaging (MRI) contraindications (e.g. claustrophobia) 
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were invited for brain MRI scanning. Of these, 1031 agreed to participate (response rate 
87.4%). We excluded scans with artefacts (n= 27) and participants with clinical stroke (n= 15) 
or cortical infarcts on MRI (n= 19) from analyses. Therefore 970 participants were included. 
The average time between the MRI scan and the week of actigraphy was 3 months (range 
0 – 27 months).
Magnetic resonance imaging
Brain imaging was performed with a 1.5 Tesla MRI scanner (General Electric Healthcare, 
Milwaukee, USA, software version 11x) with an 8-channel head coil, and included T1-
weighted, T2*-weighted, proton density weighted and fluid-attenuated inversion recovery 
sequences, as described previously.14-16 Cerebral small vessel disease was defined as WMLs 
(total volume in mL), presence of CMBs or lacunar infarcts (focal lesions ≥3 and <15 mm). 
Actigraphy
Participants were asked to wear an actigraph (Actiwatch model AW4, Cambridge Technology 
Ltd, Cambridge, United Kingdom) for seven consecutive days and nights in order to obtain 
reliable estimates.17 Actigraphs were obtained in 30-second epochs. We analyzed the 24-
hour activity rhythms non-parametrically,5 as described previously.13,18 Fragmentation was 
assessed by the intradaily variability, indicating the rate of alternating between rest and 
activity. The stability was assessed by the interdaily stability, indicating how similar the 
day-night patterns are over days. We reverse coded interdaily stability to define interdaily 
instability. Therefore, both 24-hour activity rhythm variables represent a disturbed rhythm. 
We also used actigraphy to estimate total sleep time and wake after sleep onset, which have 
been described in more detail previously.19 
Pittsburgh Sleep Quality Index
The Pittsburgh Sleep Quality Index (PSQI) was used to measure sleep quality and possible 
sleep apnea.20 Sleep quality was measured with the global PSQI score (range 0-21). 
Higher scores represent a poorer sleep quality. Possible sleep apnea was considered 
when participants reported loud snoring at least 2 nights per week together with at least 
occasional respiratory pauses, or if they reported respiratory pauses during sleep at least 
1-2 times per week.21 
Covariates
Age, sex, body mass index (BMI), depressive symptoms, activities of daily living, possible 
sleep apnea, fasting blood glucose, total cholesterol, systolic blood pressure and use 
of antihypertensives, lipid lowering and sleep medication were considered as possible 
covariates. We assessed activities of daily living with the Stanford Health Assessment 
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Questionnaire,22 depressive symptoms with the Center for Epidemiologic Studies-Depression 
scale23 and cognitive function with the Mini Mental State Exam.24 Serum glucose and total 
cholesterol were determined by an automated enzymatic procedure. Information on 
antihypertensive and lipid lowering medication was obtained from continuously monitored 
pharmacy records. Information on sleep medication was acquired by sleep diaries which 
participants kept during the week of actigraphy. Sleep medication use was analyzed as the 
total number of days a participant used sleep medication, taking into account the number 
of days the participant answered this question.
Statistical analyses
We tested whether WMLs, the presence of CMBs or the presence of lacunar infarcts were 
related to 24-hour activity rhythm and sleep parameters with linear regression adjusted 
for age, sex, BMI, activities of daily living, depressive symptoms, systolic blood pressure, 
possible sleep apnea, glucose and cholesterol levels, and use of antihypertensives, sleep 
and lipid lowering medication. To correct for head size, analyses regarding WMLs were 
additionally adjusted for intracranial volume. The number of missing values of a variable 
never exceeded 1%. Missing categorical values were added as a separate missing category.
WMLs, interdaily instability, fragmentation, sleep quality and wake after sleep onset were 
normalized and standardized. Correlations between 24-hour activity rhythm and sleep 
parameters were computed using Pearson correlation. Analyses were performed with IBM 
SPSS Statistics for Windows (Version 21. Armonk, NY:IBM Corp). 
Results
The mean age of the total population of 970 persons was 59.2 years (±7.5 standard deviation 
(SD)) and 52% were female. Other population characteristics can be found in Table 1. The 24-
hour activity rhythm parameters interdaily instability and fragmentation were moderately 
correlated (r= 0.53, P<0.001). These activity rhythm parameters were also moderately 
correlated with total sleep time (r= -0.34, P<0.001; r= -0.31, P<0.001, respectively, Table 2).
Table 3 shows the associations of cerebral small vessel disease markers with the 24-hour 
activity rhythm parameters. WMLs were significantly related to more fragmentation of 
the 24-hour activity rhythm (B= 0.09 per SD, 95% CI= 0.02; 0.15). Persons with CMBs were 
more likely to have more instability (B= 0.17 per SD, 95% CI= -0.01; 0.34) and a higher 
fragmentation (B= 0.19 per SD, 95% CI= 0.02; 0.37), although the association between CMBs 
and interdaily instability did not reach statistical significance. 
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Table 1 Population characteristics (n=970)
Measures Mean ± SD or n (%)
Demographics
Age, years 59.2 ± 7.5
Gender, female 503 (51.9%)
Body mass index, kg/m2 27.6 ± 4.0
Activities of daily living, score 0.2 ± 0.3
Depressive symptoms, score 5.3 ± 7.1
Sleep medication, days 0.42 ± 1.4
Systolic blood pressure, mmHg 134.6 ± 20.1
Diastolic blood pressure, mmHg 80.7 ± 11.2
Antihypertensive medication, yes 271 (27.9%)
Total cholesterol, mmol/L 5.6 ± 1.0
Fasting blood glucose, mmol/L 5.6 ± 1.5
Diabetes mellitus, yes 99 (10.2%)
Lipid lowering medication, yes 195 (20.1%)
Possible sleep apnea, yes 137 (14.1%)
Cerebral small vessel disease
White matter lesions, mL 3.8 ± 5.1
Lacunar infarcts, yes 43 (4.4%)
Cerebral microbleeds, yes 129 (13.3%)
24-Hour activity rhythms and sleep
Interdaily instability, score -0.8 ± 0.1
Fragmentation (intradaily variability), score 0.4 ± 0.1
Total sleep time, hours 6.3 ± 0.9
Wake after sleep onset, minutes 69.0 ± 25.3
Sleep quality, score 3.4 ± 3.3
Table 2 Correlations between 24-hour activity rhythm and sleep parameters
1 2 3 4 5
1. Interdaily instability -
2. Fragmentation (intradaily variability)  0.53 -
3. Total sleep time -0.34 -0.31 -
4. Wake after sleep onset  0.15  0.27 -0.18 -
5. Sleep qualitya  0.06  0.08 -0.05 0.10 -
Bold indicates P<0.05.
aHigher scores represent a poorer sleep quality.
These results were only moderately changed after additional adjustment for total sleep 
time, wake after sleep onset and sleep quality. No associations were found between lacunar 
infarcts and 24-hour activity rhythm parameters. The associations of WMLs and CMBs 
with fragmentation were independent of each other. When both variables were studied 
as determinants of fragmentation in one multivariable adjusted model, they were each 
associated with fragmentation (B=0.08 per SD, 95% CI=0.01; 0.15 and B= 0.17 per SD, 95% 
CI= 0.00; 0.37, respectively).
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WMLs, CMBs and lacunar infarcts were not related to total sleep time, wake after sleep 
onset and sleep quality (Supplemental Table 1). 
Table 3 Associations between cerebral small vessel disease and 24-hour activity rhythm parameters
Interdaily instabilitya Fragmentation (intradaily variability)a
 B 95% CI P value   B 95% CI P value
White matter lesionsa
Age, sex adjusted 0.036 -0.033; 0.105 0.31    0.098 0.030; 0.167 0.01
Multivariable adjusted 0.028 -0.042; 0.100 0.43    0.085 0.017;0.154 0.02
Lacunar infarcts (yes)
Age, sex adjusted -0.020 -0.311; 0.271 0.89    0.180 -0.108; 0.469 0.22
Multivariable adjusted -0.100 -0.392; 0.194 0.51    0.103 -0.188; 0.393 0.49
Cerebral microbleeds (yes)
Age, sex adjusted 0.163 -0.013; 0.338 0.07    0.197 0.023; 0.371 0.03
Multivariable adjusted 0.167 -0.008; 0.341 0.06    0.192 0.019; 0.365 0.03
Multivariable adjusted models are adjusted for age, sex, body mass index, activities of daily living, depressive 
symptoms, sleep apnea, total cholesterol, systolic blood pressure, blood glucose, antihypertensives, lipid lowering 
and sleep medication.
Analyses with white matter lesions are additionally adjusted for intracranial volume.
aStandardized variable.
Discussion
In this population-based study, we found that WML volume and presence of CMBs were 
related to more unstable and fragmented 24-hour activity rhythms, independent of total 
sleep time, and sleep quality. 
Unstable and fragmented 24-hour activity rhythms reflect disturbed activity rhythms. 
Previous studies of disrupted rhythms found that they predict morbidity, for example, 
dementia, cardiovascular disease and mortality, but also high BMI and depressive symptoms 
5,13,18,25. Little is known about cerebral small vessel disease and the associations with 24-hour 
activity rhythms and sleep in the general population. However, several potential mechanisms 
can be inferred from clinical studies. First, structural brain damage might disrupt 24-hour 
activity rhythms. Different pathological processes in cerebral blood vessels may directly 
cause structural brain damage, including those indicative of cerebral small vessel disease. 
WMLs, lacunar infarcts and CMBs can interrupt frontal-subcortical connections, including 
periventricular fibers, i.e. pathways to and from the hypothalamus, and thus interfere with 
the sleep-wake cycle.26,27 Also, the volume and cell number in the SCN, could decrease and 
the function of this internal clock could decline,4 possibly causing unstable 24-hour activity 
rhythms. In persons with brain disease such as Alzheimer’s disease, who frequently have 
structural brain damage caused by cerebral small vessel disease,8 such disturbances of 
the SCN are profound, and increase with the severity of Alzheimer’s disease related brain 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 3.1
84
pathology.4,5 In Alzheimer’s disease patients disturbances in sleep and 24-hour activity 
rhythms are often observed.5,28
Second, because the relationship between cerebral small vessel disease with 24-hour 
activity rhythms and sleep likely are bi-directional, disturbances in sleep and 24-hour activity 
rhythms could contribute to the occurrence of cerebral small vessel disease. One possible 
effect mediator is changes in the neuroendocrine system. Disruptions in the sleep-wake cycle 
can impair the neuroendocrine system, including emotional and cognitive processes.28 For 
example, sleep deprivation is related to an impaired ability to form new memories and to an 
inappropriate emotional response to negative aversive stimuli.29,30 Functional impairment in 
the neuroendocrine system may precede long-term structural changes in the brain. 
Third, an external factor may underlie the association, such as sleep disordered breathing 
or subclinical cardiovascular changes. Sleep disordered breathing causes disturbances in 
the sleep-wake pattern, such as fragmentation during sleep, and is related to stroke.31 Also, 
subclinical cardiovascular risk factors, like hypertension or the absence of blood pressure 
dipping during sleep, are often seen in patients with sleep disordered breathing.32,33 We 
accounted for subclinical cardiovascular disease by correcting for BMI, systolic blood 
pressure, total cholesterol, blood glucose, use of antihypertensive and lipid lowering 
medication, and for possible sleep apnea, as assessed by two questions from the PSQI. 
However, the PSQI cannot be used to diagnose sleep apnea. 
As people age, their circadian rhythms and sleep change. Elderly fall asleep and wake up 
earlier, have increased fragmented nights, sleep less during the night and report a lower 
sleep quality.1,2 In this study the 24-hour activity rhythm parameters interdaily instability 
and fragmentation were only moderately correlated to sleep parameters. This is in line with 
our findings that the associations of WMLs and CMBs with the fragmentation of the 24-hour 
activity rhythm were independent of total sleep time, wake after sleep onset and sleep 
quality. 
To our knowledge this is the first study using both MRI scans and actigraphy in the general 
population to study associations between cerebral small vessel disease and 24-hour activity 
rhythms. The study has several strengths. First, it is embedded in a large population-based 
study. Second, we assessed three indicators of cerebral small vessel disease in combination 
with objective 24-hour activity rhythm parameters. The study also has some limitations. 
First, the information on the participant’s clinical sleep disorders including sleep apnea was 
limited. To optimally control for the influence of sleep apnea, it needs to be assessed with 
polysomnography. Also, wrist actigraphy is only an indirect measurement of the circadian 
rhythm. Melatonin and core body temperature are more specific to study circadian rhythms. 
Finally, this study has a cross-sectional design, thus we cannot assess the causality of the 
relationship between cerebral small vessel disease and disturbed 24-hour activity rhythms. 
Our finding that cerebral small vessel disease is related to disturbed 24-hour activity 
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rhythms suggests that the disturbances seen in the sleep-wake rhythm in stroke and 
dementia patients arise early in the disease process before clinical signs are present. Future 
longitudinal studies are needed to study whether prevention of small vessel disease in the 
elderly (e.g. by antihypertensive treatment or exercise) protects against circadian rhythm 
disturbances. Alternatively, research can examine whether intervention supporting a stable 
and robust circadian rhythm protects against brain disease.
To conclude, in this population-based study of middle-aged and elderly persons, WMLs and 
the presence of CMBs were related to disturbed 24-hour activity rhythms, independent of 
sleep. Although this study cannot show the direction of the effects, these findings suggest 
that subclinical brain damage may affect circadian rhythms. 
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Abstract
Sleep apnea has been related to brain changes such as atrophy. However, which component 
of sleep apnea, the apnea-hypopnea index (AHI), nocturnal oxygen desaturation or arousals, 
can explain this association is unclear. In this large population-based study (n=681, mean 
age 62.1 years), we investigated the associations of AHI, nocturnal oxygen desaturation 
and arousals with cerebral gray matter, white matter and white matter lesion volumes. All 
participants underwent one night of polysomnography and MRI scanning of their brain. Gray 
matter, white matter and white matter lesion volumes adjusted for intracranial volume were 
studied as markers of brain atrophy. Nocturnal oxygen desaturation (per increase in events/
min) was related to a smaller white matter volume (multivariable adjusted B= -8.3 ml, 95% 
CI= -16.7; -0.02). AHI and arousals (events/min) were not associated with gray matter, white 
matter or white matter lesion volumes. This suggests that oxygen desaturation during sleep 
relates to white matter brain atrophy, and that the amount of apneas or hypopneas or sleep 
apnea related arousals did not explain this association.
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Introduction
Sleep apnea is a common disorder; over 10% of the adult population (30-70 years old) 
have an apnea-hypopnea index (AHI) ≥15, but the prevalence increases to about 20% in 
adults aged 60-70 years old.1 It is characterized by repetitive respiratory events (apneas and 
hypopneas) during sleep, leading to sleep fragmentation, nocturnal intermittent hypoxia (or 
oxygen desaturation), arousals and daytime sleepiness. Sleep apnea has been associated 
with several clinical outcomes, such as hypertension, cardiovascular disease, cognitive 
decline and mortality.2-5 Furthermore, in patients with stroke, sleep apnea (AHI ≥10) has a 
much higher prevalence than in the general population.6-8 These findings suggest that sleep 
apnea may be related to structural brain changes in adults.
Previous studies of apnea severity and brain changes are inconsistent. Whereas several 
investigators found a relation of moderate to severe sleep apnea and the presence of white 
matter change and silent cerebrovascular lesions,9-11 others reported no association.12-14 
The majority of these studies were not conducted in the general population or had a 
small sample size. Gray matter volumes were smaller in sleep apnea patients compared to 
controls, mainly in the hippocampus and frontal areas.15,16 However, gray matter volume 
differences between sleep apnea patients and controls have not been found consistently.17 
It is yet unclear how several aspects of sleep apnea (the AHI, nocturnal oxygen desaturation 
and arousals) affects cerebral gray matter, white matter and white matter lesion volumes.
In a large population-based sample of middle-aged and elderly persons, we studied the 
associations of AHI, nocturnal oxygen desaturation and arousals with white and gray matter 
brain atrophy and white matter lesion volumes. We hypothesized that the sleep apnea 
aspects are associated with gray and white matter brain atrophy and with larger white 
matter lesion volumes. We expected that the AHI would be the best predictive measure, 
because oxygen desaturation and arousal are included in its definition.
Materials and Methods
Study population
This study was conducted within the Rotterdam Study, a population-based cohort of persons 
aged 45 years and older, living in one district in Rotterdam, the Netherlands. The study targets 
neurological, psychiatric, cardiovascular and other chronic disorders.18 The Rotterdam Study 
has been approved by the Medical Ethics Committee of the Erasmus MC and by the Ministry 
of Health, Welfare and Sport of the Netherlands, implementing the “Population Studies Act: 
Rotterdam Study”. All participants provided written informed consent to participate in the 
study and to obtain information from their treating physicians. 
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From January 2012 until February 2014, 1434 persons were invited for the polysomnnographic 
(PSG) sleep study; 811 participants (56.6%) agreed. Persons who participated in the PSG 
study did not significantly differ in age or sex from persons who refused participation. Of 
the 811 persons, we excluded 15 participants because the PSG was of insufficient quality. Of 
the included persons, 724 persons (91.0%) also had a usable MRI scan of the brain, acquired 
as part of the Rotterdam Scan Study.19 Participants who used a continuous positive airway 
pressure mask, or who had a clinical stroke or MRI-defined cortical infarct were excluded 
(n=43). Therefore, the recordings of 681 persons were used in analyses. The time between 
the PSG and MRI scan was on average 10 months (standard deviation (SD) 17). 
Polysomnography
Ambulant PSG was recorded at the participant’s home using the ambulatory Vitaport 4 
(Temec Instruments, Kerkrade, the Netherlands). A trained research assistant placed all 
sensors. The PSG included electroencephalography (EEG: F3, F4, C3, C4, O1, O2, A1 and 
A2), bilateral electrooculography, electromyography, electrocardiography and respiration 
measurements.20 Respiration was measured with respiratory belts, an oronasal thermocouple, 
a nasal pressure transducer and oximetry. Participants were instructed to spend the night 
as normal as possible. There were no restrictions on medication, alcohol and coffee use, 
or bedtimes. An experienced registered polysomnogram technologist (RPSGT) scored all 
recordings for apneas and hypopneas. Apneas were defined as a continuous reduction of 
airflow of at least 90% from baseline for at least 10 seconds. Hypopneas were defined as 
a continuous reduction of airflow of at least 30% from baseline for at least 10 seconds, 
together with oxygen desaturation of at least 3% from pre-event baseline, or an arousal.21 
We calculated the AHI as the total number of apneas and hypopneas per hour of sleep using 
Prana software (PhiTools, Strasbourg, France). Nocturnal peripheral oxygen desaturation 
was defined as the number of times per minute the participant’s oxygen saturation dropped 
by at least 3% during sleep, regardless of presence of an apnea or hypopnea.21 Arousals were 
measured in events per minute. Of all participants, 21 persons did not have information on 
oxygen desaturation and 51 persons did not have information on arousals.
Magnetic resonance imaging
Brain imaging was performed with a 1.5-Tesla scanner (General Electric Healthcare, 
Milwaukee, USA, software version 11x) with an eight-channel head coil and included T1-
weighted, T2*-weighted, proton-density-weighted and fluid-attenuated inversion recovery 
sequences.19 Gray matter, white matter and white matter lesion volumes were quantified 
by a validated automatic tissue classification technique based on a k-nearest neighbor 
classifying algorithm using T1-weighted, proton density weighted and FLAIR scans.22,23 
Intracranial volume was calculated by summing gray matter, white matter, white matter 
lesions and cerebrospinal fluid volumes. 
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Covariates
Age, sex, educational level, body mass index, smoking, alcohol use, depressive symptoms, 
diabetes mellitus, myocardial infarction and use of sleep medication were analyzed as possible 
confounders based on established risk factors for brain changes.9 Additionally, systolic blood 
pressure and total cholesterol were considered as possible intermediates and entered in 
additional analyses. Information on educational level (low, intermediate, high), smoking (no, 
previous, current) and depressive symptoms (assessed using the Center for Epidemiologic 
Studies Depression scale)24 was collected during a home interview. During a research center 
visit, height and weight were measured to calculate the body mass index (kg/m2) and sitting 
blood pressure was measured twice using a random-zero sphygmomanometer. Serum total 
cholesterol was measured in mmol/L using an automated enzymatic procedure. History of 
myocardial infarction and diabetes were determined by medical records and self-report. 
Participants were asked whether they used sleep medication on the night of the PSG.
Statistical analysis
We studied whether AHI, nocturnal oxygen desaturation and arousals were associated with 
gray and white matter brain atrophy and white matter lesion volumes using multivariable 
linear regression analyses. All analyses were adjusted for intracranial volume to correct 
for head size. Furthermore, white matter lesion volumes were normalized by natural 
logarithmic transformation and standardized. All sleep apnea related determinants were 
studied continuously and categorically. For these categorical analyses, we defined low AHI 
(AHI <15), moderate AHI (15-<30) and high AHI (≥30); oxygen desaturation was transformed 
into tertiles; and arousals were analyzed dichotomously. 
We specified two etiological models and a mediator model. The first model was adjusted 
for age, sex and intracranial volume. The second model, the multivariable adjusted model, 
was additionally adjusted for body mass index, education, smoking, alcohol use, diabetes, 
myocardial infarction and the interval between brain scan and polysomnography study. The 
mediator model was additionally adjusted for systolic blood pressure and total cholesterol. 
We conducted two sensitivity analyses. First, AHI, oxygen desaturation and arousals were all 
included in one mutually adjusted model to study their independent effects. In this analysis, 
parameters were standardized to facilitate interpretation. Second, we tested whether sex-
specific differences were present for the associations.
The proportion of missing values of the covariates never exceeded 3%. Missing values 
in quantitative covariates were replaced by the mean. For missing values in qualitative 
covariates a separate missing category was used. Analyses were performed using SPSS 
Statistics (version 21; SPSS, Chicago, IL, USA).
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Results
Descriptive statistics of the participants (n=681) can be found in Table 1. Participants were 
on average 62.1 (range 51 – 95) years, 56% was female and the average body mass index was 
27.2 (SD 4.4). The average AHI was 13.5 (SD 12.5); n= 447 had a low AHI (<15), n= 153 had 
a moderate AHI (15-<30) and n= 81 had a high AHI (≥30). The average oxygen desaturation 
was 0.3 per minute (range 0 – 1.9) and the average arousal index was 0.05 per minute (range 
0 – 2.6). The AHI correlated strongly with the number of oxygen desaturations (r= 0.79, 
p<0.001), but did not correlate with the number of arousals (r= -0.001, p=0.98). The number 
of oxygen desaturations and arousals correlated weakly (r= -0.17, p<0.001).
Table 1 Descriptive statistics (n=681)
 Mean (SD), n (%)
Age, years                     62.1 (5.4)
Sex, female 380 (55.8%)
Education: Low 53 (7.8%)
                  Intermediate 409 (60.1%)
                  High 217 (31.9%)
Body mass index, kg/m2                     27.2 (4.4)
Smoking: Never 199 (29.2%)
                Current 113 (16.6%)
                Previous 368 (54.0%)
Alcohol use at night of PSG, units       0.5 (1.0)
Depressive symptoms, score       5.4 (6.7)
Systolic blood pressure, mmHg  132.9 (17.9)
Total cholesterol, mmol/l      5.6 (1.1)
Diabetes mellitus, yes     41 (6.0%)
Myocardial infarction, yes    11 (1.6%)
Sleep medication, yes    55 (8.1%)
AHI     13.5 (12.5)
     Low AHI (<15)      447 (65.6%)
     Moderate AHI (15-<30)      153 (22.5%)
     High AHI (≥30)        81 (11.9%)
Nocturnal oxygen desaturation, n/min       0.3 (0.3)
Arousals, n/min     0.05 (0.15)
Abbreviations: AHI, apnea-hypopnea index; PSG, polysomnography; SD, standard deviation.
We found no associations of AHI with gray matter, white matter and white matter lesion 
volumes, whether modeled continuously or categorically (Table 2). No sex-specific 
differences were present in the associations of AHI and brain volumes.
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Table 2 Associations of AHI and brain structural measurements (n= 681)
Gray matter (ml) White matter (ml) White matter lesions (SD)*
 B (95% CI), p B (95% CI), p B (95% CI), p
AHI continuous
     Age, sex adjusted  -0.06 (-0.24; 0.11), 0.48  -0.13 (-0.33; 0.07), 0.19 0.002 (-0.003; 0.01), 0.49
     Multivariable adjusted†  -0.06 (-0.25; 0.12), 0.49  -0.06 (-0.28; 0.15), 0.55 0.001 (-0.004; 0.01), 0.72
Low AHI (<15), n= 447 0 (reference) 0 (reference) 0 (reference)
Moderate AHI (15-<30), n= 153
     Age, sex adjusted 3.4 (-1.7; 8.6), 0.19  -2.8 (-8.7; 3.2), 0.36  -0.03 (-0.17; 0.11), 0.69
     Multivariable adjusted† 3.9 (-1.4; 9.2), 0.16  -1.9 (-7.9; 4.2), 0.55  -0.05 (-0.19; 0.10), 0.53
High AHI(≥30), n= 81
     Age, sex adjusted  -3.5 (-10.1; 3.2), 0.31  -5.6 (-13.3; 2.0), 0.15 0.04 (-0.13; 0.22), 0.62
     Multivariable adjusted†  -3.4 (-10.3; 3.5), 0.33  -4.0 (-11.9; 3.9), 0.32 0.03 (-0.16; 0.21), 0.78
Abbreviations: AHI, apnea-hypopnea index; CI, confidence interval; SD, standard deviation. Values represent 
difference in brain tissue volume per unit increase in AHI. Linear regression analyses adjusted for intracranial 
volume. *Normalized and standardized; †Additionally adjusted for body mass index, education, smoking, alcohol 
use, diabetes, myocardial infarction and interval between brain scan and polysomnography study.
More oxygen desaturations (events/minute) during sleep was related to a smaller white 
matter volume (B= -10.4 ml, 95% CI= -18.0; -2.8, Table 3). In the multivariable adjusted 
model, the effect size was attenuated (B= -8.3 ml, 95% CI= -16.7; -0.02). Further adjustment 
for the possible mediators systolic blood pressure and total cholesterol did not change the 
effect (B= -8.4, 95% CI= -16.7; -0.03). Categorical analyses confirmed a dose-dependent 
effect. No associations were found between oxygen desaturation and gray matter or white 
matter lesion volumes. We found no associations between the numbers of arousals with 
gray and white matter brain atrophy or white matter lesion volumes, whether modeled 
continuously or dichotomously (Table 4). 
In a mutually adjusted analysis, oxygen desaturation remained associated with white matter 
(B= -5.5 ml per SD, 95% CI= -9.9; -1.0) whereas the AHI and arousals were not (B= 3.4 ml 
per SD, 95% CI= -1.0; 7.8; B= -1.0 ml per SD, 95% CI= -3.7; 1.6 respectively. Parameters were 
standardized to facilitate interpretation). 
Discussion
In this large population-based study, we assessed whether aspects of sleep apnea were 
related to brain changes. The AHI, indicating the frequency of breathing pauses, and arousals 
were not related to gray and white matter brain atrophy and white matter lesion volumes. In 
contrast, nocturnal oxygen desaturation was related to white matter atrophy independent 
of covariates.
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Table 3 Associations of nocturnal oxygen desaturation with brain structural measurements (n= 660)
Gray matter (ml) White matter (ml) White matter lesions (SD)*
 B (95% CI), p B (95% CI), p B (95% CI), p
Oxygen desaturation (n/min) 
Age, sex adjusted -4.3 (-11.0; 2.3), 0.20 -10.4 (-18.0; -2.8), 0.01  0.04 (-0.14; 0.21), 0.67
Multivariable adjusted† -4.6 (-11.7; 2.7), 0.22 -8.3 (-16.7; -0.02), 0.049  -0.004 (-0.20; 0.19), 0.97
Mediator model‡ -4.6 (-11.8; 2.7), 0.22 -8.4 (-16.7; -0.03), 0.049  -0.004 (-0.20; 0.19), 0.97
Low oxygen desaturation , n= 220 0 (reference) 0 (reference) 0 (reference)
Moderate oxygen desaturation, n= 221
     Age, sex adjusted -1.4 (-6.6; 3.8), 0.60 -1.5 (-7.5; 4.6), 0.63 -0.09 (-0.23; 0.05), 0.19
     Multivariable adjusted† -1.1 (-6.5; 4.2), 0.67 -0.7 (-6.8; 5.4), 0.83 -0.11 (-0.25; 0.04), 0.14
High oxygen desaturation, n= 219
     Age, sex adjusted -2.8 (-8.1; 2.4), 0.29 -6.1 (-12.2; -0.1), 0.047 -0.00 (-0.14; 0.14), 0.99
     Multivariable adjusted† -2.6 (-8.2; 3.1), 0.37   -4.2 (-10.7; 2.3), 0.20 -0.03 (-0.18; 0.12), 0.70
Abbreviations: AHI, apnea-hypopnea index; CI, confidence interval; SD, standard deviation. Values represent 
difference in brain tissue volume per unit increase in oxygen desaturation. Linear regression analyses adjusted 
for intracranial volume. *Normalized and standardized; †Additionally adjusted for body mass index, education, 
smoking, alcohol use, diabetes, myocardial infarction and interval between brain scan and polysomnography study; 
‡Additionally adjusted for systolic blood pressure and total cholesterol.
Table 4 Associations of nocturnal arousals and brain structural measurements (n= 630)
Gray matter (ml) White matter (ml) White matter lesions (SD)*
 B (95% CI), p B (95% CI), p B (95% CI), p
Arousals continuous
     Age, sex adjusted 5.7 (-8.9; 20.3), 0.44 0.11 (-16.8; 17.0), 0.99 0.21 (-0.17; 0.60), 0.28
     Multivariable adjusted† 4.4 (-10.3; 19.2), 0.44  -0.85 (-17.8; 16.1), 0.92 0.24 (-0.15; 0.63), 0.22
No arousals, n= 396 0 (reference) 0 (reference) 0 (reference)
Arousals, n= 234
     Age, sex adjusted 2.8 (-1.7; 7.3), 0.22 1.6 (-3.6; 6.8), 0.54 0.02 (-0.10; 0.14), 0.73
     Multivariable adjusted† 2.0 (-2.7; 6.6), 0.41 2.1 (-3.2; 7.4), 0.44 0.04 (-0.09; 0.16), 0.57
Abbreviations: CI, confidence interval; SD, standard deviation. Values represent difference in brain tissue volume 
per unit increase in arousals. Linear regression analyses adjusted for intracranial volume. *Normalized and 
standardized; †Additionally adjusted for body mass index, education, smoking, alcohol use, diabetes, myocardial 
infarction and interval between brain scan and polysomnography study.
Nocturnal intermittent oxygen desaturation is related to a an increase in sympathetic 
vasoconstriction, which can increase blood pressure and change the structure and function 
of blood vessels, including blood vessels in the brain.25 We found a relation between 
nocturnal oxygen desaturation and white matter atrophy, which was not accounted for by 
systolic blood pressure or total cholesterol. Furthermore, the association between oxygen 
desaturation and white matter atrophy was independent of myocardial infarction, another 
possible cause of oxygen desaturation. This suggests that oxygen desaturation is directly 
causing white matter atrophy or a different factor, such as anemia or arteriosclerosis, might 
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underlie this association. Anemia and arteriosclerosis have both been associated with 
white matter loss and stroke.26,27 In contrast, white matter atrophy might also cause oxygen 
desaturation. Patients with stroke have a higher prevalence of sleep disordered breathing 
than persons with the same age without stroke.6 It has been found that after the acute phase 
of stroke the AHI decreases in some patients.7,28 However, it also has been reported that only 
central respiratory events (not obstructive events) decrease after this acute phase.29 
Hypoxia and hypotension have smaller effects on gray matter than on white matter 
volume.30,31 This might explain why we found no association of oxygen desaturation and 
gray matter atrophy.
Unexpectedly as white matter atrophy and white matter lesions often co-occur, oxygen 
desaturation was not associated with more white matter lesions. Vernooij et al. (2008) 
found that white matter atrophy and white matter lesions are both related to a loss of 
microstructural integrity of white matter, but in distinct brain regions.32 This indicates 
that these processes are independent, and have a different pathophysiology. The oxygen 
desaturation measured in this population-based sample might not be severe enough to 
cause white matter lesions, but can cause subtle white matter atrophy.
Previous studies of the association of apnea severity and white matter change are 
inconsistent. Several studies found that moderate to severe sleep apnea is associated with 
the presence of white matter lesions, impaired white matter integrity, silent cerebrovascular 
lesions and stroke.7,9-11,33,34 Also, smaller gray matter volumes have been found in sleep apnea 
patients, especially in hippocampal and frontal areas.15,16 However, other studies observed 
no association of sleep apnea severity with gray matter, white matter or white matter lesion 
volumes.12-14,17 We found no associations between AHI and white matter lesions or brain 
volumes. In general, previous studies had small sample sizes and were conducted in case-
control designs, whereas we assessed sleep apnea components in a large study from the 
general population. Our results suggest a less prominent association of sleep apnea with 
brain damage in the general population than in clinical samples. Many persons with mild or 
moderate sleep apnea in the general population do not seek treatment. This suggests that 
some community-dwelling persons suffer less from the consequences of sleep apnea than 
those seeking treatment with the same degree of apnea. It is also possible that sleep apnea 
patients with white matter atrophy are more impacted in their daily functioning and more 
likely to be referred than those without lesions. Therefore the results in clinical samples 
might be stronger. Another reason for the discrepancies in results is that many studies of 
sleep apnea assess sleep apnea severity only by the AHI index. The AHI is a crude measure 
of measuring sleep apnea. For example, the definitions for hypopneas used to calculate the 
AHI have varied in the field historically, calculating the AHI ignores the temporal distribution 
of the apneas and hypopneas and it does not take the duration of events into account.35
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This study has several strengths. First, it is embedded in a population-based cohort. Therefore, 
results are generalizable and we could assess many different covariates. Furthermore, to 
our knowledge this is the largest study of sleep apnea and brain changes in the cerebrum 
in the general population. However, this study also has some limitations. First, it is a cross-
sectional study. Therefore we cannot rule out a long-term effect of sleep apnea. Second, 
brain imaging and PSG were not conducted in the same day. 
Conclusion
To conclude, this population-based study showed that nocturnal oxygen desaturation is 
related to white matter atrophy, but that the AHI or sleep apnea related arousals do not 
explain this association. This suggests that oxygen desaturation is a particularly sensitive 
predictor of white matter atrophy. Future research is needed to study whether different 
causes of oxygen desaturation, such as anemia or arteriosclerosis, explain the association of 
oxygen desaturation and white matter atrophy. 
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Abstract
Study objectives: Poor sleep, accompanied by changes in the EEG, is commonly seen at 
older age. In parallel, variations in the brain, such as atrophy, vascular lesions, and brain 
connectivity commonly occur. We hypothesized that variations in brain morphology underlie 
poor sleep in middle-aged and elderly persons. 
Design: Cross-sectional study.
Setting: Population-based, Rotterdam Study, the Netherlands.
Participants: 643 participants (mean age 62 years (range 52 – 95), 54.1% women).
Interventions: None.
Measurements and Results: All participants underwent MRI and polysomnography to 
assess brain tissue volumes, vascular lesions and connectivity between brain areas, and 
absolute delta and beta power, total sleep time, sleep onset latency and wake after sleep 
onset. More beta power related to shorter sleep time (β= -0.18, 95% CI= -0.27; -0.10), longer 
wake after sleep onset (β= 0.25, 95% CI= 0.17; 0.34) and poor subjective sleep quality (β= 
0.11, 95% CI= 0.03; 0.19). Image-derived brain measures were related to beta power during 
NREM sleep: smaller gray matter volume was associated with more beta power (β= -0.10, 
95% CI= -0.18; -0.03), whereas both smaller white matter volume and less white matter 
integrity were related to less beta power (β= 0.22, 95% CI= 0.15; 0.29, β= 0.15, 95% CI= 0.06; 
0.24, respectively). We did not find direct or indirect associations of image-derived brain 
measures with delta power or other sleep parameters.
Conclusions: Brain structural variations relate to beta power. However, structural brain 
variations did not account for the associations of beta power with sleep time, sleep latency, 
wake after sleep onset, and sleep quality.
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Introduction
The electroencephalogram (EEG) is key in identifying poor sleep during polysomnography 
(PSG), the gold-standard for sleep research. Poor sleep quality has been associated with 
physical disabilities, depressive symptoms, cognitive impairment, morbidity and mortality.1-3 
Poor sleepers are characterized by lower levels of all frequencies below the beta frequency 
(delta, theta, alpha and sigma), especially delta power, during non-rapid eye movement 
(NREM) sleep, whereas beta power is higher during NREM sleep.4 Delta power (or slow 
wave activity) is an indicator of homeostatic sleep pressure, and in healthy persons gets 
stronger the longer they are awake.5 On the other hand, elevated beta power during sleep 
indicates an increased cortical activation, or hyperarousal, during sleep,4 which marks sleep 
disruption. These EEG patterns during sleep are often person specific and invariant over the 
night.6 Therefore, it has been postulated that EEG patterns may mainly relate to other stable 
characteristics, such as brain structure, and to a lesser extent to other day-by-day varying 
sleep influencing mechanisms.
About 80% of elderly persons report at least one sleep complaint, such as problems falling 
asleep, short sleep, waking up frequently, and a lower sleep quality.1, 7, 8 These changes 
can also be observed in the EEG; in older persons, lower EEG power frequencies, such as 
delta, decrease, whereas higher EEG frequencies, such as beta, increase during sleep.9-11 
However, with aging structural brain changes also occur, for example atrophy, vascular 
lesions, and reduced connectivity between brain areas.12 Studies performed in middle-
aged and elderly patients with insomnia found smaller gray matter volumes in insomnia 
patients,13, 14 suggesting an association between brain structure and sleep quality. Possibly 
these structural changes in the brain underlie the alteration of the sleep EEG at old age.
In a population-based setting of middle aged and elderly persons, we studied the associations 
between image-derived brain measures and sleep parameters, measured both subjectively 
and objectively. Brain morphology, connectivity and brain vascular pathology were assessed 
by brain magnetic resonance imaging (MRI) and beta and delta power during sleep were 
assessed with PSG. Also, the sleep parameters total sleep time, sleep onset latency and 
wake after sleep onset were measured with PSG, whereas subjective sleep quality was 
assessed by a validated questionnaire. We hypothesized that age-related structural brain 
variation (smaller tissue volumes, vascular lesions, and reduced connectivity between brain 
areas) relates to poor sleep, reflected both in EEG activity during sleep and other objective 
and subjective sleep parameters.
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Methods
Study population
This study was conducted within the Rotterdam Study, a population-based cohort among 
middle-aged and elderly adults that started in 1990 in Rotterdam, the Netherlands. The 
study aims to investigate causes and consequences of age-related diseases. Since 2005, 
brain imaging is part of the core examination in the Rotterdam Study and since 2012 PSG 
has been introduced.15 The Rotterdam Study has been approved by the Medical Ethics 
Committee of the Erasmus University Medical Center and by the Ministry of Health, Welfare 
and Sport of the Netherlands, implementing the “Population Studies Act: Rotterdam Study”. 
All participants provided written informed consent to participate in the study and to obtain 
information from their treating physicians. 
From January 2012 until February 2014, 1434 persons were invited to participate in a PSG 
sleep study; of whom 811 participants (56.6%) agreed. Persons who participated in the PSG 
study did not significantly differ in age and sex from persons who refused to participate 
in this study. Of the PSG sleep study participants, 727 persons (90.0%) had a good quality 
MRI scan of the brain, acquired as part of the Rotterdam Scan Study.16 Participants with an 
MRI-defined cortical infarct were excluded from the present study (n=22). Of the remaining 
702 persons, 643 persons (91%) had a sufficient quality EEG for quantitative analyses. The 
average time between MRI scan and PSG was 10 months (standard deviation (SD) 17).
Sleep
PSG recordings were performed at participants’ home using the ambulatory Vitaport 4 (Temec 
Instruments, Kerkrade, the Netherlands). A trained research assistant placed all sensors. 
The PSG included EEG (F3, F4, C3, C4, O1, O2, A1 and A2), bilateral electrooculography, 
electromyography, electrocardiography and respiration measurements.17 Respiration was 
measured with respiratory belts, an oronasal thermocouple, a nasal pressure transducer 
and oximetry. Participants were instructed to spend the night as normal as usual with 
no restrictions on bedtimes and the use of medication, alcohol and coffee. An registered 
polysomnogram technologist scored all PSG-recordings in 30-second epochs according to 
standard American Academy of Sleep Medicine scoring criteria.18 Each epoch was scored as 
wake, N1, N2, N3 or REM sleep. 
Quantitative EEG analyses were performed with PRANA Software Suite (PhiTools, 
Strasbourg, France). First, artifacts were automatically detected. Spectral analyses were 
then performed using 4-second windows on the same central EEG lead (C3/A2) and output 
data were averaged over 30-second epochs. This single channel was used for continuity. 
Spectral powers during NREM were finally summed in the delta (0.75-4.5 Hz) and beta (15.5-
22.5 Hz) frequency bands. Delta power and beta power were normalized by logarithmic 
transformation.
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The PSG was also used to estimate total sleep time, sleep onset latency, and wake after 
sleep onset. Sleep onset latency and wake after sleep onset were normalized by logarithmic 
transformation.
Subjective sleep quality was assessed with the global score of the Pittsburgh Sleep Quality 
Index (PSQI), which has been demonstrated to have a good test-retest reliability and 
validity.19 Higher scores represent a poorer sleep quality. The global quality score was were 
normalized by logarithmic transformation. Information on global sleep quality was available 
for 622 persons (97% of total sample).
Brain structure
Brain imaging was performed with a 1.5-Tesla scanner (General Electric Healthcare, 
Milwaukee, USA, software version 11x) with an eight-channel head coil and included T1-
weighted, T2*-weighted, proton-density-weighted and fluid-attenuated inversion recovery 
(FLAIR) sequences.16 Using automated post-processing tissue classification, we the obtained 
global volumes of total brain, gray matter, white matter and white matter lesions (ml).20, 21 
Volumes were expressed as percentages of the intracranial volume (ICV). Furthermore, white 
matter lesion volume was expressed as percentage of ICV, and normalized by logarithmic 
transformation. In addition, diffusion tensor imaging (DTI) was used in a subset of our sample 
(n= 408, 63.5%) to measure white matter microstructure. For DTI, we performed a single-
shot, diffusion-weighted, spin-echo, echoplanar imaging sequence. Maximum b value was 
1,000 s/mm2 in 25 non-collinear directions.22 All diffusion data were pre-processed using a 
standardized pipeline, including correction for motion and eddy currents, estimation of the 
diffusion tensor, and registration to tissue segmentation to obtain global mean DTI measures 
in the normal-appearing white matter.22 These measures included mean diffusivity (MD) 
and fractional anisotropy (FA). In general, higher values of MD and lower values of FA are 
indicative of poor microstructural integrity of the white matter. 
Covariates
We selected age, sex, educational level, body mass index, smoking, blood pressure, 
diabetes, myocardial infarction, stroke, depressive symptoms, cognitive function, coffee and 
alcohol use, sleep apnea and use of sleep medications as possible confounders based on 
prior knowledge. Information on educational level (low, intermediate, high), smoking (no, 
previous, current) and depressive symptoms (assessed using the Center for Epidemiologic 
Studies Depression scale23) was collected during a home interview. During a visit to the 
research center, height and weight were measured to calculate the body mass index (kg/
m2); sitting blood pressure was measured twice using a random-zero sphygmomanometer; 
and cognitive function was measured by the Mini-Mental State Examination.24 Stroke, 
myocardial infarction and diabetes mellitus were determined by medical records and self-
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report. To measure coffee, alcohol and sleep medication use, we asked the participants 
whether they used any one of these on the night of the PSG. Sleep apnea was assessed 
with the apnea-hypopnea index (AHI). Apneas were defined as a continuous reduction of 
airflow of at least 90% from baseline for at least 10 seconds. Hypopneas were defined as 
a continuous reduction of airflow of at least 30% from baseline for at least 10 seconds, 
together with oxygen desaturation of at least 3% from pre-event baseline or an arousal.25 
We calculated the AHI as the total number of apneas and hypopneas per hour of sleep.
Statistical analysis
First, we tested the associations of delta and beta activity during sleep with total sleep time, 
sleep onset latency and wake after sleep onset from the PSG, as well as subjective sleep 
quality assessed by questionnaire. Second, we studied whether smaller brain volumes, 
vascular lesions and microstructural integrity were associated with delta and beta power. 
Last, we tested whether these structural brain measures were related to total sleep time, 
sleep onset latency, wake after sleep onset and subjective sleep quality. 
All analyses were performed using multiple linear regressions adjusted for age, sex, 
time between MRI scan and PSG study, body mass index, smoking, diabetes, depressive 
symptoms, sleep apnea and coffee, alcohol and sleep medication use at the PSG night. We 
did not adjust for the other covariates because these did not change the effect estimates 
by more than 10% nor were significant predictors of the outcome. All determinants and 
outcomes were standardized.
In a sensitivity analyses, we only included persons that slept at least four hours during the 
PSG night.
Post hoc, we analyzed whether beta activity had a negative mediation effect (also called 
suppression) in the relation between white matter volume and total sleep time,26 since we 
found inverse associations in the presumed mediation pathway (i.e. a positive association 
between white matter volume and beta power and negative association between beta 
power and total sleep time). 
Only covariates had missing values. The number of missing values per parameter never 
exceeded 3%. Missing values in quantitative predictors were replaced by the mean. Missing 
values in qualitative predictors were accounted for in a separate missing category. A P-value 
<0.05 was considered statistically significant. Analyses were performed using SPSS Statistics 
(version 21; SPSS, Chicago, IL, USA).
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Results
Population characteristics are listed in Table 1. The mean age of this study sample (n= 643) 
was 62.2 years old (range 52 – 95 years) and 54% was female. Participants slept on average 
380 minutes (6.3 hours) at the PSG night (range 98 – 598 minutes).
Table 1. Population characteristics (n=643)
Measures             Mean ± SD or n (%) 
Demographics
Age, years 62.2 ± 5.4
Female 348 (54.1)
Education: Low 49 (7.6)
                  Intermediate 385 (59.9)
                  High 207 (32.2)
Health indicators
Body mass index, kg/m2 27.3 ± 4.4
Smoking: No 185 (28.8)
                Current 111 (17.3)
                Previous 347 (54.0)
Systolic blood pressure, mmHg 133.2 ± 18.1
Diastolic blood pressure, mmHg 81.3 ± 10.7
Diabetes mellitus 41 (6.4)
Myocardial infarction 12 (1.9)
Stroke 11 (1.7)
Depressive symptoms, score 5.4 ± 6.8
Cognitive functioning, score 28.6 ± 1.3
PSG related parameters
Alcohol use at night of PSG, units 0.5 ± 0.9
Coffee use at night of PSG, cups 0.9 ± 0.8
Sleep medication at night of PSG 57 (8.9)
Apnea Hypopnea Index 13.9 ± 12.9
Brain structure
Total brain volume 959.3 (98.0)
Gray matter volume 538.2 (53.2)
White matter volume 417.5 (56.6)
White matter lesion volume 3.6 (4.1)
Fractional anisotropy 0.3 (0.01)
Mean diffusivity 0.7 (0.02)
Objective sleep assessed by PSG
Delta power, μV2 145.0 (100.9)
Beta power, μV2 3.1 (2.0)
Total sleep time, minutes 379.8 ± 64.1
Sleep onset latency, minutes 21.0 ± 24.6
Wake after sleep onset, minutes 69.2 ± 44.8
Subjective sleep
Global PSQI, score 3.4 ± 3.3
Abbreviations: PSG, polysomnography; PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation
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In Table 2 the fully adjusted associations of NREM sleep delta and beta power with total 
sleep time, sleep onset latency, wake after sleep onset and sleep quality are presented. 
A higher beta power was related to a shorter total sleep time (β = -0.18, 95% CI= -0.27; 
-0.10), a longer wake after sleep onset (β = 0.25, 95% CI= 0.17; 0.34) and a lower sleep 
quality (β = 0.11, 95% CI= 0.03; 0.19, a high sleep quality score corresponds to a poor sleep 
quality). Higher delta power was related to shorter wake after sleep onset (β = -0.10, 95% 
CI= -0.19; -0.01).
Table 3 shows the associations between brain tissue volumes and delta and beta activity 
during NREM sleep. A smaller gray matter volume was associated with more beta power 
(β= -0.10, 95% CI= -0.18; -0.03), whereas smaller total brain and white matter volumes were 
associated with less beta power (β= 0.15, 95% CI= 0.07; 0.23, β= 0.22, 95% CI= 0.15; 0.29, 
respectively). White matter lesion volume was related to more beta power (β= 0.08, 95% 
CI= 0.01; 0.16). When we analyzed white matter microstructure, we found that higher FA, 
indicating better microstructural integrity, related to more beta power (β= 0.15, 95% CI= 
0.06; 0.24). The brain tissue volumes were not associated with delta power.
Table 3. Associations between brain structures and EEG activity during NREM sleep (n=643)
Delta (per SD) Beta (per SD)
 Brain structure β (95% CI) P β (95% CI) P
Tissue volumes
Total brain volume (per SD)  0.04 (-0.04; 0.12) 0.35 0.15 (0.07; 0.23) <0.001
Gray matter volume (per SD) -0.03 (-0.10; 0.04) 0.38 -0.10 (-0.18; -0.03) 0.004
White matter volume (per SD)  0.06 (-0.01; 0.13) 0.10 0.22 (0.15; 0.29) <0.001
Vascular lesions
White matter lesions volume (per SD)  0.02 (-0.06; 0.09) 0.67 0.08 (0.01; 0.16) 0.03
Microstructural integrity (n=408)
MDa (per SD)  0.04 (-0.06; 0.14) 0.41 -0.04 (-0.13; 0.06) 0.44
FAa (per SD)  0.02 (-0.07; 0.11) 0.70 0.15 (0.06; 0.24) 0.001
Abbreviations: CI, confidence interval; FA, fractional anisotropy; MD, mean diffusivity; NREM non-rapid eye 
movement; SD, standard deviation. Brain tissue volumes are expressed in % of intracranial volume. Values are 
amount of change (95% CI) in normalized and standardized brain power (per SD) per SD increase in brain tissue 
volumes, adjusted for age, sex, interval between brain scan and polysomnography study, body mass index, 
smoking, diabetes, depressive symptoms, coffee and alcohol use, apnea hypopnea index, and sleep medication 
use at polysomnography night. aAdditionally adjusted for intracranial volume, white matter and white matter lesion 
volume.
We did not find associations between structural brain variations and total sleep time, sleep 
onset latency, wake after sleep onset and subjective sleep quality (Supplemental Table 1).
Results did not change when we only included persons who slept at least four hours during 
the PSG night (n=628, results available upon request).
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In post hoc analysis, we analyzed whether beta activity had a negative mediation 
(suppression) effect in the relation between white matter volume and total sleep time.26 We 
found a significant suppression effect of beta power in the relation between white matter 
volume and total sleep time (indirect effect= -0.04, 95% CI= -0.07; -0.02). This revealed 
a suggestive, although not significant, direct association between a larger white matter 
volume and larger total sleep time  (direct effect per SD increase in white matter volume= 
0.08, 95% CI= -0.001; 0.16). This suppression effect is depicted in supplementary Figure 1.
Discussion
Among community-dwelling middle-aged and elderly subjects, we found an association 
between structural brain variation and beta power during NREM sleep: a smaller gray matter 
volume was accompanied by more beta power, whereas a smaller white matter volume 
and poor white matter microstructure were related to less beta power. Furthermore, more 
absolute beta power related to a shorter total sleep time, a longer wake after sleep onset 
and poor subjective sleep quality. However, structural brain variation did not relate to poor 
sleep, objectified by total sleep time, sleep onset latency and wake after sleep onset, nor to 
subjective sleep quality. 
EEG patterns during sleep are person specific and invariant over the night.6 Therefore, it 
has been postulated that EEG patterns may mainly relate to other stable characteristics, 
such as brain structure, and to a lesser extent to other day-by-day varying sleep influencing 
mechanisms. Because with aging both structural brain variation and sleep changes occur, 
we hypothesized that smaller brain volumes, vascular lesions, and reduced connectivity 
between brain areas relate to poor sleep. 
In line with our hypothesis, we found that a smaller gray matter volume related to more 
beta power. A previous study of gray matter volume and EEG frequencies found a positive 
relation between gray matter volume and alpha, sigma and beta frequencies, the opposite 
of what we found.27 However, a key difference between this study and ours is the age range 
(18 – 35 years versus 52 – 95 years). Several studies have found smaller gray matter volumes 
in insomnia patients.13, 14 This suggests that smaller gray matter volume is related to poor 
sleep. However, in our study a smaller gray matter volume was only related to more beta 
power and not directly related to poor sleep. This might imply that other factors than gray 
matter structure, for example gray matter functioning or genetic factors, may be more 
important in the association with these sleep parameters.
We also demonstrated an association of larger white matter volume and better white matter 
structure with more beta power. More beta power during the night indicates increased 
cortical activation (hyperarousal), causing problems falling asleep, fragmented sleep and, as 
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Brain structure, EEG activity during sleep and sleep quality
111
3.3
a consequence, short sleep duration. With aging, hyperarousal could be caused by impaired 
functioning of the circadian clock.28, 29 This is supported by our findings that more beta 
activity during NREM sleep was related to a shorter total sleep time, a shorter wake after 
sleep onset and poor subjective sleep quality. Though more beta activity during sleep is 
considered unfavourable, during wake, more beta power is associated with better vigilance 
and cognition.30-32 This may partly explain the association we found between a larger white 
matter volume and more beta power. It may be hypothesized that the important role of 
white matter in connectivity of brain regions during the day, is also reflected in more beta 
power at night. More research is needed to confirm this hypothesis. 
Brain variation occurs with age, including brain atrophy, more vascular lesions, and poorer 
brain connectivity. In this study, brain atrophy was represented by expressing brain tissue 
volumes as percentage of the ICV, with lower tissue volumes indicating more brain atrophy. 
Next to this macrostructural brain change, also microstructural changes take place with 
aging. With older age poorer microstructural integrity is seen, reflected in decreases in FA 
and increases in MD.33 In our study the association between more white matter volume and 
more beta power was supported by the observation that lower FA is associated with less 
beta power.
We did not find any associations between structural brain variations and objective total 
sleep time, sleep onset latency, wake after sleep onset or subjective sleep quality. There 
are several possible explanations for this lack of associations. First, we should consider the 
possibility that structural brain variations do not underlie the association between more 
beta power and poor sleep. It could be that other factors, for example genetic factors or 
general health, affect sleep quality more directly. Second, we found indications that the 
effect between white matter and total sleep time is suppressed by beta power. This suggests 
that the association between brain structure, specifically white matter, and total sleep 
time is obscured by the relation of white matter with beta power. White matter might be 
essential for the transportation of beta power. It may be hypothesized that the important 
role of white matter in connectivity of brain regions during the day, is also reflected in more 
beta power at night.
White matter and beta power are inversely related to total sleep time. Third, structural brain 
variation is possibly only in specific brain regions related to total sleep time, sleep onset 
latency, wake after sleep onset and subjective sleep quality. We measured global gray and 
white matter volumes, together with global microstructural white matter, but we did not 
investigate specific lobes or smaller brain regions. 
In contrast to our hypothesis, smaller gray and white matter volumes were not related to 
the slow wave delta activity. A relation has been found between gray and white matter 
volumes and slower EEG frequencies during NREM sleep.34, 35 However, in line with our 
study, Buchmann et al. (2011) did not find a relation between global gray matter volume and 
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slow wave activity.27  It is difficult to compare these sleep studies to our study, because they 
were performed in small groups of healthy participants and, except for the study of Mander 
et al. (2013), in young participants. Also, these studies used different imaging techniques. 
Possibly, only specific brain areas relate to delta activity.
Our study was embedded in a population-based cohort which gives rise to several strengths. 
First, results are generalizable and a large number of covariates was available. In addition, the 
current study consists al large sample with both ambulant PSG and a brain-MRI generating 
more power. Also, we estimated white matter microstructural integrity. Most studies 
including these measurements are small. However, this study also has some limitations. 
First, it is a cross-sectional study. Therefore we cannot say anything about the direction of 
effects or study brain atrophy over time. Although we hypothesized that brain structure 
underlies sleep quality, sleep seems to be important for brain health as well.36 Xie et al. 
(2013) found that during sleep potentially neurotoxic waste products are removed from the 
brain interstitial space. Problems in this sleep-process could lead to brain damage. Second, 
we looked at the delta and beta power frequencies derived from C3/A2, we are therefore 
not able to comment on differences between regions of the brain. Third, there was a time-
lag between the MRI and sleep measures, we have tried to minimize any confounding effects 
of this time-lag by controlling for it in all analyses.
To conclude, in this study in a middle-aged and elderly general population, we confirmed 
that more beta power during NREM sleep were related to a shorter total sleep time, a longer 
wake after sleep onset and poor reported sleep quality. In addition to this, we found that 
structural brain variation related to beta power during NREM sleep: a smaller gray matter 
volume was associated with more beta power, whereas a smaller white matter volume and 
poorer white matter microstructure were associated with less beta power. However, this 
brain structural variation did not affect other aspects of poor sleep directly, which suggests 
that brain structural variations do not account for the association between more beta power 
and poor sleep. Future longitudinal studies are needed to investigate whether age-related 
structural brain variation in specific brain areas does relate to poor sleep.
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WM volume          
(per SD)
Total effect (c)= 0.03, P= .42 Total sleep time 
(per SD)
Absolute beta 
power (SD)
WM volume        
(per SD)
Indirect effect (ab)= -0.04, 95% CI= -0.07; -0.02 Total sleep time 
(per SD)
Direct effect (c')= 0.08, P= .06
a= 0.22, P< .001 b= -0.18, P= <0.001
Supplemental Figure 1 Suppression effect of beta power on the relation of white matter volume and total sleep 
time. Analyses are adjusted for age, sex, interval between brain scan and polysomnography study, body mass index, 
smoking, diabetes, depressive symptoms, coffee and alcohol use, apnea hypopnea index and, sleep medication 
use at polysomnography night. Values represent unstandardized betas and the associated P values. The 95% CI 
for the indirect effect is obtained from Preacher and Hayes’ bootstrapping method, based on 10000 samples.26 
Abbreviations: a, effect of predictor on suppressor; b, effect of suppressor on outcome; ab, indirect effect (effect 
a multiplied by effect b) of predictor on outcome; c, total effect (including direct effect c’ and indirect effect ab) of 
predictor on outcome; c’, direct effect of predictor on outcome; SD, standard deviation; WM, white matter.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Brain structure, EEG activity during sleep and sleep quality
115
3.3
References
1. Foley DJ, Monjan AA, Brown SL, Simonsick EM, Wallace RB, Blazer DG. Sleep complaints among elderly 
persons: an epidemiologic study of three communities. Sleep 1995;18:425-32.
2. Kojima M, Wakai K, Kawamura T, et al. Sleep patterns and total mortality: a 12-year follow-up study in Japan. 
J Epidemiol 2000;10:87-93.
3. Yaffe K, Falvey CM, Hoang T. Connections between sleep and cognition in older adults. Lancet Neurol 
2014;13:1017-28.
4. Merica H, Blois R, Gaillard JM. Spectral characteristics of sleep EEG in chronic insomnia. Eur J Neurosci 
1998;10:1826-34.
5. Borbely AA, Baumann F, Brandeis D, Strauch I, Lehmann D. Sleep deprivation: effect on sleep stages and EEG 
power density in man. Electroencephalogr Clin Neurophysiol 1981;51:483-95.
6. De Gennaro L, Ferrara M, Vecchio F, Curcio G, Bertini M. An electroencephalographic fingerprint of human 
sleep. Neuroimage 2005;26:114-22.
7. Avidan AY. Sleep changes and disorders in the elderly patient. Curr Neurol Neurosci Rep 2002;2:178-85.
8. Espiritu JR. Aging-related sleep changes. Clin Geriatr Med 2008;24:1-14.
9. Landolt HP, Dijk DJ, Achermann P, Borbely AA. Effect of age on the sleep EEG: slow-wave activity and spindle 
frequency activity in young and middle-aged men. Brain Res 1996;738:205-12.
10. Carrier J, Land S, Buysse DJ, Kupfer DJ, Monk TH. The effects of age and gender on sleep EEG power spectral 
density in the middle years of life (ages 20-60 years old). Psychophysiology 2001;38:232-42.
11. Putilov AA, Munch MY, Cajochen C. Principal component structuring of the non-REM Sleep EEG spectrum in 
older adults yields age-related changes in the sleep and wake drives. Curr Aging Sci 2013;6:280-93.
12. Raz N, Rodrigue KM. Differential aging of the brain: patterns, cognitive correlates and modifiers. Neurosci 
Biobehav Rev 2006;30:730-48.
13. Altena E, Vrenken H, Van Der Werf YD, van den Heuvel OA, Van Someren EJ. Reduced orbitofrontal and 
parietal gray matter in chronic insomnia: a voxel-based morphometric study. Biol Psychiatry 2010;67:182-5.
14. Joo EY, Noh HJ, Kim JS, et al. Brain Gray Matter Deficits in Patients with Chronic Primary Insomnia. Sleep 
2013;36:999-1007.
15. Hofman A, Brusselle GG, Darwish Murad S, et al. The Rotterdam Study: 2016 objectives and design update. 
Eur J Epidemiol 2015;30:661-708.
16. Ikram MA, van der Lugt A, Niessen WJ, et al. The Rotterdam Scan Study: design and update up to 2012. Eur 
J Epidemiol 2011;26:811-24.
17. Luik AI, Zuurbier LA, Whitmore H, Hofman A, Tiemeier H. REM sleep and depressive symptoms in a 
population-based study of middle-aged and elderly persons. J Sleep Res 2015;24:305-8.
18. Berry RB, Budhiraja R, Gottlieb DJ, et al. Rules for scoring respiratory events in sleep: update of the 2007 
AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions 
Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 2012;8:597-619.
19. Buysse DJ, Reynolds CF, 3rd, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new 
instrument for psychiatric practice and research. Psychiatry Res 1989;28:193-213.
20. de Boer R, Vrooman HA, van der Lijn F, et al. White matter lesion extension to automatic brain tissue 
segmentation on MRI. Neuroimage 2009;45:1151-61.
21. Vrooman HA, Cocosco CA, van der Lijn F, et al. Multi-spectral brain tissue segmentation using automatically 
trained k-Nearest-Neighbor classification. Neuroimage 2007;37:71-81.
22. Sedaghat S, Cremers LG, de Groot M, et al. Kidney function and microstructural integrity of brain white 
matter. Neurology 2015;85:154-61.
23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl 
Psychol Meas. 1977;1:385-401.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
Chapter 3.3
116
Uitnodiging
Voor het bijwonen van 
de openbare verdediging van 
het proefschrift
Sleep, 24-hour activity
rhythms, and brain structure 
A population-based study
door
Lisette A. Zuurbier
Vrijdag 29 april 2016
om 11:30 uur
Senaatzaal
Erasmus Universiteit Rotterdam
A-gebouw 
Burgemeester Oudlaan 50
Rotterdam
Na afloop bent u van harte
welkom op de receptie
Lisette Zuurbier
Evenaar 142
2408 JS Alphen a/d Rijn
lisettezuurbier@hotmail.com
Paranimfen
Annemarie Luik
Olivera Jovanova
24. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state 
of patients for the clinician. J Psychiatr Res 1975;12:189-98.
25. Iber C, Ancoli-Israel S, Chesson AL, Quan SF. The aasm manual for the scoring of sleep andassociated events: 
Rules, terminology and technical specifications. Westchester: American Academy of Sleep Medicine, 2007.
26. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects in simple mediation models. 
Behav Res Methods Instrum Comput 2004;36:717-31.
27. Buchmann A, Kurth S, Ringli M, Geiger A, Jenni OG, Huber R. Anatomical markers of sleep slow wave activity 
derived from structural magnetic resonance images. J Sleep Res 2011;20:506-13.
28. Van Someren EJ, Riemersma-Van Der Lek RF. Live to the rhythm, slave to the rhythm. Sleep Med Rev 
2007;11:465-84.
29. Gibson EM, Williams WP, 3rd, Kriegsfeld LJ. Aging in the circadian system: considerations for health, disease 
prevention and longevity. Exp Gerontol 2009;44:51-6.
30. Belyavin A, Wright NA. Changes in electrical activity of the brain with vigilance. Electroencephalogr Clin 
Neurophysiol 1987;66:137-44.
31. Laufs H, Krakow K, Sterzer P, et al. Electroencephalographic signatures of attentional and cognitive default 
modes in spontaneous brain activity fluctuations at rest. Proc Natl Acad Sci U S A 2003;100:11053-8.
32. Ray WJ, Cole HW. EEG alpha activity reflects attentional demands, and beta activity reflects emotional and 
cognitive processes. Science 1985;228:750-2.
33. Helenius J, Soinne L, Perkio J, et al. Diffusion-weighted MR imaging in normal human brains in various age 
groups. AJNR Am J Neuroradiol 2002;23:194-9.
34. Mander BA, Rao V, Lu B, et al. Prefrontal atrophy, disrupted NREM slow waves and impaired hippocampal-
dependent memory in aging. Nat Neurosci 2013;16:357-64.
35. Saletin JM, van der Helm E, Walker MP. Structural brain correlates of human sleep oscillations. Neuroimage 
2013;83:658-68.
36. Xie L, Kang H, Xu Q, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342:373-7.
Uitnodiging
Voor het bijwonen van 
de openbare verdediging van 
het proefschrift
Sleep, 24-hour activity
rhythms, and brain structure 
A population-based study
door
Lisette A. Zuurbier
Vrijdag 29 april 2016
om 11:30 uur
Senaatzaal
Erasmus Universiteit Rotterdam
A-gebouw 
Burgemeester Oudlaan 50
Rotterdam
Na afloop bent u van harte
welkom op de receptie
Lisette Zuurbier
Evenaar 142
2408 JS Alphen a/d Rijn
lisettezuurbier@hotmail.com
Paranimfen
Annemarie Luik
Olivera Jovanova
Chapter 3.4
Gray matter, white matter and hippocampal 
volume in middle-aged and older adults with insomnia: 
A population-based study
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Abstract
Study objectives: We investigated whether gray matter, white matter and hippocampal 
volumes are related to insomnia. Furthermore, within persons with insomnia, we studied 
whether brain volumes were related to the degree of sleep onset latency, sleep duration, 
sleep efficiency and sleep quality.
Design: Cross-sectional study.
Setting: This study was performed within the Rotterdam Study, the Netherlands.
Participants: 248 persons with insomnia (mean age 63 years) and 2729 persons without 
insomnia (mean age 62 years).
Interventions: None.
Measurements and Results: Insomnia was defined by a weighted set of individual Pittsburgh 
Sleep Quality Index items. All participants had an MRI scan of the brain to measure total 
brain, gray matter, white matter and hippocampal volumes. Insomnia was associated with a 
10 ml smaller white matter volume (380 ml versus 390 ml, 95% CI= -18.9; -1.5). In persons 
with insomnia, a smaller white matter volume was related to a lower sleep efficiency (B per 
10 ml= 0.65, 95% CI= 0.09; 1.20) and a smaller gray matter volume was related to a poorer 
sleep quality (OR per 10 ml= 0.93, 95% CI= 0.87; 0.99). Furthermore, a smaller hippocampal 
volume was related to a shorter sleep duration (B per ml= 0.35, 95% CI= 0.02; 0.68) and to a 
poorer sleep quality (OR per ml= 0.50, 95% CI= 0.29; 0.87).
Conclusions: In this population-based study, persons with insomnia had smaller white 
matter volumes, suggesting that structural brain variations underlie insomnia or that 
insomnia causes structural brain variations. Moreover, the size of brain structures, such as 
the hippocampus, corresponded to the severity of insomnia.
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Introduction
Insomnia is a highly prevalent sleep disorder, especially in older persons. Over 10% of the 
adult population suffers from insomnia.1 Insomnia is characterized by problems in falling 
asleep or staying asleep, leading to daytime dysfunction because of fatigue during the day.2 
Insomnia affects physical, mental and social functioning and is related to a poor health-
related quality of life.3 The prevalence of insomnia is higher in elderly persons than in young 
or middle-aged persons; this increase in prevalence in the elderly is attributed to age-related 
sleep changes. Sleep in elderly persons is more fragmented, with less deep sleep and more 
early morning awakenings.1,4 Furthermore, elderly persons have less physical activity, less 
exposure to light and more somatic disorders, which increases the risk of insomnia.2,5 
The sleep disturbances in insomnia are thought to partly derive from hyperarousal, as 
evidenced by studies of the stress system and brain waves of persons with insomnia.2 
Insomnia is associated with an elevated activation of the hypothalamic-pituitary-adrenal 
axis and with cortical arousal during NREM sleep.6,7 However, hyperarousal of the stress 
system is mainly found in insomnia patients with an objectively measured short sleep 
duration and to a lesser extent in insomnia patients with a “normal” sleep duration (defined 
by Vgontzas et al. (2013) as ≥6 hours of sleep).8 Vgontzas et al. (2013) suggest that different 
arousal levels of the stress system between short sleeping and “normal” sleeping insomnia 
patients underlie two subtypes of insomnia; one ‘biological’ type in which insomnia patients 
have hyperarousal of the stress system and a short sleep duration, and one ‘psychological’ 
phenotype, including patients with a “normal” sleep duration and sleep misperception.8 
Previous studies found differences in brain volumes between insomnia patients and healthy 
controls.9 However, these studies were generally performed in small clinical samples and 
results are not consistent.10-18 Several studies have associated insomnia with smaller gray 
matter volumes in different brain areas, including the frontal lobe.10,11 Other researchers, 
however, found an increase in gray matter volume in patients with insomnia,12 while 
some reported no differences between persons with and without insomnia in white and 
gray matter.13 Spiegelhalder et al. (2014) reported reduced integrity of fronto-subcortical 
white matter tracts.17 Furthermore, two studies reported a difference in hippocampal 
volume between persons with insomnia and controls14,18; a finding several studies failed 
to replicate.12,15,16 Interestingly, in the studies that did not find a difference in hippocampal 
volume between insomnia patients and healthy controls, subanalyses in insomnia patients 
showed that the hippocampal volume was associated with insomnia characteristics such as 
poor sleep maintenance and the duration of insomnia.12,15,16 
In the present population-based study we examined differences in total brain, gray matter, 
white matter and hippocampal volumes between a large group of insomnia cases and 
controls. Furthermore, we investigated, in persons with insomnia, the associations of gray 
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matter, white matter and hippocampal volumes with the sleep parameters sleep onset 
latency, sleep duration, sleep efficiency and sleep quality. We hypothesized that smaller 
gray matter and white matter volumes can be found in persons with insomnia. Second, 
we hypothesized that, in persons with insomnia, smaller gray matter, white matter and 
hippocampal volumes are associated with a longer sleep onset latency, shorter sleep 
duration, a lower sleep efficiency and a poorer sleep quality.
Methods
Setting
The present study was embedded in the Rotterdam Study, a prospective population-based 
cohort of persons aged 45 years or older, living in the Ommoord district in Rotterdam, the 
Netherlands.19 The Rotterdam Study has been approved by the Medical Ethics Committee 
of the Erasmus Medical Center and by the Ministry of Health, Welfare and Sport of the 
Netherlands, implementing the “Wet Bevolkingsonderzoek: ERGO (Population Studies Act: 
Rotterdam Study)”. All participants provided written informed consent to participate in the 
study and to obtain information from their treating physicians. 
Participants
Participants with a home interview between January 2002 to December 2008 and who 
underwent a MRI scan of the brain were eligible for this study (n=5800). This home interview 
included the Pittsburgh Sleep Quality Index (PSQI)20 and the Center for Epidemiologic 
Studies-Depression scale (CES-D).21 Participants missing more than two items on the PSQI 
(n=148), participants with missing data on the CES-D (n=20), or participants with artifacts on 
the MRI scan (n=327) were excluded, leaving 5305 eligible persons. 
Insomnia
We defined insomnia cases using the PSQI. Missing items on the PSQI were imputed by 
single imputation for participants missing one or two items. An insomnia score was made 
from a weighted set of individual PSQI items, that correlated highly (0.84) with the Insomnia 
Severity Index (ISI)22 in a previous analysis of web-based data.(van Someren, manuscript in preparation, 2015) 
See Supplemental Table 1 for the individual PSQI items with their weights. The insomnia 
severity score ranged from -1.7 to 29.1 in the present study, comparable to the ISI range 
(0-28). We defined persons with an insomnia severity score ≥15 as insomnia cases, in line 
with the ISI that uses a cut-off ≥15 to define clinical insomnia. In total, 248 (4.7% of 5305) 
participants scored ≥15 and were considered insomnia cases. Controls were defined as 
participants with a PSQI score ≤5, a CES-D score <16, and a score of 0 on the sleep question 
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of the CES-D (n=2729). Participants with intermediate scores, i.e. those that did not meet 
the criteria for insomnia cases or controls (n=1569), and those participants that had no 
sleep complaints and skipped several PSQI items (n=759), were not included as controls. 
Brain imaging
Brain imaging was performed with a 1.5 Tesla MRI scanner (General Electric Healthcare, 
Milwaukee, USA, software version 11x) with an 8-channel head coil, and included T1-
weighted, T2*-weighted, proton density weighted and fluid-attenuated inversion recovery 
(FLAIR) sequences.23 Gray matter, white matter and white matter lesion volumes were 
quantified by a validated automatic tissue classification technique based on a k-nearest 
neighbor classifying algorithm, complemented with intensity based white matter lesion 
detection on the FLAIR sequence.24,25 Total brain volume was calculated as the sum of 
gray matter, white matter, and white matter lesion volumes. More information about the 
neuroimaging protocol and the visual and automated rating of brain images in the Rotterdam 
Study can be found elsewhere.23 The hippocampus was segmented using an automated 
method described previously.26 This segmentation was not performed in all participants, 
because this structure did not pass the data processing quality control. 165 insomnia cases 
and 1932 controls were included in the analyses of hippocampal volumes. 
Covariates
Age, sex, educational level, body mass index, cognitive functioning, depressive symptoms, 
hypertension, possible sleep apnea, myocardial infarction, stroke, diabetes and use of sleep 
medication were tested as potential confounders based on prior knowledge.2,27 Educational 
level, depressive symptoms (CES-D score), sleep medication use (anatomical therapeutic 
chemical (ATC) codes N05 and N06)28 and possible sleep apnea were assessed during the 
home interview. Possible sleep apnea was assessed with the PSQI.20 Sleep apnea was 
considered possible when participants reported loud snoring at least 2 nights per week 
together with at least occasional respiratory pauses, or if they reported respiratory pauses 
during sleep at least 1-2 times per week.29 At a visit to the research center, height and weight 
were measured without heavy clothing and shoes, to calculate the body mass index (kg/
m2); cognitive functioning was measured using the Mini Mental State Examination30; and 
sitting blood pressure was measured twice on the right upper arm using a random-zero 
sphygmomanometer. Hypertension was defined as a systolic blood pressure ≥140 mm Hg, 
a diastolic blood pressure ≥90 mm Hg or use of antihypertensive medication. Myocardial 
infarction, diabetes, and stroke were determined using medical records.
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Statistical analyses
We analyzed whether persons with insomnia differed from controls in total brain, gray 
matter, white matter and hippocampal volumes, using an analyses of covariance (ANCOVA). 
Model 1 was adjusted for age and sex. Model 2 was adjusted for age, sex, educational level, 
depressive symptoms, use of sleep medication, stroke and diabetes. We included a covariate 
in the model if the adjustment changed the effect estimate of the main determinants by more 
than 10%. Consequently, body mass index, cognitive functioning, hypertension, possible 
sleep apnea and myocardial infarction were not included in the models presented. Next, 
we tested whether findings reflect atrophy by testing whether the effect was independent 
of head size. To achieve this, model 3 was adjusted for the same covariates as model 2 and 
additionally for intracranial volume. However, collinearity of measures precluded this test 
as indicated by high variance inflation factors (VIF) in analyses with total brain (VIF 8.6), 
gray matter (VIF 3.7) and white matter volumes (VIF 3.4). Consequently, model 3 was only 
performed for hippocampal volumes (VIF 1.8). 
In addition, we performed two sensitivity analyses. First, significant associations in model 
2 were further analyzed to study whether white matter volumes in the frontal, parietal, 
temporal and occipital brain lobes underlay the observed associations. Second, to test 
whether the associations of total brain, gray matter, white matter and hippocampal volumes 
with insomnia differed in elderly and middle-aged persons, we added the interaction term 
age*brain volume of interest to the model. 
Next, we tested in the 248 insomnia cases whether total brain, gray matter, white matter 
and hippocampal volumes associated with sleep onset latency, sleep duration, sleep 
efficiency and sleep quality. These sleep parameters were assessed using the PSQI.20 Sleep 
onset latency, sleep duration and sleep efficiency were analyzed as continuous variables 
using a multivariable linear regression analyses. Sleep onset latency was normalized by 
logarithmic transformation and standardized. Sleep quality was analyzed as a dichotomous 
variable using logistic regression analyses. Sleep quality was dichotomized into a moderately 
poor and a very poor sleep quality. Since these analyses were performed in persons with 
insomnia, none of these persons reported a good sleep quality. 
Because of our large sample size, we were also able to differentiate insomnia cases with 
a short and those with a relatively long sleep duration using three different cut-offs (<4 
hours versus ≥4 hours, <5 hours versus ≥5 hours and <6 hours versus ≥6 hours) in a series of 
sensitivity analyses. We did not include analyses comparing insomnia cases sleeping <7 hours 
to insomnia cases sleeping ≥7 hours, because only 21 persons reported sleeping longer than 
or equal to 7 hours. We investigated whether volumes of the total brain, gray matter, white 
matter or hippocampus of insomnia cases with a relatively short sleep duration differed 
from those of insomnia cases with a relatively long sleep duration and from controls. To test 
these stratified associations, we used an ANCOVA. Again, model 1 was adjusted for age and 
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sex and model 2 was adjusted for age, sex, educational level, depressive symptoms, use of 
sleep medication, stroke and diabetes. Seven participants did not answer the sleep duration 
question, therefore 241 persons with insomnia were included in these stratified analyses. 
All statistical tests were two-sided, and a P-value <0.05 was considered statistically 
significant. Given the low prevalence of missing data (maximum of 2%), missing values for 
continuous covariates were replaced by the mean, and for missing values of categorical 
covariates a separate category was defined. Analyses were performed in SPSS version 21 
(SPSS Inc., Chicago, Illinois).
Table 1 Characteristics of the study population
Controls Insomnia cases Statistical testa
Mean (SD), n (%) n=2729 n=248 insomnia cases - controls
Age, years 62.4 (8.7) 63.0 (9.8) -0.9
Sex, female 1201 (44.0%) 203 (81.9%) 130.7***
Education: Low 259 (9.5%) 32 (12.9%)
            Intermediate 1765 (64.7%) 175 (70.6%) 9.8**
            High 668 (24.5%) 41 (16.5%)
Body mass index, kg/m2 27.5 (4.0) 28.2 (4.7)  -2.4*
Depressive symptoms, score 2.2 (3.1) 15.2 (10.6)  -19.2***
Cognitive functioning, score 28.0 (1.7) 27.8 (2.1) 2.1*
Global PSQI, score 1.6 (1.4) 12.0 (2.8)  -56.3***
Possible sleep apnea, yes 218 (8.0%) 23 (9.3%) 1.3
Sleep medication, yes 194 (7.1%) 108 (43.5%) 327.9***
Hypertension, yes 1626 (59.6%) 151 (60.9%) 1.1
Myocardial infarction, yes 112 (4.1%) 12 (4.8%) 0.3
Stroke, yes 64 (2.3%) 4 (1.6%) 0.5
Diabetes mellitus, yes 256 (9.4%) 37 (14.9%) 7.9**
Abbreviations: PSQI, Pittsburgh Sleep Quality Index; SD, standard deviation
*p< 0.05; **p< 0.01; ***p< 0.001
aStatistical test: Student’s t test for continuous variables and χ2 for categorical variables
Results
This population-based study included 248 insomnia cases and 2729 controls. Population 
characteristics can be found in Table 1. Insomnia patients were more often female and less 
educated and had a higher body mass index, more depressive symptoms, a lower cognitive 
function, more diabetes and more often used sleep medication.
Table 2 shows the results of the associations of insomnia with total brain, gray matter, white 
matter and hippocampal volumes, as tested with ANCOVA. Persons with insomnia had 15 
ml smaller total brain (909 ml versus 924 ml, 95%= -29.1; -1.1) and 10 ml smaller white 
matter volumes (380 ml versus 390 ml, 95% CI= -18.9; -1.5), in the multivariable adjusted 
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model. The association between white matter volumes and insomnia was observed in the 
frontal, temporal and occipital brain lobes (Supplemental Table 2.) Persons with insomnia 
did not differ significantly from controls on gray matter (515 ml versus 520 ml, 95% CI= 
-13.1; 2.3) and hippocampal volume (6.0 ml versus 6.0 ml, 95% CI= -0.13; 0.11). The addition 
of intracranial volume in the association of insomnia with hippocampal volume did not 
meaningfully change the results (6.1 ml versus 6.1 ml, 95% CI= -0.05; 0.18). The interaction 
term age*brain structure of interest was not significant in any analysis. 
Table 2 Brain volume differences in participants without insomnia and persons with insomnia
Case - Control
No insomnia Insomnia
Comparison of insomnia 
with no insomnia
Overall 
comparison
 (n=2729) (n=248)    
 Meana Meana Difference (95% CI) F P
Total brain volume (ml)
   Age, sex adjusted 946 931  -14.1 (-24.9; -3.4) 6.6 0.01
   Multivariable adjustedb 924 909  -15.1 (-29.1; -1.1) 4.4 0.04
Gray matter volume (ml)
   Age, sex adjusted 530 524  -5.9 (-11.8; 0.05) 3.8 0.05
   Multivariable adjustedb 520 515  -5.4 (-13.1; 2.3) 1.9 0.17
White matter volume (ml)
   Age, sex adjusted 409 400  -9.1 (-15.8; -2.4) 7.1 0.01
   Multivariable adjustedb 390 380  -10.2 (-18.9; -1.5) 5.3 0.02
Hippocampal volume (ml)c
   Age, sex adjusted 6.0 5.9  -0.03 (-0.12; 0.07) 0.28 0.60
   Multivariable adjustedb 6.0 6.0  -0.01 (-0.13; 0.11) 0.05 0.83
Abbreviations: CI, confidence interval; ICV, intracranial volume 
aEstimated means differ because of different adjustments
bAdjusted for age, sex, educational level, depressive symptoms, cognitive functioning, use of sleep medication 
and myocardial infarction
cNo insomnia, n=1926; Insomnia, n=165
Next, we examined whether in persons with insomnia the total brain, gray matter, white 
matter and hippocampal volumes were associated with sleep onset latency, sleep duration, 
sleep efficiency and sleep quality (Table 3). A smaller total brain and white matter volume 
were each related to a lower sleep efficiency (total brain, B per 10 ml= 0.36, 95% CI= 0.02; 
0.69; white matter, B per 10 ml= 0.65, 95% CI= 0.09; 1.20). Also, a smaller gray matter 
volume was associated with a poorer sleep quality (OR per 10 ml= 0.93, 95% CI= 0.87; 0.99). 
Furthermore, a smaller hippocampal volume was related to a shorter sleep duration (B per 
ml= 0.35, 95% CI= 0.02; 0.68) and a poorer sleep quality (OR= 0.50, 95% CI= 0.29; 0.87). 
Additional adjustment for intracranial volume in the associations of hippocampal volume 
and sleep characteristics mildly attenuated these results (sleep duration, B per ml= 0.32, 
95% CI= -0.04; 0.68; sleep quality, OR= 0.53, 95% CI= 0.29; 0.97). 
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To illustrate the associations between brain volumes and sleep duration in persons with 
insomnia, we categorized persons with insomnia by sleep duration (Figure 1). This figure 
shows that in persons with insomnia, total brain, gray matter, white matter and hippocampal 
volumes tend to be smaller compared to controls. Furthermore, in persons with insomnia, 
a shorter sleep duration is related to smaller brain volumes; the clearest association is seen 
with the hippocampus.
In a series of sensitivity analyses, we compared the brain volumes of insomnia cases with a 
short sleep duration to those with a sleep duration above the cut-off (≥4 hours, ≥5 hours or 
≥6 hours), and to those of controls (Table 4, Supplementary Tables 3 and 4). Results of the 
analyses with different cut-offs are very consistent. In Table 4 we present the analyses of 
insomnia cases sleeping <5 hours versus insomnia cases sleeping ≥5 hours and controls. A 
smaller total brain (901 ml versus 924 ml, 95% CI= -40.7; -3.9) and white matter volume (375 
ml versus 390 ml, 95% CI= -26.4; -3.5) were found in short sleeping insomnia cases (sleeping 
<5 hours) compared to controls. In persons with insomnia, short sleeping insomnia cases 
had smaller hippocampal volumes than the relatively longer sleeping insomnia cases (5.9 ml 
versus 6.1 ml, 95% CI= -0.38; -0.01). 
Discussion
In this large population-based study, we investigated whether total brain, white matter, gray 
matter and hippocampal volumes differ between persons with insomnia and controls. A 
smaller white matter volume was related to insomnia. In persons with insomnia, smaller 
total brain and white matter volumes were associated with a lower sleep efficiency. A 
smaller gray matter volume was associated with poorer sleep quality. Furthermore, a 
smaller hippocampus was related to a shorter sleep duration and poorer sleep quality. This 
suggests that structural brain correlates underlie the severity of insomnia or that insomnia 
causes structural brain changes. 
In this population-based study, persons with insomnia were more often female, lower 
educated and had more depressive symptoms, in line with previous studies.27 In persons 
with insomnia, we observed smaller total brain and white matter volumes than in controls, 
especially in the frontal, temporal and occipital lobes. In line with these results is a study 
of the integrity of white matter tracts in insomnia patients, reporting reduced integrity 
of fronto-subcortical white matter tracts.17 In contrast, Winkelman et al. (2010) could not 
demonstrate differences in whole brain volume between insomnia patients and controls.15 
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Figure 1. Mean total brain (A), gray matter (B), white matter (C) and hippocampal (D) volumes in persons without 
insomnia and persons with insomnia. Persons with insomnia are categorized into different sleep duration groups
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This discrepancy in results might be due to the difference in sample size between the studies; 
Winkelman et al. (2010) used a case-control design with 20 well defined insomnia patients, 
aged 25 – 55 years, whereas we studied 248 persons with insomnia, aged 45 – 92 years old.
Differences in brain structure between insomnia cases and controls might be partly explained 
by brain functional differences. Several studies point to an altered brain function as a 
possible substrate of insomnia.2,6,9,11,16,31-33 Persons with insomnia suffer from hyperarousal 
during sleep, reflected by a greater brain metabolism and more beta activity during sleep.6,31 
Hyperarousal represents enhanced sensory processing during sleep. This leads to a smaller 
difference in cortical arousal between the sleep and wake states, and to more interference of 
sleep onset or sleep maintenance by environmental stimuli.32 In addition, insomnia patients 
showed cognitive deficits, reduced attention and a decreased capability to recognize the 
optimal sleep temperature, also pointing towards brain changes in these individuals.11,16,33 
A review by Vgontzas et al. (2013) suggests that insomnia with an objective short sleep 
duration has a stronger biological basis than insomnia with a relatively long sleep duration.8 
Insomnia with a sleep duration ≥6 hours is thought to be a more psychological condition, 
without an apparent biological substrate.8 It is associated to a state of sleep misperception. 
Because of our large sample size, we were able to study structural brain correlates of 
several sleep parameters in persons with insomnia. Smaller total brain, white matter, gray 
matter and hippocampal volumes were associated with a shorter sleep duration, a lower 
sleep efficiency and a poorer sleep quality. This suggests that structural brain differences 
in persons with insomnia underlie the severity of insomnia. This might be difficult to find 
in small studies. In line with the theory that insomnia with a short sleep duration is the 
biological most severe phenotype,8 we found the smallest total brain, gray matter, white 
matter and hippocampal volumes in the very short sleeping persons with insomnia (Figure 1). 
Except for two studies14,18 previous studies did not find a difference in hippocampal volumes 
between insomnia patients and controls.12,15,16 However, in the primary insomnia patients, 
the hippocampal volume was negatively related to objectively measured poorer sleep 
maintenance and to insomnia duration in these studies.12,15,16 More apparent differences 
in brain volume between insomnia patients and good sleepers might be found if the sleep 
duration of insomnia patients is taken into account or if larger sample sizes are investigated.
Our finding that a smaller brain volume related to insomnia, and that among persons with 
insomnia structural brain correlates seem to underlie the severity of insomnia, could be 
explained by several potential mechanisms. First, age is associated with brain degeneration 
and more hyperarousal during sleep.34,35 In insomnia patients, brain degeneration might 
underlie the hyperarousal during sleep. In this study participants were on average 63 years 
old. Because of multicollinearity, we were not able to adjust the total brain, gray matter 
and white matter analyses for intracranial volume. This suggests that the amount of brain 
atrophy of the persons was small. Therefore, the size of the brain, not brain atrophy, seem 
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to underlie these results. Second, insomnia may precede brain degeneration. During sleep 
neurotoxic waste products are removed from the brain.36 Since persons with insomnia 
have sleep problems, this process might be impaired, causing brain damage. Third, genes 
associated with insomnia might also be associated to brain health. A genome-wide 
association study found alleles associated with a long sleep duration, that previously were 
associated to a better metabolic profile.37
This study has several strengths. First, it has a large sample size, the current study is much 
larger than previous studies in this field. This enabled us to study the associations of brain 
volumes and several sleep parameters within the group of insomnia cases. Furthermore, this 
study is embedded in a population-based cohort. Therefore, we could assess many different 
covariates and the results are generalizable. However, some limitations should also be 
discussed. We did not formally diagnose insomnia, but assessed insomnia using a weighted 
set of individual PSQI items, that correlated highly (0.84) with the Insomnia Severity Index 
(ISI)22. Second, this study has a cross-sectional design, and therefore we were not able to 
study causality and a possible age effect in insomnia. However, we tested the interaction 
of age with brain volumes on the risk of insomnia, and this interaction was not significant. 
This suggests that our findings do not merely reflect an aging process. We could also show 
that atrophy does not explain the results. Third, we did not measure the sleep parameters 
sleep onset latency, sleep duration and sleep efficiency objectively. Objectively measured 
sleep parameters will minimize the influence of the subjective sleep complaints. However, 
the use of subjectively measured sleep parameters probably leads to an underestimation of 
the effects. 
To conclude, in this population-based study we found structural brain differences between 
insomnia cases and controls. This difference was mainly driven by persons with severe 
insomnia, as indexed by short sleep. Furthermore, in persons with insomnia, smaller total 
brain, white matter, gray matter and hippocampal volumes were associated with sleep 
complaints such as short sleep duration, low sleep efficiency and poorer sleep quality. 
These results suggest that structural brain correlates underlie the severity of insomnia 
or that insomnia causes structural brain changes. However, group differences between 
poor sleepers and controls are small. This probably explains the inconsistent results in 
studies with a small number of participants.  Understanding the underlying neurobiology 
of insomnia, including the importance of sleep duration in persons with insomnia, might 
aid in understanding insomnia and in development of more specific therapies for insomnia 
patients. Future research is needed to validate the structural brain correlates of insomnia 
severity and to elucidate the direction of causality. 
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Supplemental Material
Supplemental Table 1 Pittsburgh Sleep Quality Index Items with their weight
Item Weight
(Intercept) 4.933
Sleep latency (minutes) 0.008
Actual sleep (hours)  -0.181
No sleep within 30 minutes 0.624
Night-time wake 0.963
Too hot 0.138
Bad dreams 0.328
Other reason for bad sleep 0.176
Bad sleep quality 3.091
Medication use 0.505
Difficulty staying awake during the day 0.596
Problems getting things done 1.901
Sleep efficiency  -4.540
Weights are derived from “van Someren, manuscript in preparation, 2015”
Supplemental Table 2 White matter brain lobe differences in participants without insomnia and persons with 
insomnia
Case - Control
No insomnia Insomnia Comparison of insomnia 
with no insomnia
Overall 
comparison
 (n=2729) (n=248)    
 Mean Mean Difference (95% CI) F P
White matter volume (ml)
   Frontal lobe 142 136  -4.0 (-7.2; -0.8) 5.9 0.02
   Parietal lobe 87 85  -2.0 (-4.1; 0.1) 3.6 0.06
   Temporal lobe 70 68  -1.6 (-3.2; -0.0) 4.1 0.04
   Occipital lobe 44 43  -1.5 (-2.6; -0.4) 6.7 0.01
Abbreviations: CI, confidence interval
Analyses are adjusted for age, sex, educational level, depressive symptoms, cognitive functioning, use of sleep 
medication and myocardial infarction
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In this thesis I investigated the associations between sleep, 24-hour activity rhythms, and 
health in a middle-aged and elderly population, with a particular focus on the relation 
between sleep and structural brain variation. In this chapter I will review the main findings 
of the studies. Next, I will address some methodological considerations, clinical implications, 
and make suggestions for future research.
Main findings
Sleep, 24-hour activity rhythms and health parameters
Sleep and 24-hour rhythm disturbances are common in older age. In the elderly about 80% 
of persons report at least 1 sleep complaint.1 Furthermore, elderly persons have problems 
falling asleep, have fragmented sleep, wake up too early, nap - involuntarily - during the day, 
do not get enough sleep at night, and report a low sleep quality.2,3 This decrease in sleep 
quality is related to several health problems, such as depression, cardiovascular disease 
and poor cognitive performance.4-6 We demonstrated that the 24-hour activity rhythm 
disturbances are related to several demographic and lifestyle factors (Chapter 2.1). Older 
age was characterized by a more stable, but also to a more fragmented activity rhythm. 
Furthermore, a high body mass index and smoking were related to unstable and fragmented 
activity rhythms. This last finding was in line with the association between 24-hour rhythm 
disturbances and mortality (Chapter 2.2); persons with an unstable and/or fragmented 
rhythm had a higher risk of mortality. 
Fragmentation of the 24-hour activity rhythm may be a general health indicator. In this 
thesis I showed that fragmentation is related to more depressive symptoms, a high body 
mass index, cerebral small vessel disease and mortality. This is in line with other studies 
that related fragmented rhythms to health problems, including cognitive deficits, high blood 
pressure, cardiovascular disease and Alzheimer’s disease.7-10 
The association between a higher age and a more stable rhythm was not in line with the 
finding of an unstable rhythm and a higher mortality risk. We had hypothesized that a higher 
age would be associated to a more unstable rhythm. This association between age and a more 
stable rhythm might be explained by changes in the life style of older persons with health 
problems; they live a more structured life compared to younger persons. This structured life 
compensates for the disturbed functioning of the suprachiasmatic nucleus, the biological 
clock of the brain. Post-mortem studies in very old persons demonstrated a reduction in 
volume and number of vasopressin-expressing neurons of the suprachiasmatic nucleus.11 
This reduction may underlie the ability to drive the circadian rhythm, a smaller amplitude 
of several circadian rhythms and a more fragmented 24-hour activity rhythm.12 The loss 
of temporal organization between different rhythms can lead to suboptimal physiological 
functioning, because physiological processes do not take place at their optimal time of day. 
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As a result people have a higher disease susceptibility. The structured life of elderly may - 
partly - compensate for the disturbances in their circadian rhythms. However, taking age, 
several demographic and health factors into account, an unstable rhythm independently 
predicted mortality in our study. This suggests that change of behavior cannot accommodate 
all circadian rhythm disturbances.
In Chapter 2.2a we discussed the importance of a different 24-hour rhythm variable: 
circadian misalignment. Circadian misalignment represents a form of ‘social jetlag’; the 
mismatch between a person’s biological clock and social clock (i.e. the clock driven by 
the schedules of daily life, such as work). This results in chronic sleep loss.13 The circadian 
misalignment was measured as the absolute difference in time spent in bed on weekdays 
and on weekends. Also it was measured as the absolute difference in midpoints of sleep 
between weekdays and weekends. Whereas fragmentation of the 24-hour activity rhythm 
was only very modestly related to circadian misalignment, the stability of the rhythm was 
related to circadian misalignment. However, an unstable 24-hour activity rhythm was 
related to mortality independently of circadian misalignment. Therefore, information about 
circadian misalignment can add to the understanding of the interrelation of sleep, 24-hour 
rhythms and health.
The mechanism behind sleep is thought to consist of two interacting processes.14 The first 
process, Process S, represents the homeostatic sleep drive, or sleep pressure. The longer you 
are awake, the stronger the sleep pressure. The sleep pressure declines during sleep. The 
second process, Process C, represents the circadian rhythm, driven by the suprachiasmatic 
nucleus or biological clock of the brain. This process is independent of prior sleep, and 
regulates the 24-hour rhythm of the sleep-wake pattern. In the studies described in this 
thesis, sleep parameters and 24-hour rhythm measures were only weakly to moderately 
related. This is reflected in the results. For example, unstable and fragmented rhythms 
related to mortality independent of sleep (Chapter 2.2). Also, brain pathology in the form 
of cerebral small vessel disease related to disturbed 24-hour activity rhythms, independent 
of sleep (Chapter 3.1).
In Chapter 2.2 I describe a significant U-shaped relationship between continuously analysed 
subjective sleep duration and mortality. However, this association was non-significant 
when adjusted for health parameters. U-shaped relationships between sleep duration 
and mortality have been described in several previous studies. Two meta-analyses found 
that both short and long self-reported sleep durations were predictors of mortality in 
cohort studies.15,16 In general, more profound associations between long sleep and all-
cause mortality were observed in the more extreme categories (≥9 hours). In our study, 
only few persons were extreme short or long sleepers. Consequently, we were limited in 
testing extreme sleep durations in our analyses. This might explain the attenuation of the 
curvilinear relation between sleep duration and mortality after further adjustment.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
General Discussion
141
4
With age, not only the number of sleep problems increase, also the prevalence of heart 
failure increases. Sleep disturbances have been reported in almost 70% of patients with 
heart failure.17 Prospective sleep studies demonstrated that short and long sleep durations 
increase the risk of cardiovascular disease.18-21 Furthermore, difficulty maintaining and 
initiating sleep are associated with incident heart failure.22 However, it was not known 
whether sleep quality in patients with heart failure changes over time (Chapter 2.3). We 
investigated the effect of clinical heart failure and subclinical cardiac dysfunction on sleep 
quality. We found that clinical heart failure, but not echocardiographic indicators of subclinical 
cardiac dysfunction, increased the risk of poor sleep quality in the general population during 
follow-up. This suggests that a poor sleep quality is only caused by severe heart failure, or 
that heart failure symptoms are on the causal pathway between cardiac dysfunction and 
sleep disturbances. Heart failure symptoms, such as restless legs or shortness of breath 
while lying flat, could cause disturbances in sleep and changes in the sleep-wake pattern. 
Heart failure and sleep problems could share common etiological mechanisms. For example, 
vascular pathologies could independently explain heart failure and sleep problems.23,24 In 
this thesis, I also discussed the association between cerebral small vessel disease, a form 
of vascular brain pathology, and sleep (Chapter 3.1). In this study, we did not find a relation 
between cereberal small vessel disease and total sleep time or sleep quality.
Brain structure and sleep
With increasing age, the brain undergoes several structural alterations, including loss of 
brain tissue and accumulation of vascular pathology. When mild, many of these changes 
may go unnoticed or do not cause overt clinical symptoms. However, even in the subclinical 
stage, such (small) brain changes can have an effect on health and behavior. In Chapter 
3.1 we studied the association between cerebral small vessel disease and 24-hour activity 
rhythm and sleep parameters. Cerebral small vessel disease causes structural brain damage, 
which may manifest as lacunar infarcts, white matter lesions or cerebral microbleeds.25,26 
These markers of cerebral small vessel disease are common in middle-aged and elderly 
persons, although they often occur unnoticed.27-29 We found that white matter lesion volume 
and presence of cerebral microbleeds were related to more unstable and fragmented 24-
hour activity rhythms, independent of total sleep time, and sleep quality. This indicates 
that subclinical brain damage affects circadian rhythms. Also, it indicates that sleep-wake 
disturbances commonly found in patients with stroke or Alzheimer’s disease may have 
arisen already early in the disease process before clinical signs are present. 
A factor possibly underlying the association between cerebral small vessel disease and 24-
hour activity rhythm disturbances is sleep apnea. Sleep apnea - characterized by repetitive 
respiratory events during sleep – can lead to reduced airflow, oxygen desaturation (hypoxia), 
arousals, and daytime sleepiness. If these respiratory events (apneas and hypopneas) occur 
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several times per hour, they can underlie the development of hypertension, cardiovascular 
disease and stroke.30-32 In Chapter 3.2 we assessed whether aspects of sleep apnea (the 
apnea-hypopnea index (AHI), nocturnal oxygen desaturation and arousals), were related 
to global structural brain changes. We found that the AHI - indicating the frequency of 
breathing pauses - and arousals were not related to gray and white matter brain atrophy 
or white matter lesion volumes. In contrast, nocturnal oxygen desaturation related to 
white matter atrophy. Because the association of oxygen desaturation and white matter 
atrophy was independent of blood pressure, total cholesterol and myocardial infarction, 
oxygen desaturation probably causes white matter atrophy directly. The association 
between cerebral small vessel disease and disturbed 24-hour activity rhythms (Chapter 3.1) 
could possibly be partly explained by oxygenation problems and fragmentation of sleep 
due to sleep apnea. In the study described in Chapter 3.1 we were only able to adjust the 
associations for possible sleep apnea. Possible sleep apnea was assessed by two questions 
from the Pittsburgh Sleep Quality Index.33,34 Adjustment for possible sleep apnea did not 
change the associations between cerebral small vessel disease and disturbed 24-hour 
activity rhythms. However, we could not account for oxygen desaturation as measured by 
polysomnography (PSG). 
Some previous studies found an association between sleep apnea severity and structural 
brain changes, although the reports are not consistent.35,36 In general, these studies had 
smaller sample sizes and were conducted in case-control designs using clinical sleep apnea 
patients versus healthy controls. Usually, associations described between sleep apnea and 
structural brain variation were less strong in the general population than in clinical samples. 
Persons with mild or moderate sleep apnea probably do not seek treatment and suffer less 
from the consequences of sleep apnea than those seeking treatment despite the same 
symptoms of sleep apnea. The advantage of studying diseases in a population-based setting 
is studying a broader range of the disease, including persons with mild signs of the disease 
and persons with severe signs. 
In Chapter 3.3 we studied the associations between brain structure and different sleep 
parameters, including sleep waves. Brain structure variations were related to beta power 
during NREM sleep: more gray matter volume was associated with more beta power. More 
beta power during the night is an indicator of hyperarousal. Hyperarousal causes problems 
falling asleep, fragmented sleep and short sleep duration. This is supported by our findings 
that more beta waves during NREM sleep were related to poor objective and subjective 
sleep quality, (i.e. a shorter total sleep time, less sleep efficiency, and poor sleep quality). 
In contrast to what we hypothesized, these associations were independent of reduced gray 
matter volumes. This suggests that gray matter brain structure does not account for the 
association between more beta power and poor sleep.
R1
R2
R3
R4
R5
R6
R7
R8
R9
R10
R11
R12
R13
R14
R15
R16
R17
R18
R19
R20
R21
R22
R23
R24
R25
R26
R27
R28
R29
R30
R31
R32
R33
R34
R35
R36
R37
R38
R39
General Discussion
143
4
In contrast, more white matter volume was related to more beta power. In line with this finding, 
higher fractional anisotropy - indicating better white matter microstructural integrity – also 
related to more beta power. Although beta power during sleep – indicating hyperarousal - 
is considered unfavourable, during the awake state, beta power is a meaningful signal. For 
example, beta power during wake is associated with better vigilance and cognition.37,38 It 
may be hypothesized that the important role of white matter in connectivity of brain regions 
during the day, is also reflected in more beta power at night. White matter volume was not 
directly related to sleep quality, including total sleep time. One possible explanation is that 
the effect between white matter and total sleep time is suppressed by beta power. In post-
hoc analyses, we found indications for a suppression effect of beta power between white 
matter and total sleep time. This suggests that the association between brain structure, 
specifically white matter, and total sleep time is obscured by the relation of white matter 
with beta waves. White matter and beta waves are inversely related to total sleep time. 
We found that persons with insomnia had smaller white matter volumes than good sleepers 
(Chapter 3.4). Furthermore, in persons with insomnia, smaller white and gray matter and 
hippocampal volumes were related to a shorter sleep duration and a poorer sleep quality. 
Vgontzas et al. (2013) suggested that there are two phenotypes of insomnia: one ‘biological’ 
phenotype in which insomnia patients have hyperarousal of the stress system and a short 
sleep duration, and one ‘psychological’ phenotype, including patients with a “normal” sleep 
duration and sleep misperception.39 Because of our large sample size, we were able to study 
the structural brain associations of several sleep parameters in persons with insomnia. 
Smaller total brain, white matter, gray matter and hippocampal volumes were associated 
with a shorter sleep duration, a lower sleep efficiency and a poorer sleep quality. This 
suggests that structural brain differences in persons with insomnia may underlie the severity 
of insomnia or that insomnia causes structural brain changes. Indeed, several studies point 
to an altered brain function as a possible substrate of insomnia.40 Persons with insomnia 
have more hyperarousal during sleep, as reflected by a greater brain metabolism and more 
beta activity.41,42 Furthermore, insomnia is characterized by problems in falling asleep or 
staying asleep, leading to daytime dysfunction because of fatigue during the day. This is 
in line with our finding that that higher beta waves during NREM sleep related to poorer 
objective and subjective sleep quality, represented by a shorter total sleep time, less sleep 
efficiency and poor sleep quality (Chapter 3.3).
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Methodological considerations
Analysing brain waves during sleep: Absolute or relative?
Measuring sleep using PSG makes it possible to study brain waves during sleep; 
electroencephalography (EEG) is central to PSG. In 1968 Rechtschaffen and Kales wrote “A 
Manual of Standardized Terminology, Techniques and Scoring for Sleep Stages of Human 
Subjects”. This manual contains a set of rules used for the scoring of sleep stages, also known 
as the R&K rules.43 In these rules EEG information was divided into 30-second epochs and 
the EEG information was used to categorize sleep into one of four sleep stages (stage 1-4, 
non-REM sleep) and REM sleep. The R&K rules were the most widely used sleep scoring rules 
until 2007, when the American Academy of Sleep Medicine updated the R&K scoring rules.44 
A major change was the combination of sleep stages 3 and 4 to form stage N3. Five different 
brain waves can be observed with EEG: delta (<4 Hz), theta (4 – 8 Hz), alpha (8 – 12 Hz), beta 
(12 – 40 Hz) and gamma (40 – 100 Hz). Delta waves are the slowest brain waves with the 
highest amplitude, and are associated with the deepest sleep (N3), also called slow wave 
sleep. The lighter sleep phases N1 and N2 are characterized by theta waves. Furthermore, 
sleep stage N2 is characterized by the occurrence of spindles and K-complexes. Alpha waves 
are most prominent when relaxing with eyes closed. Beta and gamma waves are associated 
with wakefulness. Too much beta and gamma power at night is associated with short total 
sleep time, low sleep efficiency and poor sleep quality (Chapter 3.3). 
Although the scoring of sleep stages is standardized according to the R&K scoring rules,43 or 
the updated rules of the AASM,44 such standardization is not used when studying brain waves 
during sleep directly. Some studies report absolute EEG power (Hz) and some report relative 
power (% of total power). This inconsistency causes difficulty in comparing different studies, 
but also causes differences in interpretation of the results reported. In the remaining part of 
this paragraph I will discuss the advantages and disadvantages of reporting about absolute 
and relative EEG power.
The advantage of analysing brain waves with relative EEG power is that the effects of the 
different brain waves within one study are easily comparable; each brain wave is expressed 
as percentage of the total EEG power. In other words, the brain waves are standardized 
by using relative EEG power. Furthermore, EEG patterns during sleep are highly person-
specific.45 Persons can be distinguished by their particular EEG topographic distribution. 
Relative EEG power measures can account for these individual differences in total absolute 
EEG power and thereby making comparisons between individuals easier. Relative EEG power 
is typically used as a measure when patient and control groups are compared. For example, 
Perlis et al. (2001) compared delta and beta patterns during sleep in patients with primary 
insomnia, patients with major depression (secondary insomnia) and good sleeping controls.46 
The authors found that each of these groups have characteristic temporal delta and beta 
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patterns during sleep. For example, primary insomniacs have more relative beta during 
the night compared to secondary insomniacs and good sleepers. Secondary insomniacs on 
the other hand have less relative delta power compared to primary insomniacs and good 
sleepers. The disadvantage of such outcome reports based on relative EEG power, is that 
the reader is left in doubt about what happens with the absolute EEG power. For example, if 
over time the total EEG power is higher, and absolute delta and beta power did not change, 
relative delta and beta power is decreased. Therefore, interpreting relative EEG power can 
be difficult.
Absolute EEG power measures are easier to interpret. By definition, a higher absolute level 
of a specific wave can only be interpreted as more power of that specific wave. Relative 
EEG power can be used to standardize absolute EEG power, but z-scores can also be used. 
Z-scores make the effect size of estimates of different waves better interpretable. However, 
this comes at a price, the effect estimate is more difficult to interpret. In our studies, we 
analysed absolute delta and beta power in relation to brain structures in Chapter 3.3. 
However, the disadvantages of absolute EEG power measures are: 1) that this measure can 
be influenced by the equipment used; 2) groups of individuals differ in the total amount of 
absolute EEG power due to the specific set-up; and 3) the results can only be interpreted 
against the background of total sleep time: the longer someone sleeps, the more absolute 
sleep-EEG power occurs and is recorded. To account for the total sleep time in the association 
of white matter brain volume and white matter microstructure with beta power (Chapter 
3.3), we performed two sensitivity analyses (results available upon request). First, we 
additionally adjusted the association between white matter volume and beta power during 
sleep for total sleep time. Second, we repeated these analyses limiting the assessment to 
the first four hours of sleep. In this way almost every participant had the same total sleep 
time. Importantly, our results did not change. 
To make comparison between different studies easier, I suggest a standardized method for 
the reporting of EEG power. To make the biological interpretation the most straightforward, 
it is important to report the absolute EEG power. However, to additionally report the relative 
EEG power makes the comparison between studies feasible. 
Multicollinearity
Multivariate regression models comprise many variables; most covariates are included to 
adjust the association of interest for possible confounding. However, multicollinearity (also 
called collinearity) can occur if two predictors in one multiple regression model are highly 
correlated. This can lead to unreliable effect estimates. For example, length and weight both 
are measures of body proportions. Therefore, these variables are highly correlated. Let’s 
assume the following hypothetical analysis. The length of a person predicts the income of 
this person. When weight would be added as covariate in the model of length and income, 
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it will most probably partly explain the same variance of income. Therefore, when both 
length and weight are included in this model, the model could render them both statistically 
insignificant, even though they are individually related to the outcome.
A method often used to detect multicollinearity is the variance inflation factor (VIF). The VIF 
is calculated as 1/(1-R2), where R2 (coefficient of determination) is obtained by regressing 
the predictor of interest on all the other predictors.47 R2 indicates the percentage of the 
explained variance. The VIF estimates the inflation of the variance of an effect estimate 
due to the linear correlation with other covariate(s). Therefore, the VIF is dependent on the 
complete model tested, and can differ for two variables depending on the association of 
interest. For example, a VIF of 3 reflects a three times larger variance of a specific variable 
(the square root of the variance is the standard deviation), that stems from the correlation 
with other variables. This can result in a large effect estimate, disappearance of the effect, 
or even to a change in the direction of the estimated association. In epidemiological and 
statistical literature, no standard recommendation is provided for the maximum acceptable 
VIF value. Published recommendations for VIF values range from 2.5 – 10.47,48 Note that the 
VIF can be calculated for each covariate; it is however most important for the determinant 
of interest, because only the variance of the relevant effect estimate is increased. In other 
words, if a high VIF occurs between two confounders this typically does not influence the 
main association studied.47
In neuroscience and epidemiological research of brain morphology, correction for differences 
in individual head sizes are often conducted by adjusting for intracranial volume (ICV) or by 
expressing brain volumes as percentage of the ICV. The ICV comprises total brain volume 
(white matter, gray matter and white matter lesion volumes) and cerebral spinal fluid, and 
is thought to remain stable over time as it reflects maximum attained head size. Especially 
the total brain volume is highly correlated with the ICV (In the Rotterdam Study r = 0.9, 
p<0.001). This can potentially introduce the problem of multicollinearity. I will illustrate this 
with an example of my own research (Chapter 3.4).
The Rotterdam Study includes middle-aged and elderly persons. We observe brain atrophy 
in older persons, i.e. gray and white matter volumes decrease in age. This process is often 
accompanied by an increase in white matter lesion volume, as a marker of accumulation 
of vascular pathology with age. However, the ICV generally does not change with ageing.49 
Therefore, the correlation between ICV and white and gray matter volumes may change 
with age. In an older population, adjusting for ICV and likewise expressing brain volumes 
as percentage of ICV can be used to estimate brain atrophy, i.e. the current brain size is 
adjusted for the maximum size attained during life. In the insomnia study described in this 
thesis (Chapter 3.4), we found a high correlation (r = 0.9) and a high VIF (8.6) between 
total brain volume and intracranial volume. Therefore, we decided not to adjust total brain 
volume for ICV. However, many studies that express brain structural volumes as percentage 
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of ICV, do not take multicollinearity into account. The high correlation between ICV and total 
brain volume in this study suggests that the amount of brain atrophy was small. On the other 
hand, in our study of sleep apnea and brain structure (Chapter 3.2) we deliberately adjusted 
analyses for ICV. In that study the VIF was always smaller than 2 for the determinant of 
interest. 
To get more insight into the issue of multicollinearity in epidemiologic brain research, I 
suggest that studies report the VIF of their determinant of interest. With a moderate to high 
VIF (for example a VIF > 5), studies should report the analyses both adjusted and unadjusted 
for ICV to get more insight in the possible effects of multicollinearity.
Fragmentation of the circadian rhythm and chronotype
Different persons have different chronotypes. So-called ‘morning types’ prefer to rise up and 
sleep in early, ‘evening types’ prefer to rise up and sleep in late. This preference probably 
depends on the functioning of the biological clock, located in the suprachiasmatic nucleus of 
the brain, and on the synchronisation of this biological clock by external cues of time (“The 
Zeitgebers”), such as light, temperature and exercise. The process of synchronisation by the 
environment is termed entrainment. 
A person’s chronotype impacts daily functioning, especially because most people are bound 
to work, school or social life. Most work or school times are scheduled between 9.00 and 
17.00. In general, whereas morning types will not experience problems with this schedule, 
evening types certainly may. For example, an evening type that prefers to go to bed at 
3.00, has problems waking up at 7.00, especially when this happens 5 times a week. As a 
consequence, many persons have to sleep in on weekends, to compensate for the sleep 
deprivation during the week. This misalignment is called ‘social jetlag’. 
Most sleep and circadian rhythm researchers investigate circadian rhythms as determinants 
without taking chronotype into account. However, chronotype information can add 
specificity to the associations studied, or chronotype can confound the association between 
circadian rhythms and the outcome of interest. For example, if the consequences of 
working night-shifts are studied, the consequences might be underestimated for morning 
types since this subgroup of exposed persons experiences more problems working night-
shifts than evening types. In general, persons around age 20 have the latest chronotypes, 
whereas older persons usually have earlier chronotypes.50 Therefore, older persons will in 
general have more problems with night-shifts compared to younger persons. On the other 
hand, evening types might perform poorer at school or during early working hours, because 
of daytime sleepiness and attention problems.51 Furthermore, the association between 
chronotype and sleep duration depends on time of week. When studying the average sleep 
duration per week, chronotype and sleep duration are not related. However, when sleep 
duration is analysed separately for free days and work days, sleep duration depends on 
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chronotype: the later a person’s chronotype, the longer he or she sleeps at free days and 
shorter at work days.50 
Erren and Gross (2015) wrote a letter to the editor of American Journal of Epidemiology 
about our article of circadian activity rhythms and mortality (Chapter 2.2).52 The authors 
suggested that chronotype data should have been incorporated in our study.
In our response to this letter to the editor (Chapter 2.2a), we investigated the influence of 
chronotype information on the association between disturbed circadian activity rhythms 
and all-cause mortality. First, we added employment status as a proxy of social timing as 
potential confounder in the association of circadian activity rhythms and mortality. Cohort 
studies, such as the Rotterdam Study, usually cover a large age range, including workers and 
non-workers (for example persons who are retired). Usually, non-workers are less bound by 
schedules, and therefore can live to their biological clock accordingly. Second, we calculated 
the difference in time in bed and midpoint of sleep between weekend and week days as 
measures of circadian misalignment in workers and non-workers.13 Circadian misalignment 
is subject to the interaction of chronotype and social or working times: earlier chronotypes 
show more circadian misalignment than late chronotypes when working evening or nights 
shifts, whereas late chronotypes show more circadian misalignment when working morning 
shifts. Adjustment for employment status did not influence our results: unstable and 
fragmented circadian activity rhythms predicted mortality independent of employment 
status. Yet, workers showed more circadian misalignment than non-workers. Workers 
spent over an hour more in bed during weekends than on weekdays and went to bed later. 
Their average midpoint of sleep varied between 3:27 (weekdays) and 4:20 (weekends). 
In contrast, non-workers spent only half an hour more in bed during weekends, and their 
average midpoint of sleep varied between 4:00 (weekdays) and 4:16 (weekends).
Employment status, chronotype, bedtimes and wake up times can all be assessed by 
questionnaire, although bed and wake up times are more precisely estimated when measured 
objectively. However, the question arises: Can the nonparametric circadian activity rhythms 
parameters stability and fragmentation add additional information to typical chronotype 
measures? Unstable activity rhythms are related to larger differences in time spent in 
bed and to larger differences in the midpoint of sleep on weekdays versus weekends. 
This suggests that chronotype data or circadian misalignment can be partly captured with 
actigraphy. However, fragmentation was not related to the circadian misalignment. Thus, I 
argue that fragmentation cannot be estimated subjectively. Therefore, when investigating 
circadian activity rhythms, both chronotype data and fragmentation should be incorporated 
into study protocol and assessments. 
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Clinical implications
In this thesis I studied the importance of sleep and circadian activity rhythms in relation 
to several health parameters. Although the participants of the studies in this thesis were 
derived from the general population and not from patient groups with a clinical diagnosis 
of sleep or circadian rhythm problems, I think the results of these studies have implications 
for clinical practice. 
Circadian activity rhythm as a marker of general health
Sleep problems are common in the elderly population. Poor sleep quality has been associated 
with physical disabilities, depressive symptoms, cognitive impairment and morbidity.1,53 In 
this thesis, I showed that not only sleep parameters, but also the circadian activity rhythm 
is important for health. In fact, in my studies of sleep and circadian activity rhythms with 
mortality and cerebral small vessel disease, the circadian activity rhythm had a stronger 
and independent association with mortality and cerebral small vessel disease than the 
sleep parameters (Chapters 2.2 and 3.1). Furthermore, disturbances in the circadian activity 
rhythm were also related to poor cognitive functioning and more depressive symptoms 
(Chapter 2.1). I hypothesize that the circadian activity rhythm is a marker of general health. 
This implicates that changes in the circadian activity rhythm reflect or indicate changes in 
different domains of health. I would like to distinguish two pathways, although they are 
certainly not exclusive. First, it could be that this general health marker is etiologically involved 
in general health; it is an intermediate on the causal pathway. This means, that problems in 
the circadian rhythm cause health problems such as cardiovascular disease or neurological 
disorders. It also implies that treatment of circadian rhythm disturbances could improve the 
health of a person. Second, the circadian rhythm could change because of underlying health 
problems. The circadian rhythm is only a marker signaling disease or disease processes. In 
this case treatment of the circadian rhythm disturbances might, if anything, relieve some 
symptoms, but will not truly improve general health and prognosis. In any case, information 
on the circadian rhythm of a patient should aid healthcare professionals to better monitor 
the effectivity of interventions. More longitudinal epidemiological studies with repeated 
assessments of the circadian rhythm are needed to improve our insight in whether circadian 
rhythms are cause and/or consequence of pathophysiological processes. 
Further, there is initial evidence that the circadian rhythm influences the effect of taking 
medications at different time points.54 Some drugs may have an optimal time of day to be 
administered and their effect may be decreased when taken at a different time point. This 
implies that a disturbed circadian rhythm will not only be unfavorable for general health, 
but it might directly reduce the effectiveness of pharmacotherapy. 
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Circadian activity rhythm as a marker of early disease
Disturbances in circadian activity rhythms might also be an early sign of disease. Patients 
with Alzheimer’s disease and other types of dementias suffer from circadian rhythm 
disturbances, such as high activity levels at night.10 These patients frequently have structural 
brain damage, a part of which is caused by cerebral small vessel disease. Our finding that 
cerebral small vessel disease is related to disturbed 24-hour activity rhythms suggests that 
the disturbances seen in the sleep-wake rhythm in Alzheimer’s patients arise early in the 
disease process before clinical signs are present (Chapter 3.1). Possibly, therapy aimed at 
improving the circadian rhythm, such as exercise or light therapy, can delay the progression 
of this disease.
Suggestions for future research
Future research is needed to study whether the associations between sleep/circadian 
rhythm parameters and brain structure are indeed bidirectional or whether problems in one 
of the two primarily causes problems in the other. A limitation of our studies of sleep and the 
brain was the cross-sectional design. Therefore, we were not able to study the temporality 
of the associations. One possibility is that a better brain health at older age can lead to a 
better sleep quality. Better brain health can be attained by prevention of vascular damage 
(a main cause of white matter lesions) and atrophy. Another possibility is that by improving 
sleep quality, the general health, and thereby brain health of persons is improved. Xie et al. 
(2013) found that during sleep potentially neurotoxic waste products are removed from the 
brain interstitial space.55 Problems in this sleep-process can lead to brain damage. To find 
out which preventive strategy will be more successful, more has to be known about the 
temporality of the associations (cause and effect). Nevertheless, healthcare professionals 
have to realize that persons with brain disorders often have sleep disturbances, and the 
other way around, persons with sleep problems might have (subclinical) brain damage. In 
the Rotterdam Study, the second time point measurement of actigraphy is now available. 
Together with the multiple MRI measurements that are already available in the Rotterdam 
Study, this will be one of the few cohorts that will be able to study the longitudinal relation 
of objective sleep and circadian rhythm parameters with brain structure, and thereby be 
able to assess reversed causality, and the directionality of the association between brain 
structure and sleep.
Information on the direction of effect is also important for treatment. For example, is 
treatment focussing on brain health, e.g. by treating cardiovascular risk factors, also 
beneficial for sleep disorders and age-related sleep complaints? Is treatment focussing on 
improving sleep and circadian rhythms, e.g. by light therapy or increasing exercise during the 
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day, beneficial for a healthy brain and survival? An interesting start for this kind of research 
might be in insomnia patients in whom we found that structural brain variations seem to 
underlie insomnia. Furthermore, sleep and the brain could be investigated by comparing 
persons with a sleep disorder (e.g. insomnia) and structural brain damage with sleep 
disorder patients without brain damage. Or vice versa: study persons with structural brain 
damage, such as stroke or Alzheimer’s disease patients, and compare patients with and 
without sleep problems. This will indicate which risk and protective factors are important 
for sleep and a healthy brain.
In our studies, the associations between sleep and the brain were not straightforward. 
For example, in Chapter 3.3 structural brain variation was not related to objective total 
sleep time, sleep efficiency and subjective sleep quality. On the other hand, in Chapter 
3.4 we found that the size of brain structures corresponded to the severity of insomnia. 
More research is needed to get better insight in the relation between sleep and the brain. 
First, structural brain variation is possibly only in specific brain regions related to sleep 
parameters. We measured global gray and white matter volumes, but we did not investigate 
specific lobes or smaller brain regions. Also, with our PSG analyses we only studied EEG 
power estimated from lead C3/A2. The combination of using more electrodes during PSG 
and studying brain structures in more specific regions may provide more information about 
the association of sleep and the brain. Second, brain function might have a more important 
role than brain structure in the association with sleep. Studies measuring brain function, e.g. 
using functional MRI, could perhaps shed more light on this. An important caveat, however, 
is that brain activity differs during day and night-time, and that performing functional MRI 
during sleep is practically very challenging. 
Research on the associations between PSG and circadian rhythm measures is scarce. The 
Rotterdam Study is one of the few population-based studies that implemented both ambulant 
PSG and actigraphy. Although sleep and the circadian rhythm are two different processes, 
they are closely related. As described above, the mechanism behind sleep is thought to 
consist of two interacting processes14: Process S, representing sleep pressure, and Process 
C, representing the circadian rhythm. Following this theory, disturbed circadian rhythms 
will impair sleep, but also sleep problems can disturb the circadian rhythm. To illustrate, 
sleep apnea is characterized by cessation of breathing, but also by light sleep and waking up 
during sleep, causing fragmented sleep. This sleep fragmentation will automatically lead to 
more fragmentation over a 24-hour day. Increased fragmentation is an important circadian 
activity rhythm measure related to depressive symptoms and mortality. More research is 
needed to study the associations between PSG and circadian rhythm measures, to get more 
insight in the interrelation of sleep and circadian rhythms. This will aid the about 80% of 
elderly persons with sleep complaints. 
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Furthermore, much is unknown about the influence of genetics on sleep. Genetic studies 
to sleep have been only limitedly successful. Probably, this is partly due to the use of 
subjective sleep measures. Sleep questionnaires are usually not very specific. For example, 
women report poorer sleep than men.56 Therefore, very large numbers are needed to find 
associations between genetics and sleep. Currently, the amount of polysomnographic data 
is increasing, opening ways for large collaborative efforts to address these issues. Future 
genetic research can benefit from this increase in objective sleep parameters.
Concluding remarks 
Sleep, 24-hour activity rhythms and the brain are three very important factors for a healthy 
life. With my thesis I brought these factors together in a middle-aged and elderly population. 
This unique project combined polysomnography, actigraphy and MRI and pointed out the 
complex nature of the relations between sleep, 24-hour activity rhythms and the brain. I 
believe that the combination of the interesting fields of sleep and the brain will reveal much 
more fascinating insights in the future.
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Summary
A good night of sleep is very important for a healthy life (Chapter 1). However, sleep problems 
and circadian rhythm problems are very common, especially in the older population. About 
80% of the elderly report sleep complaints. For example, elderly persons report trouble 
falling asleep, waking up too early, a low sleep quality, involuntary napping during the day, 
and obtaining not enough sleep during the night. The sleep and circadian rhythm changes 
with ageing are paralleled by structural brain changes that are also more prevalent in elderly 
populations. Typical brain changes observed in elderly populations are loss of brain tissue 
(i.e. cerebral atrophy), cerebral vascular lesions, and reduced connectivity between brain 
areas. These brain changes often occur unnoticed. However, even small brain changes can 
affect health and behavior. To date, there is only scarce knowledge whether brain changes 
typically observed in an ageing population relate to altered sleep patterns. The aim of this 
thesis was to investigate the associations between sleep, 24-hour activity rhythms and 
health parameters in a middle-aged and elderly population, particularly focusing on the 
relation between sleep and age-related structural brain changes. The analyses performed in 
this thesis were based on data from the Rotterdam Study, a large population-based cohort 
among adults aged 45 and over living in Rotterdam, the Netherlands.
In Chapter 2 I describe the associations between sleep, 24-hour activity rhythms and several 
health aspects. Chapter 2.1 describes the influence of demographics, lifestyle and sleep 
on 24-hour activity rhythms. 24-Hour activity rhythms were quantified by the stability 
and the fragmentation of the rhythm. Older age was associated with a more stable and a 
more fragmented 24-hour activity rhythm. Furthermore, a high body mass index, smoking 
and having more depressive symptoms were related to unstable and more fragmented 
rhythms. This suggests that stability and fragmentation of the 24-hour activity rhythm 
are important for major health issues in elderly. In Chapter 2.2 we studied the mortality 
risk of sleep and 24-hour activity rhythms. Whereas sleep measures were not related to 
mortality after adjustment for health parameters, unstable and fragmented activity rhythms 
were related to a higher all-cause mortality risk. This strengthens the idea that disturbed 
circadian activity rhythms reflect age-related alterations in the biological clock and could 
be an indicator of disease. Chapter 2.2 was extended with Chapter 2.2a. In this chapter 
I discuss the influence of circadian misalignment to the circadian activity rhythm and 
mortality association. Circadian misalignment refers to the difference between the timing of 
sleep on workdays compared to weekend days. I describe that although employment status 
did not influence the associations between the 24-hour activity rhythm and mortality, more 
circadian misalignment was observed in employed participants compared to unemployed 
participants. Furthermore, this circadian misalignment was associated with the stability of 
the activity rhythm. However, circadian misalignment indicators did not predict mortality. 
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In Chapter 2.3 I present a study on the differential effects of clinical heart failure and 
echocardiographic indicators of cardiac dysfunction on sleep quality. Clinical heart failure 
predicted a reduction of sleep quality in longitudinal assessment. This association was 
driven by the sleep onset latency and sleep quality components of the Pittsburgh Sleep 
Quality Index. Cardiac dysfunction, measured by echocardiography, was not related to 
sleep quality in cross-sectional or longitudinal analyses. These findings suggest that clinical 
manifestations of heart failure negatively affect sleep.
In Chapter 3 associations between sleep, 24-hour activity rhythms and structural brain 
parameters are reported. Chapter 3.1 discusses the relation of cerebral small vessel disease 
with disturbed 24-hour activity rhythms. Cerebral small vessel disease may manifest as 
lacunar infarcts, white matter lesions or cerebral microbleeds. I found that white matter 
lesion volume and presence of cerebral microbleeds are related to disturbed activity 
rhythms. This suggests that subclinical brain damage affects the 24-hour activity rhythm. 
In Chapter 3.2 I investigate different aspects of sleep apnea, the apnea-hypopnea index 
(AHI), nocturnal oxygen desaturation and arousals, in relation with brain structure. Only 
nocturnal oxygen desaturation was related to white matter brain atrophy. The amount of 
apneas, hypopneas or sleep apnea related arousals did not explain this association. Chapter 
3.3 describes the associations between brain structure and sleep parameters, measured 
both objectively with polysomnography and subjectively. The results demonstrated that 
brain structure was not associated with delta power (slow wave sleep), but it related to 
beta power during NREM sleep. Beta power during wake is associated with vigilance and 
cognition. Gray matter atrophy was associated with more beta power, white matter atrophy 
and less white matter integrity were related to less beta power. Also, more beta power 
was associated with a shorter total sleep time, a lower sleep efficiency and poor subjective 
sleep quality, all indicating poor sleep. However, these associations were independent of 
brain structural variations. Beta power during sleep is considered unfavorable, causing 
hyperarousal, but during wake beta power is a meaningful signal. Probably, the important 
role of white matter in connectivity of brain regions during the day, is also reflected in more 
beta power at night. In Chapter 3.4 differences in brain morphology between insomnia 
cases and good sleepers are explored. I found that persons with insomnia complaints had 
smaller white matter volumes compared to the good sleepers, suggesting that structural 
brain variations underlie insomnia, or that insomnia causes structural brain variations. 
Moreover, the size of brain structures corresponded to the severity of insomnia: a smaller 
white matter volume was related to a lower sleep efficiency, a smaller gray matter volume 
was related to a poorer sleep quality, and a smaller hippocampal volume was related to a 
shorter sleep duration and to a poorer sleep quality.
In Chapter 4 I review the main findings of this thesis. Furthermore, in this chapter I discuss 
methodological considerations, clinical implications and suggestions for future research.
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Samenvatting
Een goede nachtrust is belangrijk voor een gezond leven (Hoofdstuk 1). Slaapproblemen 
en problemen met het circadiaans ritme komen veel voor, vooral in de oudere populatie. 
Ongeveer 80% van de ouderen heeft slaapklachten. Ouderen hebben moeite met in slaap 
vallen, worden te vroeg wakker, rapporteren een slechte slaap kwaliteit, doen (al dan niet 
ongewild) dutjes overdag en krijgen niet genoeg slaap tijdens de nacht. Naast veranderingen 
in slaap en circadiaans ritme, komen ook structurele hersenveranderingen bij ouderen meer 
voor. Kenmerkende hersenveranderingen bij ouderen zijn een verlies aan hersenweefsel 
(cerebrale atrofie), cerebrale vasculaire laesies en een verminderde connectiviteit tussen 
hersengebieden. Deze hersenveranderingen worden door ouderen zelf niet altijd opgemerkt. 
Desondanks kunnen deze kleine hersenveranderingen gezondheid en gedrag beïnvloeden. 
Er is nog weinig bekend over de relatie tussen leeftijdsgerelateerde hersenveranderingen en 
veranderende slaappatronen. Inzicht in de relatie tussen deze veelvoorkomende problemen 
is belangrijk voor klinische oplossingen. In dit proefschrift onderzoek ik de relaties tussen 
slaap, het 24-uurs bewegingsritme en gezondheidsparameters, met name structurele 
hersenveranderingen gerelateerd aan ouderdom, in mensen van 45 jaar en ouder. Al deze 
mensen namen deel aan het Erasmus Rotterdam Gezondheid Onderzoek (ERGO), een 
groot bevolkingsonderzoek onder mensen van 45 jaar en ouder die in de wijk Ommoord in 
Rotterdam wonen. 
In Hoofdstuk 2 beschrijf ik de relatie tussen slaap, 24-uurs bewegingsritmes en verschillende 
gezondheidsfactoren. Hoofdstuk 2.1 laat zien hoe demografische kenmerken, lifestyle en 
slaap samenhangen met het 24-uurs bewegingsritme. Hiervoor bestudeerden wij de stabiliteit 
en fragmentatie van het 24-uurs bewegingsritme, gemeten met actigrafie. Een oudere 
leeftijd was geassocieerd met zowel een meer stabiel als een meer gefragmenteerd 24-uurs 
ritme. Daarnaast waren een hoge BMI, roken en meer depressieve symptomen gerelateerd 
aan onstabiele en gefragmenteerde 24-uurs ritmes. Dit suggereert dat de stabiliteit en 
fragmentatie van het 24-uur bewegingsritme belangrijk zijn bij gezondheidsproblemen 
in ouderen. In Hoofdstuk 2.2 zijn slaap en het 24-uurs bewegingsritme gebruikt 
om het overlijdensrisico te voorspellen. Hoewel slaap niet gerelateerd was aan het 
overlijdensrisico als er rekening werd gehouden met verschillende gezondheidsparameters, 
waren onstabiele en gefragmenteerde 24-uurs ritmes wel gerelateerd aan een hoger 
overlijdensrisico. Deze bevindingen versterken de hypothese dat verstoorde circadiaanse 
ritmes leeftijdsgerelateerde veranderingen in de biologische klok weergeven, waarmee 
zij een indicatie voor een slechtere gezondheid zijn. In aanvulling op deze bevindingen 
bespreek ik in Hoofdstuk 2.2a hoe ‘sociale jetlag’ een rol kan spelen in de relatie tussen het 
24-uurs ritme en de kans op overlijden. De ‘sociale jetlag’ refereert naar het verschil in het 
‘biologische’ ritme en het ‘sociale’ ritme, het ritme dat door de omgeving opgelegd wordt, 
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bijvoorbeeld door werk en kinderen. Ondanks dat de relatie tussen een verstoord 24-uurs 
ritme en de kans op overlijden niet verdwijnt als er gecontroleerd wordt voor werkstatus, 
hebben werkende mensen wel meer last van een ‘sociale jetlag ’ dan mensen die niet (meer) 
werken. De ‘sociale jetlag’ was geassocieerd met stabiliteit van het 24-uurs ritme, maar 
voorspelde zelf niet het overlijdensrisico. Hoofdstuk 2.3 gaat over de effecten van klinisch 
hartfalen en verminderde hartfunctie (gemeten met echocardiografie) op de subjectieve 
slaapkwaliteit. Klinisch hartfalen voorspelt het rapporteren van een slechte slaapkwaliteit 
(Pittsburgh Sleep Quality Index) en het langer duren van het inslaap vallen. Een verminderde 
hartfunctie was niet gerelateerd aan gerapporteerde slaapproblemen. Dit suggereert dat de 
ernst, of het bewustzijn, van hartfalen de slaap negatief beïnvloeden.
In Hoofdstuk 3 bespreek ik de associaties tussen slaap, 24-uurs bewegingsritmes en de 
hersenstructuur. Hoofdstuk 3.1 gaat over de relatie tussen schade aan kleine bloedvaten 
in de hersenen, zoals schade aan de witte stof en microbloedingen, en verstoorde 24-uurs 
ritmes. Ik heb gevonden dat een groter volume van de beschadigingen aan de witte stof en 
meer cerebrale microbloedingen gerelateerd zijn aan meer verstoorde 24-uurs ritmes. Dit 
impliceert dat subklinische hersenschade het 24-uurs ritme beïnvloed. In Hoofdstuk 3.2 
heb ik verschillende factoren van slaap apneu onderzocht, de apneu-hypopneu index (AHI), 
nachtelijk zuurstoftekort en arousals (‘word wakker’ reflex) in relatie met hersenstructuur. 
Alleen het nachtelijke zuurstoftekort was gerelateerd aan witte stof atrofie. Hoofdstuk 
3.3 beschrijft de associaties tussen hersenstructuur met objectieve slaapparameters 
(gemeten met polysomnografie) en subjectieve slaapparameters. Hersenstructuur was niet 
gerelateerd aan delta golven, die voornamelijk zichtbaar zijn tijdens de diepe slaap, maar 
wel aan de hoeveelheid bèta golven tijdens de non-REM-slaap. Bèta golven zijn gerelateerd 
aan alertheid. Een groter grijze stof volume was geassocieerd met minder bèta golven, 
terwijl een groter witte stof volume en betere witte stof integriteit geassocieerd waren aan 
meer bèta golven. Meer bèta golven tijdens de NREM slaap relateerden aan een kortere 
totale slaaptijd, minder slaap efficiency en een slechte subjectieve slaapkwaliteit, dus aan 
een slechtere slaap. Deze associaties tussen bèta golven en slaap waren onafhankelijk van 
hersenstructuur. Mogelijk  verklaart de belangrijke relatie tussen witte stof verbindingen 
en bèta golven tijdens de dag, de verhoogde hoeveelheid bèta golven tijdens de nacht. In 
Hoofdstuk 3.4 heb ik verschillen in hersenstructuur tussen mensen met subjectieve insomnie 
klachten en goede slapers onderzocht. Ik heb gevonden dat mensen met insomnie klachten 
een kleiner witte stof volume hebben. Dit suggereert dat variaties in hersenstructuur 
ten grondslag liggen aan insomnie, of dat door insomnie klachten hersenveranderingen 
ontstaan. Bovendien hing binnen mensen met insomnie, de grootte van hersenstructuren 
samen met de ernst van insomnie: een kleiner witte stof volume was gerelateerd aan een 
lagere slaap efficiëntie, een kleiner grijze stof volume was gerelateerd aan een slechtere 
slaap kwaliteit en een kleinere hippocampus was gerelateerd aan een kortere slaapduur en 
een slechtere slaapkwaliteit.
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In Hoofdstuk 4 bespreek ik de hoofdbevindingen van dit proefschrift. Daarnaast bespreek 
ik in dit hoofdstuk methodologische overwegingen, klinische implicaties en suggesties voor 
toekomstig onderzoek.
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